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CHAPTER 1 
General Introduction 

GENERAL INTRODUCTION 
HYPERTENSION 
Hypertension or high blood pressure is a condition which is found in approxi-
mately 10 percent of the adult population It is one of the major risk factors for 
cardiovascular morbidity and mortality. Despite more than 30 years of intensive 
research, the underlying cause of the elevated blood pressure is unknown in the 
majority of the cases, so they are referred to as primary or essential hyperten-
sion. Only in about 10 percent of the patients a somatic cause for the elevated 
blood pressure can be found, for example renal parenchymatic diseases, 
stenosis of a renal artery or adrenal causes. There are indications that primary 
hypertension is a multifactorial condition, a concept originally brought forward 
by Page in his Mosaic Theory in 1949 [1] and revised by him in 1982 [2]. The 
frequency of primary hypertension is higher in subjects with disorders in 
carbohydrate and lipid metabolism, pointing to a general disorder with multiple 
symptoms, either alone or in combination [3,4] 
Different kinds of pharmacological therapies can be used to decrease blood 
pressure in primary hypertensive subjects Among others, diuretics, inhibitors of 
the angiotensin converting enzyme (ACE) and a- and li-adrenergic receptor as 
well as Ca2+-antagomsts are used successfully in the therapy of hypertension 
[5] Since these drugs have quite different modes of action, it is likely that they 
interfere with one of the elements of the mosaic rather than to cure a common 
cause Moreover, the mechanism of action of e.g the ß-adrenergic receptor 
antagonists in the decrease of blood pressure is still not fully understood [6], 
which further illustrates the lack of knowledge on the (patho)physiological 
regulation of blood pressure 
Relation between primary hypertension and the sympathetic nervous system 
One of the main elements in the mosaic is the neural element This contains 
both the central nervous system and the autonomic nervous system, the latter 
consisting of both central and peripheral parts. The autonomic nervous system 
can also functionally be divided into the parasympathetic and (ortho)sympa-
thetic nervous system (SNS) The SNS has multiple and strong relations with 
the modulation of the circulation, and one of its actions is the regulation of 
vascular tone Therefore, a relation between alterations in the SNS and primary 
hypertension has been suggested [7] Activation of the SNS results in a release 
of noradrenaline in the synaptic cleft which can induce an effect through 
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postsynaptic adrenergic receptor stimulation on the target organs, like e.g. the 
blood vessels. Alterations m these postsynaptic adrenergic receptors therefore 
may be important in the pathogenesis and maintenance of the primary hyperten-
sive state. 
Because direct measurements of SNS activity are difficult to accomplish, 
several indirect methods have been suggested in the literature. One of them is 
the determination of venous plasma catecholamine concentrations. However, it 
is still a matter of debate whether plasma catecholamines are elevated in 
primary hypertension [8] Alternatively, the density and function of the post-
synaptic adrenergic receptors can be determined. This can be achieved by 
studying the characteristics of vascular adrenergic receptors or by using the 
adrenergic receptors present on circulating blood cells as a model system for 
these vascular adrenergic receptors [9] 
ß-Adrenergic receptors and their coupling to second messengers 
ß-adrenergic receptors 
ß-Adrenergic receptors are one of the most studied receptor systems in the 
literature. These receptors are widespread throughout the body, and play a role 
in the regulation of cardiac function, control of smooth muscle tone in e.g. the 
bronchi and the vasculature, and management of fat cell activity. There are 
three subtypes of ß-adrenergic receptors: ß1 -adrenergic receptors are mainly 
found in the heart, ß2-adrenergic receptors are present on vascular and bron-
chial smooth muscle cells as well as in the heart and on mononuclear leucocytes 
and ß3-adrenergic receptors, formerly called 'atypical' ß-adrenergic receptors, 
are identified on fat cells [10] 
The structure of ß-adrenergic receptors, resolved by molecular biological 
techniques, was found to be a monomeric glycoprotein of 413 amino acids, 
located in the plasma membrane As shown in Fig 1, it contains 7 transmem-
brane regions, ι e. parts of the molecule crossing the plasma membrane, 
together with extra- and intracellular loops [11] This structure appears to be 
characteristic for receptors that are coupled to so-called G-proteins, which serve 
as signal transducing molecules between these receptors and either enzymes 
which synthesize second messengers or ion channels. The second messengers 
in turn mediate the cellular effects of receptor stimulation [12]. 
Deletions and substitutions of the ß-adrenergic receptor by molecular biologi-
cal techniques have revealed the sites on the protein which are important for 
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receptor function. The transmembrane regions of the ß-adrenergic receptor are 
involved in the binding of agonists and antagonists [11]: Aspartic acid residues 
at position 79 (2nd transmembrane region) and 130 (3rd transmembrane region) 
have been identified as the binding sites of agonists [13]. The intracellular loops 
have a function in the binding of G-proteins [14]. Moreover, phosphorylation of 
specific regions of the intracellular loops affects receptor function, and therefore 
is an important mechanism in receptor regulation [15]. 
FIGURE 1 : Schematic structure of the human ß2 'ac ' rene r0 i c receptor. The seven membrane-
spanning domains are shown, as well as the phosphorylation sites for protein kinase A and С (РКА 
and PKC) and ß-adrenergic receptor kinase (BARK) [16]. 
13 
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coupling between ß-adrenergic receptors and adenylyl cyclase 
β Adrenergic receptors belong to the group of G-protein coupled receptors 
They are located in the plasma membrane and drugs can bind to the extracel­
lular part The G-protem, in this case Gs (stimulating G-protein), is located at the 
intracellular side of the membrane and acts as a mediator between the ß-
adrenergic receptor and adenylyl cyclase, an enzyme which synthesizes the 
second messenger cyclic adenosine monophosphate (cAMP). The G-protein 
consists of three subunits α, ß and γ [12] cAMP can induce changes in 
biochemical processes in the target cells, like phosphorylation of receptors and 
other proteins This leads to an effect on the cellular level, e g. vasodilation in 
the case of vascular smooth muscle cells [17] 
A model of the signal transduction between receptor and second messenger 
has been described by Lefkowitz et al [18] and is shown m Fig 2 When an 
agonist binds to a ß adrenergic receptor, a complex between agonist, receptor 
and Gs-protein is formed The σ-subunit of the Gs protein normally carries a 
guanosine diphosphate (GDP) molecule, but when the complex is formed, this 
GDP-molecule is exchanged for a guanosine triphosphate (GTP) molecule 
During this exchange process, the affinity of the ß-adrenergic receptor for its 
agonist is transiently increased, which is the result of a conformational change 
of the receptor protein After the exchange, the complex dissociates and the a-
subunit of the Gs protein (not shown in Fig 2) can stimulate adenylyl cyclase, 
resulting in an increase in the production of cAMP This stimulation requires the 
hydrolysis of GTP into GDP, which renders a Gs protein carrying a GDP-mole-
cule Whether β and γ subunits also play a role in signal transduction is not 
fully elucidated Adenylyl cyclase can also be stimulated in vitro by the com­
pound forskolin This compound probably interacts directly with adenylyl 
cyclase, but for full activation of the enzyme the presence of Gs-proteins seems 
to be necessary [46] 
regulation of ß-adrenergic receptors 
Receptors have long been seen as rather static entities, but in the last decade 
the concept of receptor regulation has evolved This regulation reflects an 
adaptation of the receptors to their environment treatment with agonists leads 
to a desensitization and down-regulation of receptors, whereas antagonists can 
induce an up regulation of the receptor number [20] Desensitization of recep-
tors can already occur in a few minutes, and this process is mediated through a 
phosphorylation of the receptor protein When phosphorylated, the receptor can 
no longer couple to the G-protein, and is therefore not functional anymore This 
14 
GENERAL INTRODUCTION 
process is called short-term receptor regulation; dephosphorylation of the 
receptor protein results in restoration of the ability of the receptor to couple to 
G-proteins [21]. A next step in the down-regulation process is the sequestration 
of phosphorylated receptors from the plasma membrane into intracellular stores. 
Internalized receptors can either be transported back to the plasma membrane or 
degraded in the lysosomes by enzymes called proteases [22]. 
FIGURE 2: Model for 
the coupling between 
ß-adrenergic receptor 
(RI and Gs-protem 
(Gs) in the signal 
transduction, accord-
ing to Lefkowitz [19]. 
After binding of a 
hormone (H) to the 
receptor w i th low 
affinity, the receptor 
can form a complex 
with a Gs-protem. 
When GDP is dissoci-
ated, the complex is 
transformed into a 
high affinity agonist 
binding state. After 
binding of GTP, the 
r e c e p t o r c o m p l e x 
returns into its low 
affinity binding state. 
A f te r d i s s o c i a t i o n 
from the receptor, Gs-
GTP stimulates the 
CAMP production of 
adenylyl cyclase. This 
s t imu la t ion causes 
Η - R - G s 
(high affinity) 
GTP' 
H — R — G S - G T P 
H + R 
V H—R 
(low affinity) 
H—R-
GDP 
- G S - G D P 
Adenylyl cyclase 
J 
G S - G D P 
A T P c A M P + PP, 
the hydrolysis of GTP into GTP and P,, which brings the system back into its original situation. 
When degraded, receptors can only be replaced by de novo synthesis of 
receptor protein. Because the transcription of DNA into mRNA followed by 
translation into protein and post-translational modification takes many hours, 
this process is called long-term receptor regulation [23]. Synthesis of new 
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receptors can probably explain the increased ß-adrenergic receptor number 
observed during treatment of animals or humans with full ß-adrenergic receptor 
antagonists such as propranolol. On the other hand, this up-regulation is not 
observed after treatment with the partial ß-agonist pindolol (a ß-adrenergic 
receptor antagonist with weak agonistic properties), and a down-regulation of ß-
adrenergic receptors is found after administration of full ß-agonists like e.g. 
salbutamol [10,24]. 
Phosphorylation of ß-adrenergic receptors can either be specific for this 
receptor type or non-specific, leading to homologous and heterologous desensit-
ization, respectively. Homologous desensitization of ß-adrenergic receptors is 
probably mediated by the enzyme ß-adrenergic receptor kinase (ßARK) [22]. The 
activity of this specific enzyme is increased during stimulation of ß-adrenergic 
receptors with a ß-agonist In contrast, heterologous desensitization can be 
induced by compounds which do not interact with ß-adrenergic receptors, and 
is likely to be mediated by cAMP-dependent protein kinase A and С [25]. 
However, recently an overlap between the different desensitization mechanisms 
has been described [26]. This further illustrates that ß-adrenergic receptors are 
dynamic entities that allow cells to adapt to environmental factors. 
Methods for investigating ß-adrenergic receptor function in hypertension 
e2-3clrenergic receptors on human mononuclear leucocytes 
The ß2-adrenergic receptor complex on mononuclear leucocytes (MNL) is 
widely used as a model system for the ß2-adrenergic receptors present on 
vascular tissue. This model has been adapted for the study of a number of 
disorders, like hypertension [9), congestive heart failure [27] and even psychia-
tric disorders such as depression [10]. The validation of the MNL ß2-adrenergic 
receptor complex as a useful model for the vascular ß2-adrenergic receptor 
complex has mainly been carried out by the group of Brodde. They compared 
li2-adrenergic receptor characteristics between MNL and myocardial tissue, 
derived from patients undergoing heart transplantation, and concluded that MNL 
could serve as a useful model for solid tissues in this respect [28]. 
An advantage of the use of MNL in studies concerning ß2-adrenergic recep-
tors is that these cells are readily available from humans. This is in marked 
contrast with vascular tissue, which can not easily be obtained from human 
sources for obvious reasons. Moreover, vascular tissue obtained during surgery 
has always been exposed to anesthetics and often to other medication. This 
may affect the characteristics of the vascular tissue under study. In a number of 
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eports, the MNL ß2-adrenergic receptor density has been compared between 
эптагу hypertensive and normotensive subjects. In some of these studies, an 
ncrease in MNL ß2-adrenergic receptor number in primary hypertensive subjects 
nas been described On the other hand, in other studies this increase was not 
statistically significant [9]. These inconsistencies may be due to the relatively 
small number of subjects in most of the studies, which can give rise to a type II 
error. Moreover, differences in methodology may have affected the results. 
Besides alterations in receptor density, changes in the coupling between ß2-
adrenergic receptors and Gs-proteins have also been investigated in studies on 
primary hypertension. In these studies, an attenuation of this coupling was 
observed in primary hypertensive subjects, suggesting a decreased ^-adrener-
gic receptor function in this group [29,30]. 
Despite the fact that MNL are easily obtainable, there are several disad-
vantages on their use in ß2-adrenergic receptor studies The MNL are not a 
homogenous population, but consist of several sub-populations, like B-, Th e ip e f- , 
Suppressor" a r ,d natural killer cells. Recently, the ß2-adrenergic receptor charac-
teristics of these sub-populations have been investigated, and were found to be 
quite different [31]. This implies that alterations in ß2-adrenergic receptor 
characteristics may be attributed to differences in MNL subset distribution 
rather than to true receptor alterations The subset distribution of MNL, howe-
ver, seems to be quite stable under baseline conditions, but a redistribution of 
the subsets has become manifest during physical stress and intravenous 
administration of ß-adrenergic receptor agonists. Recent studies have shown 
that physical stress induces a spleen-dependent lymphocytosis in which the 
MNL, released from the spleen, have a higher ß2-adrenergic receptor number 
than the already circulating ones. Moreover, physical stress causes a redistribu-
tion of MNL subsets, with e.g. a marked decline in the ratio between The|per-
and T-suppresso r cells [31,32]. This indicates that the interpretation of studies on 
the effects of physical stress on MNL ß2-adrenergic receptors is difficult. 
small vessel myograph Technique 
For studies on the vascular effects of hypertension in animal models, 
conducting arteries (aorta, femoral artery) have generally been used. However, 
the most important part of the peripheral resistance is not generated in the 
conducting arteries but in small arteries like the small muscular arteries and 
resistance arteries [33]. Because an increase in the vascular peripheral resis-
tance is one of the general findings in hypertension [7] it seems more appropri-
ate to use small arteries in studies concerning the development and mamte-
17 
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lance of the hypertensive state. These small arteries can be mounted in a small 
/essel myograph, as described by Mulvany and Halpern [34] (Fig. 3). Moreover, 
his technique allows the use of human small arteries isolated from fat biopsies, 
ïince human conducting arteries are not available for in vitro study for obvious 
easons, the small vessel myograph technique seems the most appropriate way 
о study human vascular tissue in vitro. 
:IGURE 3: Dissection and mounting of a rat mesenteric resistance artery into a small vessel 
nyograph. A mesenteric arcade (MAI is dissected (ree from the mesentenum (al and the proximal 
:nd threaded over a 40 μνη wire, fixed onto one of the myograph jaws. After inserting a second 
wire, the artery is mounted into the myograph |c). One of the jaws is fixed to an isometric force 
ransducer, which allows the registration of the force generated by the artery [34]. 
inimal models of hypertension 
The effects of an elevated blood pressure have been studied using animal 
nodels of hypertension. Several models have been described in the literature, 
ncluding spontaneously hypertensive rats (SHR), deoxycorticosterone salt-
;ensitive rats (DOCA-salt rats) and renal hypertensive rats, in which hyperten-
iion is induced by occlusion of one of the renal arteries. These models are very 
¡uitable to study the effects of hypertension on e.g. the structure of the 
/ascular wall [33] and on the function of vasoconstricting or vasodilating 
rechanisms [9). 
The responsiveness of the ii-adrenergic receptor system present on strips of 
:onducting arteries of SHR has been studied quite extensively by the group of 
\sano [9,35]. A decreased responsiveness of this system without alterations in 
he ß-adrenergic receptor itself has been observed. It was concluded that a 
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defect in the coupling between ß-adrenergic receptor and Gs-protein is respon-
sible for the attenuated responsiveness [36]. 
small arteries from biopsies of human fat tissue 
One of the major advantages of the small vessel myograph technique is that 
it can be used to study human small arteries in vitro. These arteries can be 
isolated from fat tissue from omental biopsies, obtained during laparotomy [37], 
or from biopsies from the gluteal region [38]. The amount of vascular tissue is 
too small to allow the study of li-adrenergic receptor characteristics with the 
radioligand binding technique. 
Structural alterations, i.e. an increase in the ratio between media and lumen 
thickness, have been observed in human small arteries, which probably reflect 
hypertrophy of the vascular smooth muscle cells [33]. In small arteries obtained 
from gluteal biopsies, these structural adaptations appeared to be partially 
reversible by antihypertensive treatment [38]. The ß-adrenergic receptor system 
of this tissue preparation has not been studied in vitro. However, with the 
forearm strain gauge plethysmography technique it was shown by Takeshita et 
al. [39] that the vasodilator capacity of the resistance vessels is decreased in 
borderline hypertensive subjects. Therefore, it is of interest to study vasodilating 
mechanisms, like the ß-adrenergic receptor system, in small arteries in vitro. 
The endothelium and the control of vascular tone 
In the past decade, the role of the endothelium in the regulation of vascular 
tone has been well established [40,41]. Since the original experiments by 
Furchgott and Zawadski [42], in which acetylcholine was shown to induce an 
endothelium-dependent relaxation of vascular tissue, three endothelium-depen-
dent mechanisms for the modulation of vascular tone have been described. 
Firstly, the release of endothelium-derived relaxing factors (EDRF) induces 
vasodilation. One of the EDRFs was later identified as nitric oxide (NO), syn-
thesized from L-arginine [43]; the identity of other EDRF(s) is still a matter of 
debate [45]. The arginine analogue NG-monomethyl-L-arginine was found to 
block the synthesis of EDRF, and therefore can be used as an inhibitor [43]. 
Secondly, the endothelium can release endothelium-derived constricting factors 
(EDCFs), consisting of endothelin and several other factors [44]. Thirdly, more 
19 
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recently an endothelium-denved hyperpolanzation factor (EDHF) has been found, 
which like EDRF induces relaxation of vascular tissue [45] The release of these 
endothelium-denved modulators of vascular tone can be mediated by several 
stimuli including shear stress and different compounds such as muscarinic and 
QT-adrenergic receptor agonists Because both contracting and relaxing factors 
can be released from the endothelium, this part of the vasculature seems to 
serve as an important regulator of local vascular tone 
Outline of this thesis 
The aim of the investigations, presented in this thesis, was to study the 
Function and regulation of ß-adrenergic receptors and possible alterations therein 
in hypertension To this end the function and regulation of the B2-adrenergic 
receptor complex, present on human MNL, as well as the ß-adrenergic receptor 
system in small arteries obtained from rats and human omentum biopsies have 
been investigated 
In part A of this thesis (Chapter 2 to 5), studies on the ß2-adrenergic 
receptor complex present on human MNL are described Chapter 2 contains a 
study on the characteristics of platelet a2- and MNL ß2-adrenergic receptors of 
relatively large groups of primary hypertensive subjects and of normotensive 
volunteers In Chapter 3, the coupling between the ß2-adrenergic receptor and 
the Gs-protem was investigated by inhibition of radioligand binding with the ß-
adrenergic receptor agonist isoprenalme, together with measurements of cAMP 
production. Chapters 4 and 5 deal with the regulation of the ß2-adrenergic 
receptor number of MNL In Chapter 4, the in vitro regulation of this parameter 
was investigated by a short-term incubation of MNL with adrenaline and 
noradrenaline, whereas in Chapter 5, the regulation of the ß2-adrenergic 
receptors with different kinds of ß-adrenergic receptor blockers and the ß-
adrenergic receptor agonist salbutamol was studied by treating normotensive 
subjects with these drugs for 8 days. 
In part В of this thesis studies with small arteries, derived from rats and 
human omental biopsies, are described for which the small vessel myograph 
technique was used In Chapter 6, the ß-adrenergic receptor-mediated relaxation 
of mesenteric resistance arteries obtained from spontaneously hypertensive rats 
and Wistar Kyoto rats were compared The methacholine-induced release of 
sndothelium-dependent relaxing factor (EDRF) and its inhibition with NG-mono-
methyl-L-arginine (L-NMMA) in these two kinds of rats is described in Chapter 
20 
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7. Chapter 8 deals with the question whether the ß-adrenergic receptors present 
эп the endothelium of small arteries can mediate release of EDRF. The ß-
îdrenergic receptor mediated relaxation of human small arteries, isolated from 
Dmental fat biopsies, and its relation to blood pressure and chronic medication is 
nvestigated in Chapter 9. In Chapter 10, measurements of the intracellular 
£a2 + -concentration of vascular smooth muscle cells in rat mesenteric resistance 
arteries, and the changes therein by agents that induce contractions and 
relaxations in the small vessel myograph, are described. 
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ABSTRACT 
Alterations in platelet o2-adrenoceptor and mononuclear leucocyte ß2-adreno-
ceptor characteristics in primary hypertension have been studied quite exten-
sively The results of these studies are not consistent, which may be due to the 
relatively small number of subjects in most of the studies. In the present study, 
the o2-adrenoceptor characteristics were compared between 65 hypertensive 
and 51 normotensive subjects and ß2-adrenoceptor characteristics between 72 
hypertensives and 67 normotensives. No significant differences in a2- and ß2-
adrenoceptor density were observed between the groups, but the dissociation 
constant for the o2-adrenoceptor was significantly lower in the hypertensive 
subjects. Correlations between adrenoceptor characteristics and clinical parame-
ters were investigated, which resulted in a weak though significant correlation 
between the ß2-adrenoceptor density and mean arterial pressure. The results of 
the present study were compared with the most relevant studies in the litera-
ture From our study and the literature, we conclude that the blood cell adreno-
ceptor characteristics are unchanged in primary hypertension 
INTRODUCTION 
The sympathetic nervous system can modulate cardiac output and peripheral 
vascular resistance, determinants of arterial blood pressure. An abnormality in 
the sympathetic nervous system therefore might contribute to the development 
or maintenance of primary hypertension [1] A number of studies regarding the 
connection between the sympathetic nervous system and primary hypertension 
have been based on measurements of plasma or tissue catecholamine concen-
trations. However, it is still a matter of controversy whether or not plasma 
catecholamines are elevated in patients with primary hypertension [2]. Catechol-
amines act through interaction with adrenoceptors Therefore, studying adreno-
ceptors is another way to achieve insight into the role of the sympathetic 
nervous system in primary hypertension 
Alterations in adrenoceptors in primary hypertension have been studied by 
many investigators Since human vascular tissue is difficult to obtain for in vitro 
study, the density of o2-adrenoceptors on platelets and of ß2-adrenoceptors on 
mononuclear leucocytes (MNL) have been investigated by radioligand binding 
techniques [3] This has resulted in a number of studies, which have offered 
inconsistent results concerning alterations in adrenoceptor densities in primary 
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hypertension; for a review see [4]. Many of these inconsistencies may be 
explained by the relatively small number of subjects in some of the studies. 
Also, methodological flaws, like poorly defined methods of blood pressure 
measurement, and differences in the methods of radioligand binding may have 
affected the outcome of several studies. 
In the present study, we compared the platelet o2"adrenoceptor and MNL ß2-
adrenoceptor characteristics of 80 untreated primary hypertensive (HT) and 67 
healthy normotensive (NT) subjects. To our knowledge, this is the largest group 
of subjects in one study in which these measurements were executed. We also 
measured plasma catecholamine concentrations in these subjects and searched 
for a relation between blood cell adrenoceptor characteristics, plasma catechol-
amines, blood pressure and some other variables, like urinary Na + -excretion, 
body mass index, heart rate and age. Our results were compared with those 
found in the literature. 
MATERIALS AND METHODS 
Materials 
[3H]-Rauwolscine and [125l]-(-)-cyanopindolol were purchased from Amers-
ham, UK; CGP-12177 was generously supplied by Dr. M. Staehelin from Ciba 
Geigy, Switzerland. Ficoll-Paque was purchased from Pharmacia, Sweden. All 
other reagents were of analytical grade. 
Subjects and methods 
Eighty subjects (44 male, 36 female) with untreated primary hypertension 
(HT) according to the criteria of the Joint National Committee [6] were selected 
from the outpatient clinic. Blood pressure was measured on at least three 
different occasions before a subject entered the test. No medication was used 
for at least four weeks prior to the study. 67 healthy normotensive (NT) 
volunteers (33 male, 34 female) served as a control group. Most of them were 
recruited by means of an announcement in a local newspaper, so they were not 
familiar with the investigative procedures. All subjects gave their informed 
consent. The study was approved by the local ethics committee. All blood 
pressures were recorded with a sphygmomanometer after at least 10 min of 
supine rest. For the HT subjects, the blood pressures are the average of three 
readings per visit at three separate visits to the outpatient clinic. For the NT 
subjects, the blood pressure given is the average of three readings on the day of 
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the study. Body mass index (BMI) was calculated by dividing body weight by 
square height. Urinary N a + and creatinine excretion in the 24 h preceding the 
adrenoceptor measurements were determined in 59 HT and 53 NT subjects (σ-
adrenoceptor measurements) and 57 HT and 43 NT subjects (ß-adrenoceptor 
measurements). 
The measurements were carried out in the morning. All subjects were asked 
to abstain from beverages containing alcohol or caffeine for at least 12 h, from 
smoking for at least 24 h and from eating for at least 8 h prior to the test. All 
subjects remained supine during the test. A cannula was inserted in an antecu-
bital vein, which was kept open by infusion of 0.9% NaCI solution. After at 
least 10 mm of rest, blood pressure was measured three times (NT) with a 
Hawksley Random Zero sphygmomanometer together with pulse rate. Mean 
arterial pressure was calculated by adding one third of the pulse pressure to the 
diastolic blood pressure The measurements were directly followed by blood 
sampling. 
In the blood samples, plasma adrenaline and noradrenaline were measured as 
described before [7,8], and the characteristics of the a2- and ^adrenoceptors 
were determined on platelets and MNL, respectively, in the following way: after 
centrifugaron of the blood (300 g for 15 mm at room temperature), platelet-rich 
plasma was removed and membrane suspensions were prepared as described by 
Brodde et al [9] The remaining blood cell suspension was diluted with an equal 
volume of phosphate-buffered saline solution (pH 7 4). From this suspension, 
MNL were isolated by the method of Boyum [10] o2-Adrenoceptor characteris-
tics were measured by [3H]-rauwolscme binding in the presence or absence of 
10"5 M phentolamme after an incubation of 30 mm at 25 °C [9]. ß2-Adrenocep-
tor characteristics of the MNL were determined as described earlier [5,11]. 
[125l]-(-)-cyanopmdolol binding was measured in the presence or absence of 10' 
6
 M CGP-12177 after incubation for 1 h at 37 °C 
Data analysis 
Adrenoceptor density (RT) and dissociation constant (KD) were calculated by 
subjecting the data to a non-linear least square curve fitting program using the 
Gauss-Newton algorithm [12] Statistical comparisons were made using Stu-
dent's t-test or Wilcoxon's rank sum test as appropriate Correlation coefficients 
were calculated according to the non-parametric Spearman's rank correlation 
test Multiple regression was performed by a best-subset procedure. A p-value 
< 0 05 (two-sided) was considered to be statistically significant. 
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TABLE 1 : Clinical subject characteristics of the hypertensive subjects (HT) and the normotensive 
(NTI control group 
HT NT 
AGE 
BLOOD PRESSURE (mm Hg) 
46 ± 1.3 44 ± 2 NS 
systolic 
diastolic 
MAP 
HEART RATE (тщ- 1 1 
BMI (kg/m2) 
URINARY EXCR. (mmol/24h| 
Na + 
creatinine 
PLASMA CATECHOLAMINES (nmol/l) 
adrenaline 
noradrenaline 
161 ± 3 
99 ± 1 
119 ± 2 
71 ± 1 
27 6 ± 0.5 
151.8 ± 8.6 
13.8 ± 0.8 
0.15 ± 0.01 
1.35 + 0.07 
117 ± 2 
75 ± 1 
89 ± 1 
65 ± 1 
23 3 ± 0.3 
150.7 ± 9.3 
12.5 ± 0.6 
0.16 ± 0.01 
1.53 ± 0.13 
0.0001 
0.0001 
0.0001 
0 0 0 0 5 
0 0001 
NS 
NS 
NS 
NS 
Data are given as means * SE MAP - mean arterial pressure, BMI = body mass index 
RESULTS 
Subject characteristics 
The characteristics of the NT and HT subjects are given in Table 1. Both 
groups did not differ significantly with respect to age and gender. As expected. 
systolic and diastolic blood pressure were significantly higher in the HT group. 
Heart rate and body mass index (BMI) were also significantly higher in the HT 
group. The levels of plasma adrenaline and noradrenaline were not significantly 
different between the two groups. Other parameters were determined in sub­
groups of the study population. The Na + - and creatinine-excretion did not differ 
significantly between the NT and HT subjects. 
Adrenoceptor measurements 
The characteristics of the platelet o2-adrenoceptors and lymphocyte ß2-
adrenoceptors are shown in Fig. 1. The density of o2-adrenoceptors was deter-
mined in 51 of the 67 NT subjects and in 65 of the 80 HT subjects. No signifi-
cant difference for this parameter was observed between the two groups. The 
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FIGURE 1 : Characteristics of the oyadrenoceptors on platelet membranes (upper panel) and ß2-
adrenoceptors on intact mononuclear leucocytes (lower panell of the hypertensive (HT) and 
normotensive (NT) subjects. Open symbols are males, closed symbols females. On the left Y-axis, 
the receptor density is shown, and on the right Y-axis the equilibrium dissociation constant (KD) for 
the radioligand is given. No significant differences were observed except for the KD of the a2-
adrenoceptor, which was significantly lower in the HT group (p = 0.01). 
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equilibrium dissociation constant (KD) for [3H]-rauwolscine, however, was found 
to be significantly lower in the HT subjects as compared to the NT subjects 
(1.61 ± 0.16 vs. 1.83 ± 0.08 nmol.l"1, respectively, ρ = 0.01). ß2-Adreno-
ceptor measurements were performed in all NT subjects and in 72 of the 80 HT 
subjects. Neither the fi2-adrenoceptor density nor the KD-for [125l]-(-)-cyano-
pindolol was significantly different between the two groups. Subdivision of the 
data with respect to gender did not reveal any significant sex-related differences 
in the adrenoceptor characteristics. 
Relationships between adrenoceptor characteristics and other variables 
One of the aims of the present study was to find relations between the 
adrenoceptor characteristics and catecholamines, blood pressure, age and Na + -
excretion. As shown in Fig. 2, in the present study the correlation between a2-
adrenoceptor density and MAP was not significant (r = 0.08, ρ = 0.43, η = 
113), whereas the positive correlation between ß2-adrenoceptor density and 
MAP was weak though significant (r = 0.22, ρ = 0 . 0 1 , η = 135). Similar 
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FIGURE 2: Correlations between mean arterial pressure (MAPI and platelet a2- (left panel) and 
mononuclear leucocyte ß?-adrenoceptor (right panel) density. The correlation between MAP and o2-
adrenoceptor density was not statistically significant (r = 0.08, ρ = 0.43, η = 1131 whereas wi th 
the B2-adrenoceptor density a weak though significant correlation was observed |r = 0.22, ρ = 
0 . 0 1 , η = 1351. 
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correlations were observed when the HT and NT groups were analyzed separa-
tely. Moreover, when the four highest observations for ß2-adrenoceptor density 
values were deleted form the data, the significance of this correlation was lost 
(r = 0 .11 , ρ = 0.19, η = 131). This indicates, that in our subjects the correla­
tion between ß2-adrenoceptor density and MAP does not point at a close 
relationship between these two parameters. The other correlations between 
adrenoceptor characteristics and clinical parameters in the NT and HT groups 
are listed in Table 2. 
TABLE 2: Correlations between blood cell adrenoceptor densities and clinical variables 
BMI (kg/m2 | 
BLOOD PRESSURE (mm 
systolic 
diastolic 
MAP 
HEART RATE (mm ^ 
ADRENALINE (nmol/ll 
Hg) 
NORADRENALINE (nmol/ll 
TOTAL GROUP 
a 
-0 00 
(115) 
0.08 
0 07 
0.07 
(113) 
0 14 
(107) 
0.07 
0.11 
(107) 
β 
0.18 
(1361 
0 20 
0 22 
0 22 
(135) 
-0.00 
(127) 
0.13 
-0.02 
(128) 
HT 
a 
-0.07 
(64) 
0 04 
-0 02 
0 01 
(61) 
0.13 
(55) 
0.14 
-0.09 
(56) 
lì 
0.10 
(70) 
0 14 
0 20 
0.19 
I68I 
-0.02 
(61) 
0.01 
-0 21 
(62) 
NT 
a 
-0.09 
(51) 
-0.23 
-0.15 
-0.20 
(52) 
0.07 
(521 
-0.00 
0.26 
(51) 
β 
0.35 
(66) 
0 31 
0.29 
0.32 
I67I 
-0.09 
(66) 
0.26 
0.11 
166) 
Spearman correlation coefficients between platelet σ2- or MNL f s 2 " a d r e n o c e P t o r densities and 
clinical parameters are given for the total group and for the hypertensive (HTI and normotensive 
(NT) subjects; when underlined, the correlation was statistically significant (P < 0.05). Between 
brackets, the number of subjects for which the correlation was detenmend is shown. MAP: mean 
arterial pressure, BMI = body mass index. 
Since adrenoceptor density may be controlled by more than one variable, we 
performed a best-subset multiple regression with the adrenoceptor characteris­
tics as the dependent variables and the other parameters from this study as 
independent variables. The results, expressed as pie charts, are shown in Fig. 3. 
For the o2-and ß2-adrenoceptor density, the three variables which explain most 
of the variation are shown. For the platelet o2-adrenoceptor density, these 
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variables were age, heart rate and plasma noradrenaline; for the li2-adrenocep-
tor density BMI, mean arterial pressure and heart rate. However, these variables 
explained less than 10 % (o2-adrenoceptor) and 15 % (ß2-adrenoceptor) of the 
variance in adrenoceptor characteristics. MAP could explain only 3 % of the 
variance in ¿^-adrenoceptor KD, which further indicates that blood pressure 
seems to play an irrelevant role in the determination of the adrenoceptor 
characteristics. On the other hand, multiple regression with MAP as the depen-
dent variable showed that almost 40% of its variance can be explained by BMI, 
whereas other variables, including adrenoceptor characteristics, do not signifi-
cantly contribute (less than 1 %) to the explanation of the variance in MAP 
(data not shown). 
NA 0.015 
HR 0.020 
Age 0.029 
Other 0.032 
BM1 0.095 
a2-adrenoceptor density 
on platelet membranes 
ß2-adrenoceptor density 
on intact MNL 
FIGURE 3: Explanation of the variance ¡n platelet o2- (panel A| and mononuclear leucocyte l i 2 -
adrenoceptor (panel B) density by clinical parameters, as determined by best-subset multiple linear 
regression. The (independent! clinical parameters were age, body mass index (BMII, MAP, heart rate 
IHR), plasma adrenaline and plasma noradrenaline (NA|. The three parameters that explain most of 
the variation are given in the diagram, together with the fraction of the variance explained by them; 
for the other three, the explained variance is pooled. The unexplained variance is shown under 
'unexplained'. 
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DISCUSSION 
The aim of the present study was to investigate blood cell σ2- and ß2-adre-
noceptor characteristics and their relations with blood pressure, plasma cate-
cholamines and some other variables in HT and NT subjects. To this end, the 
data were compared between the two groups and analyzed for correlations 
between study parameters by linear and multiple regression analysis. 
Oj-Adrenoceptor alterations in primary hypertension 
In a number of reports, the characteristics of platelet o2-adrenoceptors from 
HT and NT subjects have been compared. An overview of these reports is given 
in Table 3. The o2-adrenoceptor density and dissociation constant (KD) as well 
as the variation in these parameters are in agreement with those observed in 
most of the other studies In some reports, the o2-adrenoceptor density was sig-
nificantly higher in the HT subjects [13,17,20] In others, no difference was 
observed between the two groups [14-16,21-23], or the density was even 
lower in the HT group [18,19]. In one study [24], two distinct classes of 
binding sites were reported for the radioligand [3H]-rauwolscine in the NT group, 
and therefore this study was not included in the Table. When the results of the 
present study are taken into account, we conclude that the platelet a2-adreno-
ceptor density is not increased in primary hypertension. 
The KD for [3H]-rauwolscine was significantly lower in the HT as compared to 
the NT subjects This is not in agreement with the results from other studies 
[13-23] However, in most of these studies, I3H]-yohimbine was used as a 
radioligand Whether this can explain the lower KD observed in the present 
study will need further research. It has to be noted that the difference in KD 
between HT and NT subjects was rather small when compared with the 
variation in the individual values, making a physiological role questionable 
Therefore, we conclude that no major alterations are present in the platelet σ2-
adrenoceptor characteristics in primary hypertension. 
ß2-Adrenoceptor characteristics in primary hypertension 
In the present study, no significant difference was found in the ß2-adreno-
ceptor characteristics of MNL from HT and NT subjects. This is in agreement 
with most of the other studies in this field [13,25-27/30-32], from which an 
overview is given in Table 4. However, Brodde et al [17,28,33] and Middeke et 
al [27] found an increased ß2-adrenoceptor density in MNL from HT subjects. 
Moreover, a positive correlation between blood pressure and ß2-adrenoceptor 
density has been reported [17,27-29,33]. 
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TABLE 3· Overview of studies on o2-adrenoceptor density in platelets from hypertensive and 
normotensive subjects 
Ref 
[13] 
[14] 
[151 
[16] 
[17] 
118) 
[19] 
[20] 
[21] 
[22] 
[23] 
This 
study 
η (HT) 
10cf 
12? 
20 
7 d , 3 9 
14¿,169 
40 
7cJ,129 
8¿,49 
7d,39 
19¿,119 
5á ,179 
7 
29ö,36V 
η (NT) 
12d 
189 
17 
16¿,39 
7¿,29 
40 
7d ,129 
12 
7d ,39 
10<J,29 
11 ¿,309 
13 
28¿ 249 
Age 
50 ± 2/50 ± 3 
37/36 
36/34 
50 ±2 /49 ± 6 
46 ±2 /42 + 3 
51/51 
50/? 
51 ±1 /51 ± 1 
40 ± 3/39 ± 3 
72 ± 6 / 7 0 ± 7 
22 ±1 /21 ± 1 
46 · 1 /47+2 
Tissue 
M 
Ρ 
Ρ 
M 
M 
Ρ 
M 
M 
M 
M 
M 
M 
Ligand 
[3H]DHE 
[JH]YOH 
[3H]YOH 
[3H]RAU 
[3H]YOH 
(3H]YOH 
(3H]YOH 
[3H]YOH 
[3HYOH] 
[3H]RAU 
[3H]RAU 
(3H]RAU 
BP 
? 
sphyg 
sphyg 
sphyg 
? 
sphyg 
? 
> 
? 
sphyg 
? 
sphyg 
HT 
141 ± 3 / 9 7 ± 2 
150/99 
1 8 2 ± 2 2 / 9 7 ± 9 
> 1 6 0 / > 9 5 
164 ± 3 / 1 0 3 ± 2 
1 7 2 ± 1 8 / 1 0 0 ± 8 
? 
> 1 4 0 / > 9 0 
1 4 5 ± 4 / 8 9 ± 3 
1 6 5 ± 1 4 / 1 3 3 ± 1 9 
142 ± 2 / 1 1 0 ± 2 
1 6 0 ± 3 / 9 9 ± 1 
Ref - reference. Age is given for HT/NT in yrs. Tissue Ρ = intact platelets, M = platelet 
membranes, Ligand [3H]DHE - [3H]dihydroergocryptme, [ 3 H]Y0H = [3H]yohimbine, (3H]RAU = 
[3H]rauwolscine, BP method of blood pressure determination, sphyg = sphygmomanometer, 
blood pressures (systolic/diastolic) are given in mm Hg for hypertensives (HT) and normotensives 
In order to find an explanation for the discrepancies in the outcome of the 
different studies, we examined the reports for methodological differences 
Different inclusion criteria for HT subjects (diastolic blood pressure > 90 mm 
Hg [30,32] or > 95 mm Hg [17,25,28,33], mean arterial pressure > 105 mm 
Hg [27], blood pressure > 140/90 mm Hg [13] or > 150/90 mm Hg [26]) have 
been used, whereas in two studies the inclusion criterion was not defined 
[29,31]. Moreover, it is striking that in 4 studies no blood pressure values were 
supplied at all [25,27,29,32], whereas in more than half of the studies no 
method of blood pressure determination (e g position of the subject, resting 
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TABLE 3 continued 
Ref 
113] 
[14] 
[15] 
[16] 
[17] 
(18] 
[191 
[20] 
[21] 
[22] 
[23] 
This 
study 
NT 
1 2 2 x 4 / 7 6 ± 2 
120/77 
1 1 7 ± 1 0 / 7 0 ± 8 
< 1 4 0 / 0 0 
1 2 8 ± 2 / 7 6 ± 1 
?/90 
7 
< 1 4 0 / < 9 0 
112 ± 3 / 7 2 ± 3 
91 ± 1 l / 7 9 ± 6 
88 ±3/63 + 3 
119 ± 2 / 7 5 + 1 
HT RT 
1 9 7 ± 1 6 a ' 
1 8 3 ± 2 2 a 
2 6 5 b 
2 5 3 b 
5 6 4 ± 4 3 a d 
505 ± 3 7 a c 
3 3 3 ± 1 9 a " 
2 4 ± 7 C " 
1 3 9 ± 6 a -
3 1 5 ± 3 9 a ' 
2 1 3 ± 8 a 
288 ± 6 2 ° 
2 7 0 ± 2 8 a 
1 9 4 ± 1 0 a 
NT RT 
1 2 2 ± 1 1 a 
1 7 6 ± 2 0 a 
2 4 6 b 
2 4 4 b 
508 ± 8 6 a d 
4 7 4 ± 6 6 a c 
1 6 5 ± 1 0 a 
31 ± 6 ° 
1 7 6 ± 1 8 a 
2 1 4 ± 3 5 a 
211 ± 8 " 
2 8 9 ± 9 7 a 
2 1 5 ± 1 0 a 
171 ± 1 1 a 
H T K D 
1 9 ± 3 
( n - 6 ) 
3 5 
3 4 + 1 0 
7 1 ± 0 6 d 
6 5 ± 0 6 C 
2 3 ± 0 3 
2 1 ± 1 8 
2 2 ± 0 3 
4 0 ± 0 5 
1 9 ± 0 3 
1 0 ± 0 3 
3 6 + 1 2 
1 6 + 0 2 ' 
N T K D 
2 3 ± 3 
(n = 9) 
2 9 
3 5 ± 0 8 
5 6 ± 0 9 d 
4 4 ± 0 4 e 
1 9 ± 0 2 
2 0 ± 2 0 
2 5 ± 0 3 
4 3 ± 0 5 
? 
1 0 ± 0 2 
2 1 ± 0 3 
1 8 ± 0 1 
(NT], RT = a2 adrenoceptor density expressed as a fmol/mg protein, ь sites/platelet or c fmol/10 8 
platelets, KD = dissociation constant for the radioligand, d = a2 adrenoceptor characteristics after 
low N a + diet, a = o2 adrenoceptor characteristics after high N a + diet * Ρ < 0 05 
period, measurement device) was defined Differences in blood pressure and 
inclusion criteria are likely to affect the results of the studies 
Another factor may be that the origin of the control group, either recruited 
from a population which was unfamiliar with the investigative procedures or 
from e g hospital personnel, was not described in most of the studies Familia­
rity with the investigative procedures may reduce the amount of stress, ex­
perienced by the subjects during the study, which in its turn may influence the 
ß2-adrenoceptor density [37] Age and gender of the subjects seem to have no 
influence on the contradictory results of the studies 
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TABLE 4: Overview of studies on (^-adrenoceptor in mononuclear leucocytes in relation to 
primary hypertension 
Ref. 
[131 
[25) 
[261 
[27] 
[28] 
130] 
[17] 
[31] 
[32] 
[33] 
(34] 
[35] 
[36] 
This 
study 
η (HT) 
12 
26 
22 
6á,4S 
2 4 á , 2 l 9 
8 
40 
8¿,4? 
8 
10 
1 2 ¿ , 1 8 Í 
15¡í,209 
46 
4 0 O 2 Î 
η (NT) 
16 
28¿/129 
11 
5¿,59 
29¿.12S 
8 
40 
12cí,59 
16 
10 
8¿,69 
18 
17 
33<J,349 
Age 
50 ± 3 / 5 0 ± 2 
18-85 
44 ± 2/29 ± 3 
47/41 
45 ± 3/36 ± 3 
28-44/25-40 
46 ± 3/43 ± 3 
46/38 
21-30/21-30 
42 ± 3 / 2 7 ± 2 
5 0 ± 9 / 4 7 ± 1 5 
41 + 3/? 
43 + 1/41 ± 3 
46 ±1 /44 ± 2 
Tissue 
M 
M 
M 
С 
M 
M 
M 
с 
M 
с 
с 
с 
с 
с 
с 
Ligand 
[3H]DHA 
[3H]DHA 
[3H]DHA 
[ 1 2 5 I]CYP 
[ 1 2 5 | ) C Y p 
[ 1 2 5 I ]HYP 
[ , 2 5 I ]HYP 
[3H]DHA 
[ 1 2 5 I ]PIN 
[ 1 2 5 I]CYP 
[3H]CGP 
[3H]CGP 
[ 1 2 5 I]CYP 
[ 1 2 5 I]CYP 
BP 
? 
sphyg 
7 
r.z. 
sphyg 
? 
7 
7 
? 
Tonomed 
? 
? 
sphyg 
sphyg 
HT 
141 ± 3 / 9 7 ± 2 
?/>95 
1 3 2 ± 2 ( M A P | 
? 
1 7 0 ± 3 / 1 0 9 ± 2 
> 130/90-105 
1 6 7 ± 3 / 1 0 1 ± 2 
1 6 3 ± 6 / 1 0 7 ± 3 
?/>90 
161 ± 9 / 1 0 3 + 9 
120±11(MAP) 
? 
127±1(MAP) 
161 ± 3 / 9 9 ± 1 
For abbreviations, see legend to Table 3. [3H]-CGP = [3H]-CGP-12177. Receptor density (RT): " in 
fmol/mg protein, b m sites/cell, c m fmol/10 6 cells. d age < 3 0 yr (n = 13), c age > 60 yr (n = 12), ' 
high N a + diet (400 meq/d); β low N a + diet (10 meq/d). 
Differences in the experimental protocol for the radioligand binding studies 
were also considered as an explanation for the discrepancies between the 
studies. The choice of radioligand seems to have no influence, since both 
increased and unchanged receptor densities were reported with the different 
radioligands. Another factor may be the use of intact MNL or broken MNL, 
which we have shown earlier to affect the characteristics of binding [5]. Howe­
ver, when the six studies in which an increased li2~
ad renoceptor density was 
40 
BLOOD CELL ADRENOCEPTORS AND PRIMARY HYPERTENSION 
TABLE 4' continued 
Ref 
[13] 
[25] 
[26] 
[27] 
[28] 
[30] 
117] 
[311 
[32] 
[33] 
[34] 
[35] 
[36] 
This 
study 
NT 
122 ± 4 / 7 6 ± 2 
7 
91 ±2|MAP) 
? 
1 2 3 ± 2 / 7 8 ± 1 
< 1 3 0 / < 9 0 
127 + 2 / 7 8 ± 1 
? 
>/<90 
120 + 3/71 ± 3 
9 2 ± 9 ( M A P ) 
? 
9 5 ± 2 ( M A P ) 
117 + 2/75 + 1 
HT RT 
40 ± 4 " 
? 
? 
1 3 2 3 ± 1 0 0 b ' 
8 5 9 ± 2 6 0 b " 
8 1 2 ± 2 3 1 b 
1424 + 7 2 b ' 
1 8 ± 2 " 
1872 + 8 8 " ' 
6 6 8 + 4 2 a ' 
9 5 2 + 2 1 0 " ' 
766 ± 9 9 " · β 
1 5 1 2 ± 1 0 1 b ' 
1 9 5 0 ± 6 2 5 b -
1 8 1 9 + 4 2 4 b " 
2 0 0 ± 0 1 4 c 
1 1 3 5 ± 6 0 b 
NT RT 
4 8 ± 3 a 
9 4 8 ± 1 0 8 b d 
1 1 8 8 ± 7 5 b ° 
9 3 4 ± 1 4 4 b 
4 2 0 ± 1 1 9 b 
9 3 0 ± 5 0 6 " 
774 ± 4 9 " 
1 5 ± 1 a 
1 0 2 8 ± 4 4 b ' 
48 0 ± 3 . 8 ° 
8 2 0 + 93"·' 
771 ± 8 θ " β 
1080 + 7 7 " 
1 2 7 8 ± 3 5 6 " 
1378 + 3 5 6 " 
1 91 ± 0 09° 
1 0 5 2 ± 3 6 " 
H T K D 
? 
3 71 ± 0 3 
? 
9.1 ± 7 4 
55.1 ± 4 3 
? 
57 + 8 
27 6 ± 3 3 
0.66 ± 0 0 5 
7 
17 8 ± 3 1 
0 1 6 ± 0 22 
0 11 ± 0 0 8 
? 
7 9 ± 0 3 
N T K D 
? 
3 0 8 ± 0 . 2 
? 
8 . 2 ± 6 6 
68 1 ± 3 1 
? 
4 9 ± 8 
2 3 . 7 + 4 4 
0 56 ± 0 . 0 4 
? 
1 8 . 3 ± 2 2 
0 1 8 ± 0 19 
0 1 4 ± 0 14 
? 
7 . 7 ± 0 . 2 
reported are compared, in three of them [17,27,33] intact MNL were used, 
whereas in the other three an MNL membrane preparation was used [26,28,31]. 
This suggests that the use of either intact or broken MNL does not affect the 
identification of an increased ß 2 " a c , r e n o c e P t o r density in the HT group. More-
over, no relation was found between the identification of ^ " ^ r e n o c e p t o i 
alterations in HT subjects and other experimental factors, such as incubatior 
time and temperature, unlabelled ligand for determination of non-specific binding 
or incubation buffer solution in the different studies. 
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Correlations 
Some of the receptor binding parameters showed a significant correlation 
with other parameters determined in this study. The correlation between ß2-
adrenoceptor density and MAP was the strongest one observed (r = 0.22), but 
only explains 5 % of the variance and therefore seems clinically irrelevant. For 
this correlation, much higher coefficients have been reported [17,26,28,29], 
which may be explained by the higher ß2 adrenoceptor density of the HT 
subjects in these studies. Moreover, a positive correlation between MNL ß2-
adrenoceptor density and MAP seems to be in disagreement with the increased 
peripheral resistance which is generally observed in hypertension [1]. When the 
ß2-adrenoceptors on MNL are considered to mirror the ß2-adrenoceptors on solid 
tissues [38], an increased ß2-adrenoceptor-mediated vasodilation would be 
expected in the HT subjects, which is not observed in this group. 
Multiple regression analysis 
In order to find out whether adrenoceptor density can be controlled by the 
clinical parameters determined in this study, we used a best-subset multiple 
linear regression procedure with the receptor densities as the dependent 
variables and the clinical parameters as the independent variables. No more than 
15% of the variance in adrenoceptor densities could be explained by the clinical 
parameters. In contrast to previous reports [16,32], urinary Na + - and creatinine 
excretion also could not explain a considerable part of the variability in the 
adrenoceptor characteristics This suggests that either the biological variability 
of blood cell adrenoceptor characteristics is very large, or that these characteris-
tics are controlled by other clinical parameters than the ones determined in the 
present study. Furthermore, blood cell adrenoceptors may be no suitable model 
in hypertension research, because the correlation between their density and 
MAP appeared to be very weak. 
Studying the literature and discussing our results raises questions about the 
use of receptor determinations on blood cells in epidemiologic studies. No 
definite answers so far have been given to problems like the choice of the 
proper radioligand, the use of intact or broken cells, definition of non-specific 
binding, trapping or uptake of radioligand in intact cells, temperature and 
incubation time in binding studies etcetera. We think that receptor deter-
minations can be useful in studies in which patient groups serve as their own 
control, but that in comparing populations more care should be taken to the 
above mentioned pitfalls 
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Conclusions 
The results from the present study indicate, that no alterations in the density 
of o2-adrenoceptors on platelet membranes and ß2-adrenoceptors on intact MNL 
are present in primary hypertension. These findings are in agreement with most, 
though not all, of the relevant literature. The correlations, observed between 
clinical parameters and adrenoceptor characteristics, are not very descriptive for 
the σ- or li-adrenoceptor density on blood cells. The very weak correlation 
between MAP and adrenoceptor characteristics suggests that the adrenoceptor 
density of blood cells is not a very useful parameter in hypertension research. 
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CHAPTER 3 
Forskolin-stimulated adenylyl cyclase activity is 
decreased but ß2-adrenergic receptor function is 
unchanged in primary hypertension 
W.M. Blankesteijn, P.H.G.M. Willems, S.J. Graafsma, 
JJ .H .H .M. de Pont, Th. Thien 
J Card ¡ovase Pharmacol, in Dress 

a,-ADRENERGIC RECEPTOR FUNCTION IN PRIMARY HYPERTENSION 
ABSTRACT 
ß2-Adrenergic receptor function may be decreased in primary hypertension, 
resulting in an increased peripheral resistance To study the ß2-adrenergic 
receptor function, we used circulating mononuclear leucocytes as a model 
system Twenty untreated hypertensive (HT) subjects (10 <S, 10 9) and 20 age-
and sex-matched healthy normotensive (NT) volunteers were studied The ß2-
adrenergic receptor density was not significantly different between HT and NT 
subjects, but the dissociation constants for the high and low affinity agonist 
binding states, studied by isoprenaline competition assays, were significantly 
higher in the HT subjects Stimulation of adenylyl cyclase with isoprenaline (10 
μΜ, li-adrenergic receptor mediated stimulation) was not significantly different 
between the two groups The forskolm-mediated direct stimulation of adenylyl 
cyclase was significantly higher in females when compared to males For both 
sexes the forskolm-induced cAMP production was lower in the HT group, 
reaching statistical significance in the males In conclusion, no major abnorma­
lities were observed in ß2-adrenergic receptor function in mononuclear leuco-
cytes The putative relation between the decreased forskolm-mediated adenylyl 
cyclase activity and primary hypertension will need further study 
INTRODUCTION 
One of the mam findings in primary hypertension is an increase in peripheral 
vascular resistance Alterations in adrenergic responsiveness of the vasculature 
are thought to play a role in the genesis and maintenance of the hypertensive 
(HT) state- either an elevated σ-adrenergic (vasoconstricting) or a blunted ß-
adrenergic (vasodilating) responsiveness for circulating catecholamines can 
result in an increased peripheral resistance [1] 
In a number of rat models of hypertension, like spontaneously hypertensive 
rats (SHR) and deoxycorticosterone-salt (DOCA-salt) rats, the relaxation of 
vascular tissue through ß2-adrenergic receptors was found to be decreased [2] 
This was explained by a decrease in the ß2-adrenergic receptor-mediated 
production of the second messenger cyclic adenosine monophosphate (cAMP) 
Since access to human vascular tissue is difficult, alterations in cAMP produc-
tion in the vasculature of primary hypertensive subjects can not be measured 
easily As an alternative, the ß2-adrenergic receptor system present on 
mononuclear leucocytes (MNL) can be used as a model system for the vascular 
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ß2-adrenergic receptor [3,4] With this approach, however, conflicting results 
were obtained with respect to ß2-adrenergic receptor numbers [5 10] and ß2 
adrenergic receptor-stimulated cAMP production [5,8,11] in hypertensive 
subjects. 
Besides ß2 adrenergic receptor density, the function of the ß2 adrenoceptor 
adenylyl cyclase complex is an important determinant of the vasodilating 
potency of this receptor system An estimate of receptor function can be 
obtained by the study of its agonist binding behavior in agonist competition 
experiments, or by its ability to stimulate the production of second messenger 
According to the model proposed by Lefkowitz [12], ß2-adrenergic receptors 
with a high affinity for agonist are an intermediate in the coupling cycle 
between receptor, the stimulating G-protein (Gs) and adenylyl cyclase, the 
second messenger generating system [13,14] A decrease in the fraction of ß2-
adrenergic receptors in the high affinity agonist binding state or a decrease in 
the affinity of the receptor for agonists may point to an attenuated vasodilating 
potency of this receptor system Measurement of the cyclic AMP production of 
adenylyl cyclase, stimulated by isoprenaline, gives additional information about 
the ß2 adrenergic receptor function 
In the present study, MNL membranes of HT subjects and age-matched 
normotensive (NT) controls were used to investigate possible alterations in the 
ß2-adrenergic receptor and its coupling to adenylyl cyclase In order to correct 
for gender as a possible confounder, both groups consisted of 10 males and 10 
females To our knowledge, this is the first study in which the whole complex 
of ß2-adrenergic receptor, Gs-protein and adenylyl cyclase on MNL was investi-
gated in relation to hypertension and gender To this end, the number of ß2-
adrenergic receptors was determined by radioligand binding experiments, the 
high affinity binding state for agonists was examined by isoprenaline competi-
tion for radioligand binding and the activity of adenylyl cyclase was determined 
by stimulation with either isoprenaline (ß2 adrenergic receptor-mediated) or 
forskolm (activation of adenylyl cyclase by a direct interaction [15]) 
MATERIALS AND METHODS 
Materials 
[125 l ] (-)-lodocyanopindolol ([125I]-CYP, ± 1800 Ci/mmol) and [8-3H]ade-
nosine 3',5'-cyclic monophosphate ([3H] cAMP, ± 18 Ci/mmol) were purchased 
from Amersham UK, CGP-12177 was supplied by Dr M Staehelin from Ciba 
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Geigy, Switzerland cAMP was obtained from Boehringer, Mannheim, FRG, 
forskolm from Calbiochem, La Jolla, CA, USA, and isoprenahne from Lansberg 
BV, Uden, The Netherlands All other reagents were of analytical grade. 
Subjects 
Twenty untreated patients (10 male, 10 female) with primary hypertension 
but no co-existing diseases and diastolic blood pressure (DBP) > 90 mm Hg 
after 5 mm supine rest on at least 3 different occasions were recruited from the 
outpatient clinic These patients were without medication for at least four 
weeks, except for two women who used oral contraceptives, these women did 
not differ from the rest of the group in any of the determined parameters 
Twenty healthy normotensives, DBP < 90 mm Hg and without medication, 
served as a control group The normotensives were recruited by a newspaper 
announcement and matched for age and gender with the hypertensive subjects 
The mean age (± SD) was 48 2 ± 13 8 and 49 0 ± 10 5 years for the HT and 
NT males, respectively, and 46 3 ± 13 8 and 46 8 ± 1 1 9 years for the HT 
and NT females, respectively 
Experimental procedures 
All blood samples were collected in the morning with the subjects in a 
supine position The subjects were asked to abstain from smoking for at least 
24 h and from beverages containing caffeine or alcohol for at least 12 h before 
the test First an antecubital vein in the right arm was cannulated and then the 
subject rested for 20 mm, whereafter blood pressure was measured simul-
taneously with an Artenosonde 1225 (left arm) and with a Hawksley Random 
Zero sphygmomanometer (right arm), both in triplicate Heart rate was deter-
mined from an electrocardiogram Then, 30 mm after cannulation, a blood 
sample was taken for the determination of catecholamines [16], followed by a 
sample in hepannized tubes for the determination of ß2-adrenergic receptor 
characteristics and adenylyl cyclase activities Urinary Na + -excretion was 
determined in urine collected during the 24 h preceding the test 
Isolation of the mononuclear leucocyte membranes 
The blood samples were diluted with an equal volume of phosphate buffered 
saline (PBS, pH 7 4), and the mononuclear leucocytes (MNL) were isolated by 
the method of Boyum (17] The MNL were washed three times with PBS and 
finally counted in a Technicon H1 blood analyzer The MNL membranes were 
prepared using the method of Sandnes et al [18] with minor modifications. The 
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MNL were lysed for 5 mm at 4 °C in hypotonic buffer containing 5 mM Tris/HCI 
pH 7.4, 0.4 mM MgCI2 and 3 mM KCl, and the membrane fraction was col­
lected by centrifuging the suspension for 15 mm at 25.000 χ g at 4 °C in an 
MSE Hispin 21 centrifuge. After washing the membrane fraction in a buffer 
containing 50 mM Tris/HCI pH 7.4, 4 mM MgCI2 and 30 mM KCl, followed by a 
second centrifugaron, the membrane preparation was immediately used in the 
radioligand binding assay and the adenylyl cyclase assay. 
[1 2 5I]-CYP binding and isoprenaline competition assays 
Binding of the non-selective ß-adrenergic receptor antagonist [125I]-CYP to 
the MNL membranes was performed using a previously published method 
[chapter 5 of this thesis] with small modifications. Briefly, aliquots of the MNL 
membrane preparation, suspended in incubation buffer containing 10 mM 
Tris/HCI pH 7.4, 0.154 M NaCI, 20 mM MgCI2 and 1 5 mM EDTA, were 
incubated with various concentrations of [125I]-CYP ranging from 2 to 150 pM 
in triplicate, in the presence or absence of 1 μΜ ( ±)-4-(3-t-Butylammo-2-
hydroxypropoxy)-benzimidazol-2-one (CGP-12177) to determine non-specific 
binding (total incubation volume 400 μ\) for 1 hr at 37 °C. After incubation, 
samples were filtered over Whatman GF/C glass fibre filters. Each sample 
contained the membranes derived from 2.10 5 -1.10 6 MNL. Receptor density 
(sites/cell) was calculated by dividing the number of receptors by the number of 
cells the membranes were derived from. 
Receptor affinity for agonists was determined by isoprenaline competition 
for [ 1 2 5 l ] CYP binding. For the isoprenaline competition experiments, basically 
the method for radioligand binding, described above, was used. Samples were 
incubated for 60 mm at 37 °C under constant mixing with a fixed [1 2 5I]-CYP 
concentration of 20 pM For the competition curve 14 isoprenaline concentra­
tions ranging from 1 nM to 20 μΜ were used. Both the binding and competition 
curves were analyzed using LIGAND, a non-linear weighted least square curve 
fitting program [20] 
Determination of adenylyl cyclase activity 
Membranes were suspended in an incubation buffer described by Meurs et 
al. [21] containing 50 mM Tris/HCI pH 7.4, 5 mM MgCI 2 , 1 mM adenosine 
triphosphate, 1 mM DL-dithiothreitol, 20 mM creatine phosphate, 0.5 mg/ml 
creatine Phosphokinase, 0 1 mM theophylline, 1 mM ascorbic acid and 0.1 mM 
guanosine triphosphate. Membrane samples (from 2 . 1 0 5 to 1 . 1 0 6 cells) were 
incubated for 10 mm at 37 °C under constant mixing in the presence of buffer, 
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10 5 M isoprenaline or 3 10 4 M forskolin (total volume 100 μ\) in triplicate. 
Stock solutions of isoprenaline (1 mg/ml in deionized water) and forskolin (2 
mg/ml in ethanol) were diluted with incubation buffer to the concentrations 
indicated above After incubation, the samples were placed at 100 °C for 5 
mm, and centrifuged for 5 mm at 10,000 g. The supernatants were dried under 
N 2 at 50 °C and stored at -20 °C until further assay The cAMP content of the 
samples was determined with the binding protein assay described by Brown et 
al [22]. Briefly, the binding protein was isolated form the cortex of fresh bovine 
adrenal glands, obtained from the local slaughter house. The cortices were 
homogenized in 1 5 volume of ice-cold medium (0 25 M sucrose, 50 mM Tris-
HCI pH 7 4, 25 mM KCl and 5 mM MgCI2), and centrifuged for 5 mm at 
2000 g. The supernatant was centnfugated at 5000 g for 15 mm, and stored at 
-20 °C in 1 ml samples until further use 
The samples were incubated with 2 pmol [3H]-cAMP and an appropriate 
dilution of cAMP binding protein, in 50 mM Tris/HCI pH 7 4, 8 mM theophylline, 
5 mM EDTA, 1 7 mM M g S 0 4 7 H 2 0 and 6 mM DL-dithiothreitol for 60 mm at 
0 °C Standard solutions of cAMP ranging from 1 to 100 pmol cAMP were 
treated in the same way for the production of a calibration curve in each 
experiment After incubation, a suspension of charcoal ( 1 % w/v) and bovine 
serum albumin (2% w/v) in 50 mM Tris/HCI pH 7 4 was added and the tubes 
were briefly agitated. The samples were centrifuged for 5 mm at 1200 g at 
4 °C A sample of the supernatant, representing the bound fraction was taken 
for counting the radioactivity 
Statistical analysis 
The results were expressed as mean ± SE unless indicated otherwise For 
statistical comparison, Wilcoxon's rank sum test was used Correlation coeffi­
cients were calculated according to the Spearman non-parametric correlation 
test A p-value < 0 05 (two-sided) was considered to be statistically signifi­
cant. 
RESULTS 
Subject characteristics 
In Table 1, the characteristics of the HT subjects and the NT controls are 
listed Both the HT and the NT groups consisted of 10 male and 10 female 
subjects, in order to correct for gender as a confounding factor. As expected, 
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the two groups differed significantly in systolic (SBP) and diastolic blood 
pressure (DBP), as measured by the Artenosonde 1225 and the Random Zero 
sphygmomanometer The systolic and diastolic blood pressure tended to be 
higher in HT females as compared to HT males. The heart rate was significantly 
higher in the HT subjects This effect, however, was entirely due to the NT 
males. Urinary 24 hr sodium-excretion was not different between HT and NT 
subjects, but was significantly lower in the females of both the NT and HT 
groups Body mass index and plasma catecholamines were not significantly 
different between the NT and HT groups and no sex-related differences were 
observed. The plasma Mg2 f-concentration was 0 85 ± 0 04 mmol/l in the HT 
and 0 85 ± 0 03 mmol in the NT group 
[125I]-CYP binding experiments 
Binding of [125I]-CYP to the ß2-adrenergic receptors on MNL membranes 
was saturable and of high affinity The li2-adrenergic receptor density (Rt), 
expressed as the number of sites/cell, and the equilibrium dissociation constant 
(KD) for [125I]-CYP are shown in Table 2 The Rt tended to be higher in the HT 
subjects, but the difference was not statistically significant The KD was 
significantly higher (1 3-fold) in the HT subjects Subdivision of the data with 
respect to gender showed that the difference in KD was 1 4-fold higher in the 
HT than in the NT females The difference between the NT and HT males was 
less marked and not statistically significant 
Isoprenaline competition for [ l]-CYP binding 
In Fig 1, a representative curve of an isoprenaline competition experiment 
for [125I]-CYP binding is given The association kinetics, studied in preliminary 
experiments, indicated that at the concentration of [125I]-CYP used (20 pM) 
equilibrium was reached within 60 mm (data not shown) All isoprenaline 
competition curves were significantly better fitted by a two affinity state model 
(F-test), except one curve from a HT male subject, which showed no significant 
improvement of the fit when a two-state model was used instead of a one-state 
model In some preliminary experiments, the effect of the non-hydrolyzable 
GTP analogue 5' guanylyl-imidodiphosphate (Gpp(NH)p, 0.5 mM) was tested. 
This compound prevented the unmasking of the high affinity agonist binding 
state, resulting in a steepening of the isoprenaline competition curve with a 
single (low affinity) binding state (Fig 1) 
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% SPECIFIC [ t , e l ] - C Y P BINDING 
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• • - / / — ι 1 ι-
Ο - Gpp(NH)p 
• + Gpp(NH)p 
. 5:— 
С - 9 - 8 -7 - 6 - 5 
LOG [ISOPRENALINE] 
FIGURE 1 Representative 
curve of an isoprenalme com­
petition experiment for the 
binding of the radioligand 
[ 1 2 b l | CYP to the u2-adrenergic 
receptors on human MNL 
membranes The membranes 
were incubated in the absence 
(open symbols) and presence 
(closed symbols) of the GTP 
analogue GpplNHIp (0 5 mM| 
On the ordinate, the binding of 
[ 1 P 5 I ] CYP relative to the bin­
ding in absence of isoprene 
line, indicated by С on the 
abscissa, is shown The curve 
without GpplNHIp was signifi­
cantly better fitted by a two 
affinity binding state model, 
with a high and low affinity 
binding state for isoprenalme, 
whereas with GpplNHIp a sin 
gle low affinity binding state 
was observed 
Fitting of the isoprenalme competition curves with a two affinity state model 
resulted in estimations for the fraction of the ß2-adrenergic receptor population 
in the high affinity agonist binding state (%RH) and dissociation constants for 
the high and low affinity agonist binding states (KH and KL). The results, 
subdivided according to hypertensive state and gender, are shown in Table 2. 
The %RH was not different between the NT and HT subjects, but both KH and 
KL were significantly higher in the HT subjects (1 3- and 1.4-fold, respectively). 
When the data were subdivided according to gender, KH appeared to show 
sex-related differences in the HT but not in the NT group (Table 2). In contrast, 
no sex-related differences were found for KL. Normalization of the isoprenaline 
competition curves and analysis of each of the four groups (NT δ, NT 9, HT 6, 
HT 9) as a single curve showed similar results for KH, KL and %RH as fitting of 
the individual curves followed by averaging the results (data not shown). 
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TABLE 2' 
HT all 
6 
9 
NT all 
i 
? 
Radioligand binding and isoprenalme competition experiments 
η 
20 
10 
10 
20 
10 
10 
«О 
8 2 ± 0 6 a 
8 2 + 1 0 
8 1 ± 0 8 ' 
6 5 í 0 8 
7 0 ± 0 9 
5 9 ± 1 2 
R
, 
978 ± 57 
928 ± 72 
1028 ± 91 
854 ± 83 
867 ± 97 
841 ± 140 
к
 h 
K H 
12 1 ± 1 8" 
8 0 ± 1 8 
15 9 ± 2 4 " 
9 2 ± 2 3 
1 1 5 + 4 4 
6 9 ± 1 6 
K L b 
361 
323 
395 
263 
257 
266 
± 34" 
± 38 
± 54 
± 29 
± 38 
± 4 5 
% R H
h 
39 3 ± 2 0 
33 6 ± 2 0» 
44 5 ± 3 8 
38 6 ± 2 7 
35 8 ± 4 2 
41.1 ± 3 2 
Data are mean ± SEM KD = equilibrium dissociation constant for [1 2 5I)-CYP (pM), R, = H2-
adrenergic receptor density (sites/celll, KH = dissociation constant for the high affinity agonist 
binding state |nM|, Ku = dissociation constant for the low affinity agonist binding state InMI, %RH 
= fraction of ß2 adrenergic receptors in high affinity agonist binding state KD and RT were 
determined in saturation binding experiments, and KH, KL and %RH in isoprenalme competition 
studies h one HT <S subiect showed an insignificant two affinity state model, data are not 
included (HT £ η = 9) For other symbols, see legend to Table 1 
Adenylyl cyclase activity 
The stimulation of adenylyl cyclase by isoprenalme (10 μΜ) and forskolin 
(300 //M) was studied in 19 NT and 16 HT subjects. In the other 5 subjects, 
determination of adenylyl cyclase activity failed due to a contamination of the 
radiolabeled cAMP The HT male who did not show two binding states in the 
isoprenalme competition experiment had no abnormal adenylyl cyclase activity, 
and therefore was included in this part of the study. The membranes derived 
from 1 0 6 MNL showed no significant differences in basal adenylyl cyclase 
activity (HT δ: 4.1 ± 0.7; HT 9. 5 4 ± 1.8, NT δ. 4.8 ± 1.0; NT 9: 6.6 ± 
1.3 pmol cAMP/10 6 cells.10 mm) Moreover, no significant difference in the 
isoprenalme-induced increase in adenylyl cyclase activity was observed between 
the NT and HT subjects of either sex, as shown in Fig 2 Both parameters, 
however, tended to be slightly lower in the HT group. The direct stimulation of 
adenylyl cyclase with forskolin resulted in a higher adenylyl cyclase activity than 
the ß2-adrenergic receptor mediated stimulation with isoprenalme. The forskolm-
mduced cAMP production, corrected for basal activity, was significantly lower 
in the MNL membranes of the HT subjects, but also showed higher values in 
females as compared to males (HT δ: 3 6 ± 1.5; HT 9 9 1 ± 0.7 NT d : 8.3 ± 
1.9; NT 9: 15 7 ± 3.5 pmol/106 cells.10 mm, p < 0 . 0 5 ) . The lower forskolin-
¡nduced cAMP production was only statistically significant when HT and NT 
males were compared (Fig 2) Analysis of variance showed a significant 
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nfluence of both gender and blood pressure status on the forskolin stimulated 
adenylyl cyclase activity (both ρ < 0.01). 
cAMP production (pmol/10 cells. 10min) 
HT male 
( η = 1 0 ) 
HT female NT female 
(n=6) ( η = 1 0 ) 
-IGURE 2: cAMP production Icorrected for basal activity) in MNL membranes of HT (hyperten­
sive) and NT (normotensive) males and females after fl2-adrenergic receptor-mediated stimulation of 
ädenylyl cyclase with 10 μΜ isoprenaline (solid bars) or direct stimulation with 3 0 0 μΜ forskolin 
hatched bars). Means are given t SE; the number of subjects in each group is given in parenthe­
ses. * : ρ < 0.05. 
In order to exclude an effect of possible differences in the MNL subsets 
Detween the HT and NT subjects or males and females, adenylyl cyclase 
activities were expressed as a fraction of basal activity [30]. When expressed in 
this way, the differences between the groups were similar to those observed for 
the absolute adenylyl cyclase activities (Table 3). 
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TABLE 3° Adenylyl cyclase activities expressed as a fraction of basal activity 
HT 6 NT 9 HT 9 NT 9 
Isoprenalme 1 64 ± 0 14 1 84 ± 0 13 1 95 ± 0 23 1 79 ± 0 17 
Forskolm 1 95 ± 0 25° 2 78 ± 0 24 3 51 ± 0 61 3 90 ± 0 58 
10 9 6 10 
Data are means + SEM For further abbreviations, see legend to Table 1 Basal activities of the 
four subgroups are given in the text ° ρ < 0 05 compared to NT males 
Correlations 
Since a relationship between sodium and abnormal cell surface receptor 
function was proposed by Insel et al. [23], we analyzed our data for correlations 
between 24 hr sodium-excretion and adenylyl cyclase stimulation. For both 
isoprenalme- and forskolin-stimulated adenylyl cyclase activity a weak but 
significant negative correlation with sodium-excretion was observed in the HT 
(isoprenalme: r = -0.50, ρ < 0 05, forskolm: r = - 0 . 5 1 , ρ < 0.05) but not in 
the NT (isoprenalme: r = -0.27, ρ > 0 . 1 ; forskolm: r = -0.19, ρ > 0.2) 
subjects In addition, the forskolin-stimulated adenylyl cyclase activity correlated 
with KH and %RH in the HT but not in the NT subjects (KH: r = 0.67, ρ < 0 . 0 1 ; 
%RH r = 0 59, ρ < 0 05) 
DISCUSSION 
In this study, human MNL were used as a model to examine possible alter­
ations in the vascular ß2-adrenergic receptor adenylyl cyclase complex in 
primary hypertension. The model has been adopted in many studies on ß2-
adrenergic receptor density changes in primary hypertension [2], but the ß2-
adrenergic function in primary hypertension is investigated in only two studies. 
This has urged us to examine the functional characteristics of the ß2-adrenergic 
receptor adenylyl cyclase complex of HT and NT subjects in more detail and 
with special emphasis on gender. 
[125I]-CYP binding studies 
With the MNL model we observed a small, statistically insignificant increase 
in total ß2-adrenergic receptor density in HT subjects. This observation confirms 
earlier studies [5,6,7,10 and chapter 2 of this thesis], in which no significant 
increase m receptor density was found. There are, however, other reports [8,9 
and chapter 4 of this thesis] in which such an increase has been described. The 
reason for this discrepancy is unclear. 
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The higher equilibrium dissociation constant (KD) for the antagonist [ I)-
CYP m HT subjects, especially in females, has not been reported in other 
studies [5,8,9 and chapter 2 of this thesis] This may be due to the small 
number of subjects [5,9] or the use of male subjects only [8] However, a 
functional significance for the increased KD in HT subjects seems unlikely 
Isoprenalme competition for [125I]-CYP binding 
The data derived from all isoprenalme competition experiments except one 
were best fitted assuming a two affinity state model [29] This is in agreement 
with the model for agonist binding to ß-adrenergic receptors, as proposed by 
Lefkowitz et al [12]. A significantly higher KH was observed m HT females only 
(2 3-fold), whereas KL was 1 4 fold higher in all HT subjects This suggests that 
the affinity for agonists is decreased in the HT subjects Whether the increased 
affinity constants have physiological implications remains to be established, e g 
in concentration-response curves for the isoprenaline-mediated cAMP produc-
tion. 
No difference in the %RH was observed between the NT and HT groups, but 
the %F?H appeared to be lower in males as compared to females, irrespective of 
blood pressure In other studies, performed by Feldman et al [5] and Naslund et 
al [10] in relatively small groups of subjects, the %RH was found to be signifi-
cantly lower in the HT subjects [5] Possible explanations for the discrepancies 
between these two studies and the present one are 1) The use of older 
subjects in the present study (mean age 47 3 ± 11 2 yr) as compared to 
Feldman (age range 20-35 yr [5]) and Naslund (mean age 35 ± 2 yr [10]) 
Since ß adrenergic receptor function was reported to decrease with age [2], this 
may have masked a difference in the %RH in our study. However, primary 
hypertension usually becomes clinically manifest at middle age, and therefore it 
seems also relevant to select subjects in this age range for a study of ß-
adrenergic receptor function 2) The lack of a controlled sodium intake in the 
present study Low sodium intake was shown to correct the decreased %RH, 
observed in HT subjects on a high sodium diet [5,10] In the present study, the 
24 hr urinary sodium excretion was found to be slightly, but insignificantly, 
lower in the HT subjects which may further mask a putative decrease in %RH 
between the two groups 
Adenylyl cyclase activity 
The isoprenalme-stimulated adenylyl cyclase activity in MNL membranes 
was not significantly altered in the HT subjects In other studies either a 
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decrease [5,11] or an increase [8] of this parameter has been found. This 
suggests that at high isoprenalme concentrations the adenylyl cyclase activity of 
MNL shows no major changes in primary hypertension. 
Stimulation of the cAMP production with forskolin was approximately two­
fold higher in the females as compared to the males. This seems in agreement 
with earlier reports on sex-related differences in cAMP production of MNL 
membranes [27,28] Besides this sex-related difference, a lower forskolin-
stimulated cAMP production was observed in the HT subjects as compared to 
their NT counterparts, but this difference only reached statistical significance for 
the males. From these findings, it can be concluded that gender seems to be the 
most important determinant of the forskolin-stimulated cAMP production in this 
study, but that blood pressure status also may play a role. This is further 
supported by analysis of variance, which showed a significant influence of both 
classifying variables The cause of the decreased forskolin-stimulated cAMP 
production in males and HT subjects is unknown and will need further study 
However, an effect of differences in MNL subset distribution can probably be 
excluded because similar results were found when the cAMP production was 
expressed as a fraction of basal cAMP production, a procedure which has been 
reported to eliminate the effect of MNL subsets [30] Another explanation may 
be that the amount of adenylyl cyclase molecules is decreased in males and 
maybe also in HT subjects, but further research will be needed to confirm this 
hypothesis and to study its physiological implications 
Relation between sodium-excretion and ß2-adrenergic receptor function 
Because an increase in (S2-adrenergic receptor function during a low-sodium 
diet was reported for HT subjects [10,23,26], we analyzed our data for such a 
correlation The HT subjects in our study showed a weak negative correlation 
between urinary sodium-excretion and both isoprenalme- and forskolm-mediated 
cAMP production Our data therefore support a relation between dietary sodium-
mtake and ß2-adrenergic receptor function, but suggest that the possible site of 
regulation may be adenylyl cyclase rather than the ß2-adrenergic receptor itself. 
Conclusions 
The results from the present study allow the following conclusions: 1) The 
forskolin-stimulated cAMP production in MNL membranes is lower in male 
subjects as compared to females, 2) The forskolin stimulated cAMP production 
may also be decreased in HT subjects, especially in males, but the isoprenaline-
stimulated cAMP production is unimpaired This suggests that the coupling 
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between the Gs-protein and adenylyl cyclase is unimpaired in primary hyperten-
sion; 3) The density of the MNL ß2~adrenergic receptors is unchanged in HT 
subjects, but the dissociation constants for isoprenaline binding to MNL ß2-
adrenergic receptors are increased. The physiological role of the latter finding 
remains to be established. The observations from the present study once more 
stress the importance of matching male and female subjects in hypertension 
research. 
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CHAPTER 4 
In vitro down-regulation of ß2-adrenoceptors on 
mononuclear leucocytes: 
Alterations in primary hypertension? 
W.M. Blankesteijn, E.G.J. Voors, Th. Thien 
submitted for publication 

IN VITRO DOWN-REGULATION OF B2-ADRENOCEPTORS WITH CATECHOLAMINES 
ABSTRACT 
The effect of a short-term incubation with adrenaline and noradrenaline on 
the ß2-adrenoceptor characteristics of mononuclear leukocytes (MNL), obtained 
from primary hypertensive (HT) and normotensive (NT) subjects, was studied 
This incubation induced a concentration-dependent down regulation of the ß2 
adrenoceptors, in contrast to the increase observed after a bicycle exercise test 
The latter finding can be explained by a redistribution of MNL subsets, a 
problem which is avoided by the in vitro incubation with catecholamines. In the 
pilot studies, the changes in ß2-adrenoceptor density, induced by the bicycle 
exercise test and the in vitro incubation with catecholamines, were paralleled by 
changes in isoprenaline-induced cAMP production of the MNL membranes Both 
the li2-adrenoceptor density and the catecholamine evoked decrease in this 
density were significantly higher in 6 HT females as compared to matched NT 
controls Moreover, a highly significant correlation was observed between the 
decrease in ß2-adrenoceptor density and mean arterial pressure The characteris-
tics of the isoprenalme inhibition of radioligand binding were unchanged by the 
catecholamine incubation, and were also not significantly different between the 
HT and NT subjects The findings from the present study suggest that the ß2-
adrenoceptors on MNL from HT subjects are more sensitive to down-regulation 
by short-term incubation with catecholamines 
INTRODUCTION 
Alterations in the sympathetic nervous system are thought to play a role in 
the pathogenesis of primary hypertension [1] Because ß-adrenoceptors are one 
of the effector systems of the sympathetic nervous system, the alterations in 
hypertension may be the result of defects in these receptors This hypothesis 
has been studied quite extensively by measuring the ß2-adrenoceptor number on 
mononuclear leukocytes from primary hypertensive (HT) subjects under baseline 
conditions [2 15] In the HT subjects, the number of ß2-adrenoceptors on MNL 
was found to be increased in some studies [2-7], but not in all [8-15]. In other 
studies the coupling between ß2-adrenoceptors and stimulating G-proteins (Gs) 
was investigated, and found to be either attenuated [12 14] or unchanged [15] 
in the HT subjects 
Because the baseline MNL ß2-adrenoceptor characteristics showed no 
consistent alterations in HT subjects, it is of interest to investigate the ß2 
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adrenoceptor regulation in HT subjects under physical or mental stress. The 
receptor density is a dynamic parameter, which can rapidly be regulated by 
agonists and antagonists [16] Agonists induce a decrease in the receptor 
number and function (down regulation), whereas treatment with antagonists 
results in an increased receptor number (up-regulation). Short term dynamic 
exercise [7-Э, 17-19] as well as mental stress [20] have been shown to induce 
an increase in the MNL ß2-adrenoceptor number. However, because physical 
stress results in an increase in plasma catecholamines, which are agonists for 
ß2-adrenoceptors, a down-regulation would be expected [21]. The increase in 
receptor density, however, could be ascribed to a release of MNL from the 
spleen, which causes a redistribution of MNL subsets, each of these MNL 
subsets was shown to have different ß2-adrenoceptor number [22-24]. 
The release of MNL and the redistribution of MNL subsets during dynamic 
exercise seriously hampers the study of the effects of physical stress on the ß2-
adrenoceptor characteristics To overcome this problem, we incubated MNL 
with catecholamines for 10 mm in vitro, in order to mimic the effects of an 
exercise test The effects of this short-term incubation with adrenaline and 
noradrenaline on the density of ß2-adrenoceptors on MNL and their coupling to 
Gs-proteins were investigated To this end, the isoprenaline-mediated inhibition 
of radioligand binding was studied in 17 subjects The relationship between 
receptor characteristics and blood pressure was investigated by including 6 
subjects with untreated primary hypertension in the study. 
MATERIALS AND METHODS 
Materials 
[125l]-(-)-lodocyanopindolol ([125I]-CYP, ± 1800 Ci/mmol) and [8 ^ - a d e -
nosine 3' 5'-cyclic monophosphate ([3H]-cAMP, 20 30 Ci/mmol) were pur-
chased from Amersham UK, CGP-12177 was supplied by Ciba Geigy, Switzer-
land Adrenaline and noradrenaline were purchased from Sigma, St Louis MO, 
USA All other reagents were of analytical grade 
Subjects 
Twenty-two subjects were included in the study. Five of them (all 
normotensive (NT), 3 d, 2 9) performed a bicycle exercise test. In vitro incuba-
tions with catecholamines were executed with mononuclear leukocytes (MNL) 
from the remaining 17 volunteers 6 were primary hypertensive (HT) subjects 
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(all 9), 6 were NT controls which were matched for age, sex and body mass 
index (BMI) and 5 were other NT volunteers (4 d , 1 9). For pilot experiments, 
buffy coats from healthy NT blood donors were purchased from the local Blood 
Bank. The NT subjects had diastolic blood pressures (DBP) < 90 mm Hg, and 
were unfamiliar with cardiovascular or other disorders. The patients with 
primary hypertension, but no co-existing diseases, were recruited from the 
outpatient clinic and had DBPs > 90 mm Hg after 5 min supine rest on at least 
3 different occasions. All subjects were without medication for at least four 
weeks. 
Experimental procedures 
All blood samples were collected in the morning with the subjects in a supine 
position. The subjects were asked to abstain from smoking for at least 24 h and 
from beverages containing caffeine or alcohol for at least 12 h before the test. 
First an antecubital vein in the right arm was cannulated; then the subject 
rested for 20 min, whereafter blood pressure was measured with a Hawksley 
Random Zero sphygmomanometer, in triplicate. Heart rate (HR) was determined 
directly after each blood pressure measurement. Then, more than 25 min after 
cannulation, a blood sample was taken for the determination of catecholamines 
[25], followed by a sample in heparinized tubes for determination of ß2-adreno-
ceptor characteristics. 
In a subgroup of NT volunteers, a bicycle exercise test was performed 
obtaining the control blood samples. This test was performed according to a 
standardized procedure [8] consisting of 3 successive periods of 6 minutes 
each, wherein the subjects exercised at 25, 50 and 75 % of their previously 
determined individual maximal work load. 
Isolation of the MNL and incubation with catecholamines 
The blood samples were diluted with an equal volume of phosphate buffered 
saline (PBS, pH 7.4), and the mononuclear leukocytes (MNL) were isolated by 
the method of Böyum [26]. The MNL were washed three times with PBS and a 
sample was counted in a blood analyzer (Technicon HI ) . After suspending the 
MNL in PBS buffer with 1 mM ascorbic acid (pH 7.4), they were incubated for 
10 min at 37 °C in the presence or absence of catecholamines (1 //mol/l 
adrenaline and 10 μπηοΙ/Ι noradrenaline). In pilot experiments with buffy coats 
obtained from the local Blood Bank, these catecholamine concentrations were 
shown to induce a significant down-regulation of MNL li2-adrenoceptors (Fig. 
1). In all experiments, the concentration of noradrenaline was chosen to be 10-
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fold higher than the adrenaline concentration, in order to mimic the venous 
concentration ratio of catecholamines [25]. After catecholamine incubation, the 
MNL were isolated by centrifugaron (10 mm, 300 χ g, 4 °C), suspended in ice-
cold hypotonic lysing buffer (5 mM Tris/HCI pH 7.4, 0.4 mM MgCI2 and 3 mM 
KCl) and further prepared and washed as earlier described [27]. 
Isoprenaline competition experiments and cAMP measurements 
ß2-Adrenoceptor affinity for agonists was determined by isoprenaline com-
petition for [125I]-CYP binding as described before [15]. Aliquots of the MNL 
membrane preparation, suspended in incubation buffer containing 10 mM 
Tris/HCI pH 7.4, 154 mM NaCI, 20 mM MgCI2 and 1.5 mM EDTA, were 
incubated for 60 mm at 37 °C with 20 pmol/l of [125I]-CYP in the presence of 
increasing concentrations of isoprenaline (1 nmol/l - 20 μηηοΙ/Ι, total incubation 
volume 400 μ\) Non specific binding was determined by replacing the isoprena­
line for CGP-12177 (1 μπηοΙ/Ι) After incubation, samples were filtered over 
Whatman GF/C glass fibre filters. Each sample contained the membranes 
derived from 5.10 5 -1.10 6 MNL. ß2 Adrenoceptor density was estimated from 
the control point of the competition curves (no isoprenaline added), corrected 
for non-specific binding and expressed m sites/cell by dividing the number of 
receptors by the number of cells the membranes were derived from The 
competition curves were analyzed using LIGAND, a non-linear weighted least 
square curve fitting program [28]. The ß2 adrenoceptor mediated cAMP produc-
tion was studied by incubating samples of MNL membranes with 10 μΜ of 
isoprenaline for 10 mm at 37 °C, as described before [15]. The cAMP produc­
tion of the MNL membranes was corrected for the baseline production. 
Statistical analysis 
The results were expressed as mean ± SE unless indicated otherwise. Mean 
Arterial Pressure (MAP) was defined as (diastolic blood pressure + ((systolic -
diastolic blood pressure)/3) For statistical comparison of HT and NT subjects 
Wilcoxon's rank sum test was used The effect of catecholamine treatment was 
analyzed using Wilcoxon's signed rank test for paired observations. Correlation 
coefficients were calculated according to the Spearman non-parametric correla­
tion test. A p-value < 0.05 (two-sided) was considered to be statistically 
significant. 
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RESULTS 
Subjects 
The clinical parameters from the subjects, used in the present study, are 
listed in Table 1. In this Table, the HT subjects were compared with their 
matched NT controls The data from the other NT subjects as well as the 
subjects which participated in the bicycle exercise test are also given. As 
expected, blood pressure was significantly higher in the HT subjects as com­
pared to the NT controls. For the other parameters, no significant differences 
were observed between the two groups. 
TABLE 1 Clinical parameters of the primary hypertensive (HT) subjects and the matched and 
other normotensive (NT) controls 
age (yr) 
BMI (kg/m2) 
A (nmol/ll 
NOR Inmol/I) 
SBP (mm Hg) 
DBP (mm Hg| 
HR (mm 1) 
η 
HT 
47 3 ± 6 1 
24 2 ± 1 0 
0 14 ± 0 03 
1 29 ± 0 25 
175 ± 5 a 
104 ± 3° 
71 ± 6 
69 
MATCHED HT 
48 2 ± 5 3 
24 8 ± 1 0 
0 09 ± 0 02 
1 55 ± 0 34 
119 ± 3 
74 ± 3 
73 ± 4 
69 
OTHER NT 
30 0 ± 4 8 
22 8 ± 0 8 
0 11 ± 0 02 
1 05 ± 0 07 
120 ± 8 
62 ± 5 
70 + 4 
2á,39 
BE 
40 4 ± 4 2 
23 3 ± 1 1 
0 19 ± 0 09 
2 12 ± 0 62 
115 ± 4 
70 ± 3 
55 ± 4 
3¿,29 
Data are presented as means + SE BE - bicycle exercise test, BMI - body mass index, A = 
plasma adrenaline, NOR = plasma noradrenaline, SBP = systolic blood pressure, DBP = diastolic 
blood pressure, HR = heart rate a Ρ < 0 05 
Concentration-dependence of ß2-adrenoceptor regulation by catecholamines 
The results of pilot experiments, performed with buffy coats from the local 
Blood Bank, regarding the effect of an incubation with different concentrations 
of adrenaline and noradrenaline on receptor density are shown in Fig. 1 The 
maximal decrease in ß2-adrenoceptor density was reached at a concentration of 
1 μπηοΙ/Ι adrenaline and 10 /ymol/l noradrenaline Lower concentrations showed 
a less pronounced down-regulation of receptor density, whereas higher concen­
trations failed to induce a stronger down-regulation. Therefore, these concentra­
tions of adrenaline and noradrenaline were chosen for the studies with HT and 
NT subjects. 
71 
CHAPTER 4 
вГ 
te 
Ui 
о 
ω 
•Ό 
6? 
ΙΟ
7
 / ΙΟ 6 Ι Ο 6 / ΙΟ 3 ΙΟ 5 / КГ1 
[Α / NOR ] 
FIGURE 1 Concentration dependence of the down regulation of MNL IS2 adrenoceptors by short 
term incubation with catecholamines Concentrations of adrenaline and noradrenaline are given on 
the X axis For the experiments, buffy coats were used, each point represents an experiment 
ß2-Adrenoceptor density and its regulation by in vitro incubation with catechol-
amines 
The total number of ß2-adrenoceptors, estimated by the binding of 20 pM 
[125I]-CYP to the MNL membranes, was significantly higher in the HT subjects 
as compared to their NT controls (Table 2). The decrease in the estimated total 
ß2-adrenoceptor density, resulting from catecholamine incubation, is shown in 
Fig 2 (left panel HT subjects, middle panel NT sub|ects). A decrease in 
receptor density was observed in all subjects, this decrease was significant in 
both groups (P = 0 03, Wilcoxon's signed rank test for paired observations). 
However, the decrease in ß2-adrenoceptor density resulting from catecholamine 
treatment, defined as the difference between control and treated receptor 
density, was significantly larger in the HT group as compared to the matched 
NT subjects (P = 0 0 1 , Wilcoxon's rank sum test for two samples). In Fig. 2, 
right panel, the effect of a bicycle exercise test on the MNL ß2-adrenoceptor 
density is depicted As expected, in all 5 NT subjects an increase in this 
parameter was observed 
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TABLE 2: Characteristics of MNL ^-adrenoceptors and changes induced by catecholamine 
treatment 
CONTROL CATECHOLAMINES 
RT (sites/cell) 
RH (sites/cell) 
RL (sites/cell) 
KH (nmol/l) 
KL ЦлтюІ/І) 
HT 
1112 ± 115" 
3 8 8 ± 50 
15.4 ± 4.2 
0.51 ± 0.12 
6 9 
NT 
629 ± 48 
224 ± 50 
10.7 ± 4.8 
0.22 ± 0.03 
6 9 
HT 
775 ± 63° 
273 ± 34 
24.4 ± 8.6 
0.74 ± 0.22 
6 9 
NT 
4 7 3 + 51 
205 ± 34 
40.8 ± 17.6 
1.52 ± 0.61 
6 9 
Data are means ± SE. HT = hypertensives, NT = normotensives, RT = total ß 2 ' a c l r e n o c e P t o r 
density on MNL, RH = number of ^-adrenoceptors with high affinity for isoprenaline, KH = 
dissociation constant for high affinity site, KL = dissociation constant for low affinity binding site. 
• = Ρ < 0.05 compared to NT. 
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FIGURE 2: Effect of incubation of intact MNL with 1 μΜ adrenaline and 10 μΜ noradrenaline on 
the MNL B2-adrenoceptor density m HT subjects (left panel) and NT subjects (middle panel). Open 
circles represent the matched controls of the HT subjects whereas open squares represent other NT 
subjects. In the right panel, the effect of a bicycle exercise test on ß2-adrenoceptor density is 
shown. 
Isoprenaline-induced cAMP production 
In the bicycle exercise tests and the pilot in vitro incubations, the production 
of cAMP, the second messenger of the ß 2 " a d r e n o c e P t o r system, was determ-
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¡ned. The cAMP production, induced by isoprenaline (10 μΜ), was corrected for 
the baseline cAMP production of the MNL. The results are shown in Fig. 3. In all 
4 in vitro incubations with 1 μΜ adrenaline/10 μΜ noradrenaline (panel A), a 
decrease in cAMP production was observed. In contrast, in all 5 bicycle exercise 
tests (panel B) an increase in cAMP production was observed after the test. 
< CONTROL A/NOR BEFORE AFTER 
FIGURE 3: cAMP production of MNL membranes, stimulated by 10 μΜ isoprenaline. The left panel 
shows the effect of short term incubation of intact MNL w i t h 1 μΜ adrenaline and 10 μΜ 
noradrenaline, whereas the right panel shows the effect of a bicycle exercise test. The MNL, used in 
the left panel, were isolated from buffy coats. For the experiments shown in the right panel, NT 
subiects were used. 
Effect of catecholamine treatment on the high affinity agonist binding state 
The binding of agonists to G-protem coupled receptors is characterized by 
two binding states, a high and low affinity binding state [28]. The high affinity 
binding state probably reflects the complex which is formed between agonist, 
receptor and G-protem and can only be observed in the absence of GTP. In pilot 
experiments, the addition of GppNHp, a non-hydrolyzable analogue of GTP, was 
shown to prevent the formation of high affinity agonist binding sites (see 
Chapter 3 of this thesis). The results of the isoprenaline inhibition experiments 
are shown in Table 2. In control samples, the total number of ^-adrenoceptors 
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and the number of ß2-adrenoceptors with high affinity for the agonist ¡soprena-
line were significantly higher in the HT subjects. After incubation with catechol-
amines, the differences were no longer statistically significant. The other 
characteristics of the isoprenalme inhibition experiments were not significantly 
different between the two groups. 
TABLE 3 Overview of the correlation coefficients between blood pressure and receptor binding 
parameters in all 17 subjects tested 
R T con R T con"RT cat R T con /RT cat K L con 
SBP 0 63 b 0 63 b 0 57a 0 5 1 a 
DBP 0 56a 0 7 5 е 0 5 4 a 0 23 
MAP О 5 6 a 0 7 6 е О 5 6 a 0 24 
RT c o n = a2-adrenoceptor density of control, RT c a t = li2-adrenoceptor density after catecholamine 
treatment, KL c o n = dissociation constant of the low affinity isoprenalme binding a Ρ < 0 0 5 , ь Ρ 
< 0 0 1 , c Ρ < 0 0 0 1 
Correlations 
In order to investigate the possible relationship between blood pressure and 
the down-regulation of ß2-adrenoceptors by incubation with catecholamines, we 
determined the correlation between these parameters. Using the results from all 
subjects, a highly significant correlation was observed between the mean 
arterial pressure (MAP) and the decrease in the number of ß2-adrenoceptors, 
induced by catecholamine treatment (r = 0.76, ρ = 0 0003, η = 17, Fig 4) 
The total ß2-adrenoceptor density under control conditions, but not after in vitro 
incubation, also correlated significantly with MAP The other correlations 
between blood pressure and receptor characteristics are shown in Table 3. No 
significant correlations between age, plasma catecholamines, HR or BMI and the 
ß2-adrenoceptor characteristics were observed 
DISCUSSION 
The aim of the present study was to investigate the effects of a short-term 
incubation with catecholamines on the ß2-adrenoceptor complex of MNL in 
relation to blood pressure. Because in vivo stress tests induce an increase in 
MNL number together with a redistribution of MNL subsets, each with different 
ß2-adrenoceptor characteristics [22,23], we developed an in vitro model. With 
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this test, we investigated the down-regulation of the ß2-adrenoceptor numbei 
and the change in coupling between ß2-adrenoceptor and G-protem. 
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rIGURE 4 : Correlation between mean arterial pressure (MAPI and the decrease in 52-adrenoceptor 
jensity, induced by in vitro incubation with 1 μΜ adrenaline and 10 μΜ noradrenaline. Filled and 
зреп circles represent the HT and NT subjects, respectively. 
i2-Adrenoceptor density is higher in HT subjects 
In the present study, the receptor density was estimated from incubation with 
20 pM [1 2 5I]-CYP, and corrected for non-specific binding. The KD for [1 2 5I]-CYP, 
determined in earlier studies [8,9], was approximately 7 pM, so at the concen­
tration of [1 2 5I]-CYP, used in the present study, 75 % of the receptors will be 
Dccupied [29]. Therefore, the ß2-adrenoceptor density, as determined in the 
sresent study, can serve as a sufficiently accurate estimate of the total ß2-
adrenoceptor number on MNL. 
A significantly higher number of ß2-adrenoceptors was found on the MNL 
nembranes from the HT subjects. An increased ß2-adrenoceptor density was 
described before in a number of studies [2-7], but in other studies, the ß2-
adrenoceptor density was not significantly higher in HT subjects [8-15, 31]. In 
эп earlier study from our group with large numbers of HT and NT subjects (n = 
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67 and 72, respectively) no significant difference in ß2-adrenoceptor density 
was observed between the two groups [36] Because the number of subjects in 
the present study was small, the possibility of a type II error can not be 
excluded 
Concentration-dependence of the ß2-adrenoceptor down-regulation with cate-
cholamines 
Incubation of MNL with adrenaline and noradrenaline for 10 mm showed a 
concentration-dependent decrease in ß2-adrenoceptor density The maximal 
decrease in this density was approximately 40% of control This is in agreement 
with the results of Sandness et al [32], who observed a down-regulation of 
53 8% after incubation of MNL with 1 μΜ isoprenaline for 10 mm Lower 
concentrations of catecholamines induced a less marked down-regulation, a 
finding which is similar to the isoprenaline-induced down-regulation [32] 
Therefore, it is questionable whether nanomolar concentrations of catechol­
amines, observed in venous plasma [25], can induce a down-regulation of ß2-
adrenoceptors However, it has to be noted that the concentration of catechola-
mines, necessary to induce vasodilation through vascular postjunctional ß-
adrenoceptors in isolated arteries, is considerably higher than the venous plasma 
concentrations of catecholamines [35] Moreover, the noradrenaline concentra-
tion in the synaptic cleft during physical stress is considerably higher than the 
venous concentrations [37] 
Down-regulation of MNL ß2-adrenoceptors by in vitro incubation with catechola-
mines 
In vitro incubation of MNL with 1 μΜ adrenaline and 10 μΜ noradrenaline for 
10 mm induced a down-regulation of the ß2-adrenoceptors in all subjects This 
seems to be in contrast to the results of physical and mental exercise tests [7-
9,20 and this study], which showed an up regulation of this receptor, probably 
resulting from a redistribution of MNL subsets [22,23] Short term incubation 
with ß adrenoceptor agonists has been shown to induce a down-regulation of 
MNL ß2 adrenoceptors before [32,33] This down-regulation probably can be 
explained by a rapid sequestration of the receptors to intracellular stores during 
incubation with ß-adrenoceptor agonists [34] Because receptor measurements 
were carried out on an MNL plasma membrane preparation, these receptors 
probably were no longer present in the assay, resulting in the decrease in 
receptor density observed in the present study 
77 
CHAPTER 4 
The decrease in absolute ß2-adrenoceptor density, resulting from incubation 
with catecholamines, was significantly stronger m the HT subjects than in their 
matched NT controls MNL ß2-adrenoceptors are generally used as a model for 
the vascular ß2-adrenoceptors [30], so this finding may suggest that in HT 
subjects under short-term stress the vascular ß2-adrenoceptors a r e down-
regulated more strongly This could have implications for the vasodilation, 
mediated by vascular ß2-adrenoceptors, in HT subjects. However, further 
research will be needed to confirm an attenuated ß2-adrenoceptor function in 
vivo in HT subjects under physical stress. 
Effect of in vitro incubation with catecholamines on MNL ß2-adrenoceptor 
function 
In some pilot experiments of the present study, the isoprenahne-mediated 
cAMP production of MNL membranes was determined. After incubation with 
catecholamines, the cAMP production was found to be decreased, whereas in 
the bicycle exercise test, an increase in this parameter was observed. These 
changes in cAMP production were in agreement with the changes in ß2-adreno-
ceptor density, determined under similar conditions. This suggests that the 
alterations in ß2-adrenoceptor density, observed in this study, reflect a change 
in ß2-adrenoceptor function of MNL A desensitization of the MNL ß2-adreno-
ceptor complex together with a down-regulation of cell surface ß2-adrenocep-
tors by short term incubation with ß-agonists has been described before [19] 
Whether this desensitization, like the down regulation of ß2-adrenoceptors, is 
also more pronounced m HT subjects remains to be established. 
Conclusions 
In the present study, the effect of a short-term in vitro incubation with 
catecholamines on MNL ß2-adrenoceptor characteristics is described. In contrast 
to the physical exercise test, a decrease in MNL ß2-adrenoceptor density was 
observed in all subjects, which is in agreement with the literature on receptor 
regulation Incubation with catecholamines was shown to induce a significantly 
larger decrease in this receptor number m HT subjects. Together with the highly 
significant correlation between blood pressure and decrease in ß2-adrenoceptor 
density, this suggests that the catecholamine-induced down-regulation of MNL 
ß2-adrenoceptors is more important than the baseline ß2-adrenoceptor density in 
the determination of blood pressure. 
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BETA-BLOCKER TREATMENT AND B2-ADRENOCEPTOR AFFINITY 
ABSTRACT 
The effect of ß-adrenoceptor antagonists (BAAs) differing in lipophilicity and 
partial agonist activity (PAA), and a full agonist, on the dissociation constant for 
[125l]-(-)-iodocyanopindolol binding to ß2-adrenoceptors (KD) has been investi-
gated. 
Twelve healthy, normotensive male volunteers (mean age 22.3 y) were 
treated with different BAAs according to a cross-over design. The drugs used 
were propranolol (highly lipophilic BAA, no PAA), pindolol (moderately lipophilic 
BAA, strong PAA), dilevalol (highly lipophilic BAA, weak PAA) and salbutamol 
(full agonist). Before and after a single dose and an 8 day course of one of the 
drugs, blood pressure and the ß2-adrenoceptor characteristics of mononuclear 
leukocytes (MNL) were determined Between the treatment periods, there was a 
wash-out interval of 14 days 
All BAAs decreased the blood pressure, but only propranolol lowered heart 
rate. Treatment with salbutamol decreased the diastolic and increased the 
systolic blood pressure and heart rate. Three hours after the single dose of any 
of the BAAs, a more than 2-fold increase in KD was observed, and the increase 
became larger after 8 days of administration (up to 3.7-fold increase). In 
contrast, no effect on KD was observed after treatment with salbutamol. BAAs 
with PAA and salbutamol induced a 30 % decrease in ß2-adrenoceptor density. 
It is concluded that treatment with BAAs, irrespective their lipophilicity or 
PAA, induces a decrease in the affinity of MNL ß2-adrenoceptors for antago-
nists. This phenomenon may help to explain the contradictory relationship 
between the kinetics and dynamics of BAAs. 
INTRODUCTION 
ß-Adrenoceptor antagonists (BAAs) are frequently used in the treatment of 
cardiovascular diseases, especially hypertension. However, their precise 
mechanism of action is still a matter of debate [1]. Some of the BAAs are able 
to induce a peripheral vasodilating effect via so-called ancillary properties, like a-
adrenoceptor antagonism or partial agonist activity (PAA) for ß2-adrenoceptors 
[2,3]. Those properties are called "ancillary" because all BAAs, irrespective of 
these properties, lower blood pressure to approximately the same extend [1,3]. 
On the other hand, such activities may give rise to important differences in the 
effect of BAA treatment on the ß-adrenoceptor density, as determined by 
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radioligand binding experiments Using the ß2-adrenoceptors of circulating 
mononuclear leukocytes (MNL) as a model [4], the ß2-adrenoceptor density 
appeared to decrease after repeated administration of a BAA with PAA, such as 
pindolol (PIN) In contrast, during treatment with propranolol (PRO), a BAA 
without PAA, either an increase [3,5,6] or no change [7] in this receptor density 
was observed 
A second parameter derived from radioligand binding studies is the equilibrium 
dissociation constant for the radioligand (KD) Although it has attracted less 
attention than ß2-adrenoceptor density, an increase in this parameter has been 
reported several times after treatment with PRO [3,5-8] During treatment with 
PIN, the increase in KD was found to be less marked [3,5-7] From those 
studies, it was concluded that the increased KD after PRO treatment was the 
result of adsorption of this highly lipophilic BAA to MNL plasma membranes, a 
process which was less likely to occur with the moderately lipophilic PIN [5-7] 
However, in none of these studies the question was addressed whether the 
increased KD for the radioligand, although probably the result of drug adsorption 
to plasma membranes, represents a decreased affinity of ß2-adrenoceptors for 
BAAs Such a decreased affinity would affect the interaction between BAAs 
and the ß2-adrenoceptors at the site(s) of action 
The aim of the present study was to investigate the effect of treatment with 
BAAs differing in lipophilicity and ancillary properties on the KD of a radioligand 
for ß2-adrenoceptors on MNL Healthy volunteers received a single dose and 8 
days of treatment with different BAAs, and changes in blood pressure, heart 
rate and ß2-adrenoceptor characteristics were studied PRO was used as a 
highly lipophilic drug without PAA, whereas the moderately lipophilic PIN was 
used as a compound with strong PAA Dilevalol (DIL), the R,R isomer of 
labetalol, was used as a highly lipophilic BAA with a weak PAA for ß2-adreno-
ceptors Salbutamol (SAL) was also tested, in order to investigate the effect of 
a full agonist on the ß2-adrenoceptor characteristics The effect of trapping of 
BAA in intact MNL [4], as a contributory factor to the changes in KD, was 
studied by comparing the ß2-adrenoceptor characteristics of intact and broken 
MNL after one week of PIN treatment 
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MATERIALS AND METHODS 
Materials 
[125l]-(-)-lodocyanoptndolol |[125I]-CYP) was purchased from Amersham 
International ( ± 1850 Ci/mmol). CGP-12177 was generously supplied by Dr. M. 
Staehelm from Ciba Geigy All other reagents were of analytical grade. 
Subjects and treatments 
Twelve male non-smoking normotensive volunteers (age 22.3 ± 2.3 y| were 
studied All subjects gave their written informed consent and the study was 
approved by the Hospital Ethics Committee The subjects were asked to abstain 
from beverages containing caffeine or alcohol for twelve hours before each test. 
The part of the study involving the BAAs was performed double blind, whereas 
the effect of the (Ì adrenoceptor agonist salbutamol (SAL, 4 mg 1.1 d ) was 
monitored at the end of the study in an open design The BAAs were adminis 
tered orally in equipotent doses [13,14,15] propranolol sustained release (PRO) 
160 mg о d , pindolol sustained release (PIN) 20 mg o d and dilevalol (DID 400 
mg o.d The volunteers were randomised into 3 groups according to the Latin 
square method Since all subjects were tested before and after each of the 4 
treatment periods, they acted as their own controls and a placebo treatment 
period was not necessary 
On Day 1, volunteers visited the outpatient clinic in the morning. After 
cannulating an antecubital vein in the left arm, the subjects rested supine for at 
least 15 mm, followed by measurement of the blood pressure with a Hawksley 
Random Zero sphygmomanometer and heart rate registration, both in triplicate 
Thereafter, a 40 ml blood sample was drawn in hepannised tubes for the 
determination of baseline ß2-adrenoceptor characteristics. Then the first dose ol 
BAA was given The subjects were allowed to move freely for 3 h, after which 
the same protocol was followed, and a second blood sample was drawn. 
On the next days (Day 2 to 7), the volunteers took the dose of BAA in the 
morning On Day 8, before the intake of the BAA, the volunteers again visited 
the outpatient clinic and blood samples were taken before and after drug 
administration, in the same sequence as on Day 1. Between the treatment 
periods, a wash-out interval of 2 weeks was maintained, resulting m a complete 
study period of 10 weeks. 
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Isolation of mononuclear leukocytes 
For the measurement of ß2-adrenoceptor characteristics, mononuclear 
leukocytes (MNL) were isolated from the blood samples [16]. Fresh whole blood 
was diluted with an equal volume of phosphate buffered saline (PBS, pH 7.4) 
containing 2.7 mM KCl, 7.7 mM Na2HP04, 1.5 mM KH2P04 , and 150 mM 
NaCI, and layered on Ficoll Paque (Pharmacia Fine Chemicals, Sweden) in the 
proportion of 5:2 in Sarstedt tubes (25 ml). Tubes were centrifuged at 800 χ g 
for 15 min at room temperature. The MNL were harvested in Falcon tubes and 
washed 3 times with PBS at 4°C. After the last washing step, the cells were 
suspended in incubation buffer, containing 10 mM Tris pH 7.2, 150 mM NaCI, 
0.55 mM ascorbic acid and 0 . 1 % bovine serum albumin to prevent cell ad­
hesion. Cell density was determined with a Coulter Counter (Coulter Electronics, 
Holland) [17]. 
Comparison of intact and broken MNL 
In a separate group of 7 healthy normotensive subjects the effects of 8 days 
of treatment with PIN retard (20 mg o.d.) on the characteristics of the ß2-
adrenoceptors on intact and broken MNL were compared. The same administra-
tion protocol as for the double blind test was used. Blood was drawn before the 
first (Day 1,• t = 0 hr) and 24 hrs after the last (Day 8, t = 0 hr) dose of PIN, 
and MNL were isolated as described above. For the preparation of broken cells, 
a modification of the method of Sandnes et al. [18] was used. Half of the MNL 
were lysed in an ice-cold hypotonic buffer (5 mM Tris, pH 7.4 with 0.4 mM 
MgCI2 and 3 mM KCl) for 5 min. The suspension was centrifuged in an MSE 
Hispin 21 centrifuge at 25,000 χ g, for 15 min at 4°C. The supernatant was 
discarded and the remaining pellet was resuspended in a buffer containing 50 
mM Tris, pH 7.4 with 4 mM MgCI 2 and 30 mM KCl and again centrifuged. The 
supernatant was discarded again and the pellet, resuspended in incubation 
buffer for the radioligand binding assay, was homogenised with 10 strokes of a 
tight fitting tissue grinder (Kontes, Vineland NJ, USA) on ice. The other half of 
the MNL was washed twice in PBS for 20 min, and harvested by centrifugation, 
bringing the total number of washings to 5. The additional washings were done 
to obtain comparable dissociation conditions for any possible retained BAA in 
the intact and broken MNL. The li2-adrenoceptor characteristics of the matching 
preparations of intact and broken MNL were always determined in the same 
radioligand binding experiment. 
86 
BETA-BLOCKER TREATMENT AND B2-ADRENOCEPTOR AFFINITY 
Radioligand binding assay 
Receptor binding assays were performed as previously described [17]. Briefly, 
samples of approximately 10 6 cells were incubated with various concentrations 
of [1 2 5I]-CYP, ranging from 2-150 pM, in the presence or absence of 1 μΜ 
CGP-12177. After terminating the incubation by the addition of 3 ml of ice-cold 
buffer (10 mM Tris pH 7.4 and 150 mM NaCI), the samples were rapidly 
filtrated over Whatman GF/C glass fibre filters. After rinsing the filters three-
times, the bound activity was counted in a Philips PW 4800 automatic gamma 
counter (efficiency 66%). Non-specific binding was defined as radioactivity 
bound in the presence of 1 μΜ CGP-12177. 
Analysis of data 
The data in this study are presented as means ± SE unless indicated other­
wise. Receptor density and equilibrium dissociation constant (KD) were calculat­
ed by subjecting the binding data to analysis with the LIGAND nonlinear least 
square curve fitting program [19]. Statistical analysis of the results was 
performed using Student's t-test for paired samples or Wilcoxon's signed rank 
test, as appropriate, considering Ρ < 0.05 (two-sided) as significant. 
TABLE 1 : Influence of S-adrenoceptor drugs on blood pressure 
DAY 1 DAY 8 
t = 0 hr t = 3 hr t = 0 hr t = 3 hr 
PRO 117 + 2 75 ± 3 109 ± 2 a 68 ± 3 b 113 ± 2 a 71 ± 2 111 ± 1 b 65 ± 3" 
PIN 117 + 2 76 ± 2 112 ± 2 b 63 ± 2 C 119 ± 1 71 ± 2 b 113 ± 2 64 ± 3 C 
DIL 114 + 2 74 ± 3 112 ± 3 63 ± 2 C 114 ± 3 73 ± 2 113 ± 2 62 ± 4 b 
SAL 114 + 2 79 ± 2 121 ± 3 b 67 ± 3 b 119 + 3 a 76 ± 3 120 ± 3 a 71 + 4 " 
Influence of treatment with different drugs (PRO = propranolol, PIN = pindolol, DIL = dilevalol 
and SAL = salbutamol) on blood pressure of healthy volunteers. Values are given as means ± SE. 
Each pair of columns represents the systolic (left) and the diastolic (right) blood pressure on the 
first (day 1) and the last (day 8) day of treatment. Blood pressures were determined before (t = 0 
hr) and 3 hrs after (t = 3 hr) intake of the drug indicated in the most left column. Significant 
differences from pretreatment values (Student's t-test): a = P<0.05, b = P<0.01, c = P<0.001 
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RESULTS 
Evaluation of the wash-out intervals 
In this study, wash out intervals of 14 days were maintained between each 
BAA treatment. Blood pressure (Table 1), heart rate (Table 2) and ß2-adreno-
ceptor characteristics (Fig. 1 and 2) before each of the four treatment periods 
were the same, indicating that the wash-out interval was sufficient. 
Effects of BAA treatment on blood pressure and heart rate 
In Table 1, the changes in blood pressure resulting from drug treatment are 
shown. A single dose of PRO and PIN resulted in a significant decrease in both 
systolic (-7 and -4 %, respectively) and diastolic (-9 and -17%, respectively) 
blood pressure 3 h after intake, whereas a single dose of DIL only decreased the 
diastolic blood pressure ( 15%). A single dose of the agonist SAL led to a 6% 
increase in systolic blood pressure and a 15% decrease in diastolic blood 
pressure 3 h after intake On Day 8, t = 0 h, 24 h after the dose of BAA 
administered, there were only small differences from pretreatment values. After 
intake of the final dose of drug (Day 8, t = 3 h), similar effects on blood 
pressure were found as on Day 1, t = 3 h 
TABLE 2 Influence of ß adrenoceptor drugs treatment on heart rate 
DAY 1 DAY 8 
t = 0 hr t = 3 hr t = 0 hr t = 3 hr 
PRO 69 ± 4 61 ± 2" 54 ± 2 b 54 ± 2 b 
PIN 67 ± 2 63 ± 2 a 7 1 + 2 64 ± 3" 
DIL 66 ± 3 65 ± 2 58 ± 1 b 63 ± 4 
SAL 62 ± 3 71 ± 3C 66 ± 2" 73 ± 3 b 
Influence on heart rate of treatment of the volunteers with the different ß-adrenoceptor drugs For 
explanation of the abbreviations used, see legend to Table 1 
The heart rate of the subjects (Table 2) decreased during treatment with all 
BAAs. A single dose of PRO and PIN caused a decrease in heart rate of 12 and 
6% of pretreatment values, respectively; the decrease after the single dose of 
DIL was not significant. SAL induced a significant increase in heart rate 
( + 15%). On Day 8, t = 0 h, 24 h after the drug intake on Day 7, a decreased 
heart rate as compared to pretreatment values was still observed for PRO and 
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DIL (-22 and -12%, respectively), but not for PIN. The final dose of PRO caused 
a decrease in heart rate of 22% of the pretreatment value, whereas the final 
dose of PIN decreased heart rate by 5% (Day 8, t = 3 h). After the final dose 
of DIL, the heart rate was no longer significantly different from the pretreatment 
value. The final dose of SAL led to a significant increase in heart rate ( + 18%). 
• • DAY 1 Г>ГЗ DAY 1 Ï77ÏÛ DAY 8 ^JT I DAY 8 
t = 0 hr t = 3 hr t = О hr t = 3 hr 
PRO PIN DIL SAL 
FIGURE 1: Effect of BAA treatment on the equilibrium dissociation constant (KD) of [125I]CYP for 
the u2-adrenoceptor. f l 2 '
c n a r a c t e r i s t i c s w e r e
 determined before and 3 hrs after intake of propranolol 
(PRO), pindolol (PIN), dilevalol (DILI or salbutamol (SAL), both on the first (day 1) and last (day 8I 
day of the treatment period Significant differences against pretreatment values (Wilcoxon's rank 
sum testi, a = P<0.05, b = P<0 0 1 , с = P<0.001 
Effects on ß2-adrenoceptor equilibrium dissociation constant 
The binding of [125I]-CYP to the ß2-adrenoceptors on intact human MNL was 
saturable (mean receptor density before treatment: 1233 ± 51 receptors/cell) 
and of high affinity (mean dissociation constant before treatment: 13.9 ± 0.5 
pM). The effect of BAA treatment on the KD is shown in Fig. 1. Three hours 
after a single dose of any of the BAAs, there was a significant increase in the 
equilibrium dissociation constant (KD) of the radioligand: for PRO, PIN and DIL, 
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the increases in KD were 118% (P < 0 001), 104% (P < 0 01) and 1 6 1 % 
(P < 0 01) of pretreatment values, respectively (Day 1, t = 3 h). Repeated 
administration further increased KD-values ( 2 7 1 % , 2 0 8 % and 207%, respec 
tively, on Day 8, t = 3 h, all Ρ < 0 001) The increase in KD appeared to 
persist for 24 hrs after dosing for PRO, PIN and DIL, these increases were 
177%, 8 1 % and 102% of pretreatment values, respectively (Day 8, t = 0 h, Ρ 
< 0 0 0 1 , Ρ < 0 0 1 , Ρ < О 001 compared to pretreatment value, respectively) 
The increase was observed for all the BAAs used, irrespective their level of 
lipophilicity or PAA Administration of the full ß-agonist SAL did not cause any 
change in KD, neither after single nor after repeated dosage 
DAY 1 
t = 0 hr 
DAY 1 
t = 3 hr 
DAY 8 
1 = 0 hr 
DAY 8 
t = 3 hr 
2000 
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> I 
г 
• · 
J 
Τ ι 
•f 
4" 
'Ϋ / 
s 
PRO PIN DIL SAL 
FIGURE 2 Effect of BAA treatment on the ß2 adrenoceptor density on MNL See legend to Fi-
gure 1 for explanation of the abbreviations 
Effects on ß2-adrenoceptor density 
Although a single dose of BAA caused marked increases in KD, it did not 
induce any change in the ß2 adrenoceptor density of the MNL (Fig 2). After 
BAA treatment for 1 week, PRO showed small, insignificant changes in ß2-
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adrenoceptor density, both before and 3 h after the final dose on Day 8. In 
contrast, PIN caused a 43% decrease in ß2-adrenoceptor density 24 h after the 
drug intake on Day 7 (P < 0.001 compared to the pretreatment value), whereas 
the decrease observed after DIL treatment was smaller (-13%) and was not 
statistically significant. Three hrs after the final dose (Day 8, t = 3 h), PIN and 
DIL (the drugs with PAA) showed a decrease in ß2-adrenoceptor density of 
approximately 30%. The decrease in ß2-adrenoceptor density after treatment 
with the ß-agonist SAL was about 30% (P < 0.05 compared to pretreatment 
value), which was similar to the decrease in density resulting from the adminis-
tration of BAAs with PAA. 
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FIGURE 3: u 2 " a d r e n o c e P t o r density (sites/cell) and dissociation constant (KD, pM) of intact and 
broken MNL of 7 subjects, before and 24 after 7 days of PIN treatment Values for each individual 
are given The increase m KD was significant for both intact and broken MNL, but the relative 
changes in KD were not significant between the two MNL preparations, a = P<0 .05 (Signed rank 
test) 
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Comparison of the increase in ß2-adrenoceptor KQ in broken and intact MNL 
The increase in the KD of [125I]-CYP for the ß2-adrenoceptor after BAA 
administration can be considered to result from uptake of drug into the intact 
MNL, giving rise to interference of the drug with the radioligand in the binding 
assay. To test this hypothesis, 7 healthy volunteers were treated with PIN 
(sustained release, 20 mg o.d.) for 7 days and the KD-values of the broken and 
intact MNL from them were compared. Both before the first (Day 1, t = Oh) 
and 24 h after the last PIN intake (Day 8, t = 0 h), blood was collected and 
characteristics of the ß2-adrenoceptors of broken and intact MNL were deter-
mined. The effects of the treatment on the ß2-adrenoceptor density and KD are 
shown in Fig. 3 Before treatment with PIN, the KD-value was significantly 
lower in broken MNL than for the intact MNL (7 3 ± 0.5 and 11 5 ± 0.4 pM, 
respectively, Ρ < 0 05). After PIN treatment, the KD-values for the broken and 
intact MNL were increased by 3 2 % and 57%, respectively. The changes in KD 
were not significantly different between the two MNL preparations. In contrast 
to KD, the mean ß2-adrenoceptor density was not significantly different bet-
ween the broken and intact MNL either before or after PIN treatment (intact 
MNL before 1162 ± 181 and after 673 ± 90 sites/cell, and broken MNL before 
897 ± 121 and after 505 ± 59 sites/cell). As indicated in Fig 3, PIN treatment 
led to a decrease in receptor density in 6 of the 7 sub le ts , and 1 subject 
showed an increase in both the broken and intact MNL. Due to this sub|ect, the 
fall in receptor density resulting from PIN treatment was not statistically 
significant in the group as a whole. 
DISCUSSION 
The aim of this study was to investigate the influence of a single dose and 
repeated administration of various BAAs on the ß2-adrenoceptor dissociation 
constant (KD) of circulating MNL from healthy volunteers. During treatment with 
the BAAs, significant decreases in blood pressure were observed, as could be 
expected from the well known hypotensive action of this kind of drugs [1]. 
Administration of a single dose of any of the three BAAs, irrespective of their 
hpophilicity or ancillary properties, led to an increase in KD of the radioligand 
and administration for 8 days produced a more pronounced increase. Interes-
tingly, the full agonist SAL did not affect the KD at all, indicating that the effect 
on K0 was restricted to the BAAs In contrast to the effect on KD, a single dose 
of the BAAs did not result in a change in ß2-adrenoceptor density. A significant 
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reduction in receptor density was observed after 8 days of treatment wi th 
compounds containing PAA (PIN and DIL) A similar decrease in ß2-adrenoceptor 
density was observed after SAL treatment for 8 days 
An increase in KD has been described in a number of studies on the effect of 
PRO administration on MNL ß2-adrenoceptor density [3,5-7] As one explanation 
for the increase in KD, adsorption of PRO to the plasma membrane, due to the 
lipophilic character of the compound, was suggested by Mohnoff et al. [6] and 
Giudicelli et al [7]. They both used PIN, a moderately lipophilic compound [9], 
as a control and did not observe a significant increase in KD after treatment with 
it Surprisingly, here, all BAAs, irrespective of their degree of lipophihcity or 
PAA, caused a rise in the KD for [125I]-CYP binding to the в г ^ г е п о с е р і о г в on 
MNL In contrast to the BAAs, no change in KD was observed during treatment 
with the full ß2 adrenoceptor agonist SAL, not even 3 h after administration 
Since PRO and PIN have quite different lipophilicity, whereas PRO and DIL are 
almost similar (η-octanol aqueous buffer distribution coefficients PRO 20 2, DIL 
11.5 and PIN 0 82, respectively, at pH 7 4, 37 °C [9]), attributing the increase 
in KD to adsorption of BAA to the plasma membrane, due to the lipophilic 
character of the drugs, cannot completely account for the phenomenon 
Additional experiments with a hydrophilic BAA are needed to definitively 
exclude adsorption of drug to the plasma membrane as an explanation for the 
elevated KD 
As an alternative explanation for the increase in KD, uptake of BAA into the 
MNL during treatment should also be considered [4] In the radioligand binding 
experiment with intact MNL, the intracellular^ stored drug could be released 
and might interfere with the radioligand, possibly resulting in an elevated KD In 
order to test this hypothesis, 7 healthy volunteers were treated with PIN for 7 
days, and broken and intact MNL were compared During the preparation of 
broken MNL, the membranes underwent two additional washing steps, so the 
washing protocol for the intact MNL was extended from 3 to 5 washes This 
was needed to maintain comparable experimental conditions Both in broken and 
intact MNL, an increase in KD was observed due to BAA treatment Although 
the increase in KD was less marked in the broken MNL, the change in KD 
resulting from BAA treatment was not significantly different between the two 
preparations Therefore the increased KD-value can only marginally be attributed 
to drug uptake in the intact MNL 
When the effect of 3 and 5-times washing of intact MNL after 7 days of PIN 
treatment (Day 8, t = 0 h) is compared, an increase in KD of 8 0 % was 
observed in the 3-times washed MNL, whereas after washing 5-times the 
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increase was 57%. Although the increase in KD tended to be lower in the more 
times washed MNL, the difference was not significant, which indicates that the 
increase in KD observed here was only partly reversible by additional washing. 
This is not in agreement with the report of Elfellah and Reed [5], in which the 
rise in KD of the ß2-adrenoceptor o n guinea pig gastrocnemius muscle observed 
after PRO treatment was reversed by 5 washings in total. 
Because a number of experimental artefacts could be excluded, at least in 
part, as the origin of the elevated KD due to BAA treatment, it seems likely that 
the increase in it reflects a decrease in the affinity of the radioligand for the ß2-
adrenoceptor. Because the radioligand is, in fact, a radiolabelled BAA, a 
decrease in affinity will affect the binding of BAA to ß2-adrenoceptors during 
treatment. Has the putative decrease in affinity any implications for the blood 
pressure lowering effect of BAAs? The fact that the decreased agonist affinity 
was already observed 3 h after a single dose of the BAAs, and that blood 
pressure was decreased at that time [20] while the ß2-adrenoceptor density 
was unchanged, suggests that the decreased affinity may play a role in the 
antihypertensive action of BAAs. Perhaps the phenomenon may explain part of 
the complex relationship between the pharmacokinetics and pharmacodynamics 
of BAAs [1,3). Further studies are needed to determine whether the affinity for 
(endogenous) agonists is also changed during treatment with BAAS. 
Besides an effect on KD, repeated administration of PIN and DIL (the BAAs 
with PAA)decreased the MNL li2-adrenoceptor density, whereas PRO had no 
such action. The effect of PRO treatment on the ß2-adrenoceptor density on 
human MNL is conflicting; m some studies PRO has appeared to induce an 
increase in the ß2-adrenoceptor density [3,5,6,8], whereas in another study the 
ß2-adrenoceptor number on MNL remained unchanged [7]. In contrast, ß2-
adrenoceptor density is known to decrease after prolonged PIN administration 
[3,6,7]. The down-regulation of ß2-adrenoceptor density observed here after 
repeated DIL administration had previously been shown by Sbirrazzuoli et al. 
[21] in a broken MNL preparation. Although the number of subjects (n = 6) in 
their study was limited, the results of the studies are generally in agreement. 
The down-regulation during DIL treatment was comparable with that after PIN 
treatment. Since PAA was reported for both PIN [2] and DIL [22,23], the down-
regulation observed after DIL treatment is likely to be the result of its PAA. 
It is interesting to note that the down-regulation of the ß2-adrenoceptors on 
MNL in this study was of the same order of magnitude during treatment with a 
partial (PIN, DIL) and a full (SAL) ß-adrenoceptor agonist. In the present study, 
the down-regulation was limited to a maximum of about 30% of the baseline 
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ß2-adrenoceptor number. This decrease in receptor number apparently could be 
reached during treatment with a partial agonist, even with a compound that has 
only moderately strong PAA, such as DIL. A full agonist appeared to be unable 
to reduce the ß2-adrenoceptor number on MNL any further, so either the 
agonistic activity of PIN and DIL was already sufficiently strong to induce the 
maximal down-regulation, or down-regulation is a process that needs very weak 
agonistic activity to be manifested maximally. 
From the present data, it is concluded that treatment with non-selective 
BAAs, irrespective of their lipophilicity or ancillary properties, causes a decrease 
in the MNL ß2-adrenoceptor affinity for antagonists. Since a decrease in 
receptor affinity was observed for all BAAs in the present study, whereas 
treatment with the agonist SAL did not result in a change in affinity, the effect 
may be a general property of BAAs, but not agonists. If the finding is extrapo-
lated to ß2-adrenoceptors at the hypotensive site(s) of action of BAAs, it may 
help to explain the complex relationship between plasma concentration and 
antihypertensive activity of this type of drug. The decrease in receptor affinity is 
not related to the decrease in receptor density, as induced by repeated adminis-
tration of BAAs with PAA. 
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fl-ADRENERGIC RECEPTOR-MEDIATED RELAXATION IN SHR AND WKY 
ABSTRACT 
An attenuated ß-adrenergic receptor-mediated vasodilation may explain the 
increased peripheral resistance observed in hypertension. To investigate this, 
the isoprenahne-induced relaxation of mesenteric resistance arteries was 
compared between SHR and WKY rats using a small vessel myograph. The 
arteries had similar diameters but the contractile force induced by cumulative 
addition of K+ (10-130 mM) was 1.3-fold higher for the SHR. The ß-adrenergic 
receptor-mediated relaxation of arteries, precontracted with 40 mM K + , was 
significantly smaller in the resistance arteries of SHR (SHR. 41 ± 3 % (n = 
11); WKY: 56 ± 3 % (n = 15), ρ = 0.003) The pD 2 value for isoprenalme 
was significantly lower in SHR (7 13 ± 0.09 vs. 7 41 ± 0.07; ρ = 0.02). In 
contrast, when precontracted with phenylephrine (σ1-adrenoceptor agonist, 3-
10 μΜ), isoprenalme could induce an almost complete relaxation of the resis­
tance arteries from both SHR and WKY. Moreover, now the pD 2 values for 
isoprenalme tended to be higher in the SHR. Forskolm, a stimulator of adenylyl 
cyclase activity, induced an almost complete relaxation of K + -precontraction 
with no significant differences between SHR and WKY arteries. We conclude, 
that the kind of precontraction plays an important role in the appearance of an 
attenuated isoprenalme-mduced relaxation of SHR mesenteric resistance 
arteries 
INTRODUCTION 
An increased peripheral vascular resistance is generally observed in hyperten­
sion [1]. One of the mechanisms that may explain this observation is an 
elevated sympathoadrenal activity, resulting in an altered sensitivity of the 
postjunctional adrenergic receptors [21. Both a- and ß-adrenergic receptors are 
present on the smooth muscle of the vascular wall. Stimulation of the a-
adrenergic receptors leads to a vasoconstriction whereas stimulation of ß-
adrenergic receptors results in vasodilation. Therefore, the increased peripheral 
resistance can be explained by either an increased sensitivity of the σ-adrenergic 
receptor system or a blunted ß-adrenergic receptor response. 
Because studies regarding alterations in σ-adrenergic receptors in hyperten­
sion have yielded contradictory results, the ß-adrenergic receptor system has 
been investigated more extensively [2,3]. In most of these studies animal 
models of hypertension, like spontaneously hypertensive rats (SHR), have been 
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used. In conducting arteries of SHR, like aorta and femoral artery, the ß-adrener-
gic responsiveness was shown to be decreased in a number of studies [4-10]. 
The main part of the vascular resistance, however, is generated in the smaller 
arteries or resistance vessels [11]. Therefore, these vessels seem more appropri-
ate to study alterations in ß-adrenergic responsiveness in hypertension than the 
larger conducting arteries 
In the present study, we examined the properties of the ß-adrenergic receptor 
system in rat mesenteric resistance arteries To this end, the relaxation of these 
resistance arteries in response to isoprenahne (ß-adrenergic receptor-mediated 
relaxation) and forskolin (stimulation of adenylyl cyclase activity) were com-
pared between SHR and normotensive Wistar Kyoto (WKY) rats. In order to 
investigate the role of different kinds of precontraction on the ß-adrenergic 
responsiveness, we compared the isoprenahne relaxation after precontraction 
with K+ (contraction by membrane depolarization) and phenylephrine (σ·|-
adrenergic receptor-mediated contraction) in SHR and WKY 
MATERIALS AND METHODS 
Materials 
Isoprenahne was purchased form Lansberg BV, Uden, The Netherlands, 
phenylephrine from Genfarm BV, Maarssen, The Netherlands and forskolin from 
Sigma, St Louis, MO, USA All other reagents were of analytical quality 
Preparation of the mesenteric arteries 
Male SHR and WKY rats were obtained from Harlan Olac LTD,, Bicester, UK. 
At the age of 12-18 weeks, the rats were killed by cervical dislocation, 
whereafter the intestine was removed and stored for less than 24 h at 4°C in 
PSS-solution (120 mM NaCI, 4.7 mM KCl, 2.5 mM CaCI2, 25 mM NaHC0 3 , 
1 1 7 mM MgCI 2 , 1.2 mM KH 2 P0 4 , 2.7 //M EDTA and 5.5 mM glucose). 
Storage for up to 24 hrs did not affect any of the parameters determined in this 
study Parts of the small intestine, 7-15 cm from the stomach, were fixed on a 
wax plate and submerged under PSS Side branches of the superior mesenteric 
artery were dissected and mounted on a small vessel myograph as described by 
Mulvany and Halpern [11] (see also the General Introduction of this thesis). 
Briefly, two stainless steel wires (diameter 40 μπ\) were inserted into the lumen 
of the resistance arteries The wires were mounted between an isometric force 
transducer (Kistler Morse DSC 6, Seattle, WA, USA) and a displacement device 
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(Mitatoyo, Tokyo, Japan) m a 10 ml organ chamber. The organ chamber was 
filled with PSS solution, maintained at 37 °C and continuously aerated with 
95% 0 2 and 5% C 0 2 (pH 7.4) After equilibration for 1 h at 37 °C, the arteries 
were set to a normalized internal circumference ( Ц ) , estimated to be 0 9 times 
the circumference they would maintain if relaxed and exposed to a transmural 
pressure of 100 mm Hg ( L 1 0 0 ) , a procedure described in detail by Mulvany and 
Halpern [11] The mean internal diameter at 100 mm Hg was 238 ± 39 /ял 
(η = 1 1 , mean ± SD) and 246 ± 67 μχτ\ (η = 15) for SHR and WKY, respec­
tively, which is characteristic for resistance vessels [11]. The arteries mounted 
in the myograph were 1 8-2 0 mm long 
Contraction and relaxation of resistance arteries 
After normalization, the resistance arteries were contracted for 1 mm by 
exchanging the PSS for K-PSS, in which all NaCI was replaced by KCl (total K + -
concentration 125 mM), followed by rinsing twice with PSS This procedure 
was repeated after 15 mm 
A cumulative concentration response curve was recorded by increasing the 
К
+
-concentration stepwise from 10 to 125 mM K + After washing twice in 15 
mm, the arteries were contracted with a mixture of 3 0 % K-PSS and 7 0 % PSS 
(total K + -concentration 40 mM), which gave precontractions of 70-90% of the 
maximal contractions observed in the concentration response curves. In 
preliminary experiments, 6-hydroxy-dopamme treatment did not affect the K + -
mduced contraction, indicating that this contraction is the result of depolariza­
tion of smooth muscle cells rather than nerve endings The relaxing effect of 
isoprenalme and forskolin was then studied by a stepwise increase in their 
concentration (10 nM - 3 2 μΜ) Thereafter, the effect of phenylephrine 
precontraction on the isoprenalme relaxation was studied by contracting the 
arteries with 3-10 μΜ of phenylephrine, after stabilization, the relaxing effect of 
isoprenalme was studied as described above 
Data analysis 
The concentration response curves were analyzed using GraphPad, a non­
linear curve fitting program (GraphPad, Institute for Scientific Information, San 
Diego, CA, USA). Sensitivities to drugs, expressed as pD 2 values and maximal 
effects were calculated on the basis of data from individual arteries. The 
responses to relaxing agents were expressed as the absolute decrease in 
tension (mN) and as a percentage of the precontraction. The data are expressed 
as mean ± SEM Statistical analysis of the results was performed using a two-
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sample Wilcoxon rank sum test for comparison of the SHR and WKY arteries, 
and a paired Wilcoxon signed rank test for comparison of the different precon-
tractions. A p-value < 0.05 (two-sided) was considered to be statistically 
significant, whereas insignificant differences are indicated by NS (not signifi­
cant) in the text. 
RESULTS 
Concentration response curves for K + 
The contractions of the mesenteric resistance arteries, induced by a cumula­
tive increase in К '-concentration, are shown in Fig. 1. The maximal contractile 
force of SHR arteries was 1.3-fold higher than of WKY arteries, a difference 
which was statistically significant (p = 0.03). The pD 2 values for K + were 1.33 
± 0.04 (n = 11) and 1.35 ± 0.03 (n = 15, NS) for SHR and WKY, respectively. 
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FIGURE 1 : Concentration-response curves for the absolute contraction, expressed in mN, of 
mesenteric resistance arteries of SHR (solid line, η = 11) and WKY (dashed line, η = 15) to 
cumulative addition of K* Curves are constructed by fitting the averaged data from the individual 
experiments Error bars indicate the SEM 
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Relaxation of the arteries with isoprenaline 
The relaxation with isoprenaline was studied after precontraction of the 
arteries with 40 mM K + ; this precontraction was stable for at least 40 min. As 
shown in Fig. 2, panel A, the precontraction was slightly but insignificantly 
higher in the SHR arteries (Table 1). After precontraction, increasing doses of 
isoprenaline (10 nM - 30 //M) were added to the organ bath, which resulted in a 
concentration-dependent partial relaxation of the arteries. The absolute relaxa-
tion, expressed in mN, was not significantly different between the two groups 
(Table 1). However, when the relaxing response to isoprenaline was expressed 
as a percentage of the precontraction with 40 mM K+ (Fig 2, panel В), a 
significant attenuation of the relaxing effect of isoprenaline was observed in 
SHR as compared to WKY. No decrease in fractional relaxation was observed 
for the endothelium-dependent relaxation, induced with methacholine (see 
chapter 7 of this thesis); this indicates that the attenuated isoprenaline-induced 
relaxation does not reflect a general defect in the relaxation of SHR mesenteric 
resistance arteries. The pD 2 for isoprenaline was significantly lower in the SHR 
arteries, precontracted with 40 mM K + (Table 1). 
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FIGURE 2: Relaxation of mesenteric resistance arteries, precontracted with 40 mN K + , by 
cumulative addition of isoprenaline. Solid line - SHR (n = 11), dashed line = WKY (n = 15). In 
panel A, the absolute relaxation is shown, whereas in panel В the relaxation is expressed as a 
fraction of the precontraction С - force in the absence of isoprenaline. Error bars represent SEM. 
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TABLE 1 Comparison of the relaxations induced by isoprenalme and forskolm in SHR and WKY 
mesenteric resistance arteries 
ISOPRENALINE 
K+-precontraction 
precontraction (mN| 
relaxation (mN) 
fractional relaxation (%) 
p D 2 ( log M) 
η 
PE precontraction 
precontraction (mN) 
relaxation (mN) 
fractional relaxation (%) 
p D 2 ( log M) 
η 
FORSKOLIN RELAXATION 
К
 +
 -precontraction 
precontraction (mN| 
relaxation (mN) 
fractional relaxation (%) 
p D 2 ( log M) 
η 
SHR 
5 7 + 0 5 
2 3 + 0 2 
41 ± 3 
7 13 ± 0 0 9 
11 
4 7 + 0 6 
4 4 + 0 7 
93 + 2 
7 05 ± 0 11 
8 
4 8 + 0 4 
4 0 + 0 4 
8 1 + 3 
7 08 ± 0 12 
11 
WKY 
5 2 ± 1 3 
2 9 ± 0 5 
56 ± 3 
7 41 ± 0 07 
15 
6 5 ± 1 0 
6 2 ± 1 1 
91 ± 3 
6 76 ± 0 11 
12 
4 3 + 0 4 
3 7 + 0 8 
84 + 2 
7 01 + 0 13 
15 
Ρ 
NS 
NS 
0 003 
0 02 
NS 
NS 
NS 
0 07 
NS 
NS 
NS 
NS 
Data are expressed as mean + SEM and calculated on the basis of the results of curve fits from 
individual arteries NS - not statistically significant, PE = phenylephrine 
In order to study a possible effect of the precontraction on isoprenalme 
relaxation, we also used the o^selective adrenergic agonist phenylephrine [12] 
as a precontracting agent The contraction induced by phenylephrine (3-10 μΜ 
in PSS) was significantly stronger than the response to K + in WKY arteries, but 
significantly weaker in SHR arteries (Table 2). 
Phenylephrine induced an oscillating contraction in all arteries tested, a 
phenomenon which was also observed with oxymethazoline, noradrenaline and 
serotonin (data not shown) In part of the arteries (SHR 3 of 1 1 , WKY- 3 of 15) 
the phenylephrine response was transient and did not reach sufficient stability 
to study the isoprenaline-mediated relaxation, in preliminary experiments, the 
phenylephnne-induced contraction was sufficiently stable for more than 20 mm 
(not shown) In contrast to «"""-precontraction, the li-adrenergic receptor-
mediated relaxation was almost complete in phenylephrine precontracted 
arteries (Fig. 3, panel A). The fractional relaxation, depicted in Fig 3, panel B, 
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was similar in SHR and WKY, although the concentration response curve for 
WKY was shifted to the right. This resulted in a slightly higher pD2-value for 
isoprenaline in SHR (Table 1). 
TABLE 2: Effect of different precontractions on the relaxing properties of isoprenaline 
KH 
SHR ( n - 8 ) 
precontraction ImN) 
relaxation (mN) 
% relaxation 
p D 2 (Ml 
WKY (n =11) 
precontraction (mN) 
relaxation (mN| 
% relaxation 
p D 2 
5.8 ± 0.5 
2.4 ± 0.2 
4 1 + 3 
7 14 ± 0 0 7 
5.6 + 0.8 
3.1 ± 0 5 
56 ± 3 
7 37 ± 0.05 
phenylephrine 
4.7 ± 0.6 
4.4 ± 0.7 
94 ± 6 
7 05 ± 0.10 
6.5 + 1.1 
6 1 ± 1.1 
91 ± 10 
6.76 ï 0.11 
0.005 
0.001 
0.007 
NS 
0.003 
0 001 
0.001 
0.001 
For explanation, see legend to Table 1. 
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FIGURE 3: Relaxation of mesenteric resistance arteries, precontracted with 3-10 μΜ phenyl­
ephrine, by cumulative addition of isoprenaline. Solid line - SHR (n = 81; dashed line = WKY (n = 
12). For details, see legend to Fig. 2. 
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Relaxation of the mesenteric resistance arteries with forskolin 
The forskolin mediated relaxation of the arteries, precontracted with 40 mM 
K + , is shown in Fig. 4. In panel A, the absolute relaxation is shown. As 
observed for the ¡soprenaline relaxation, the precontraction of the SHR arteries 
was not significantly different from the precontraction of the WKY arteries. 
Forskolin almost completely relaxed the arteries of both SHR and WKY and the 
concentration response curves showed no marked differences between the two 
groups. The pD2 values were not significantly different between the two groups 
(Table 1). 
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FIGURE 4: Relaxation of mesenteric resistance arteries, precontracted with 40 mM K + , by 
cumulative addition of forskolin See legend to Fig. 2 for details. 
DISCUSSION 
In the present study, the properties of the ß-adrenergic receptor system 
present in mesenteric resistance arteries were compared between SHR and 
WKY rats. To our knowledge, this is the first study in which this system is 
investigated in resistance vessels, which contribute strongly to the vascular 
resistance and therefore are one of the primary targets for hypertension 
research. 
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K+-precontraction 
The maximal contraction of the mesenteric resistance arteries, induced by 
125 mM K + , was significantly higher in the SHR as compared to the WKY. This 
is in agreement with other studies [8-10], in which strips of conducting arteries, 
mainly femoral arteries, from SHR and WKY were used. These results indicate 
that both in conducting arteries and in resistance arteries of SHR an abnormality 
is present which results in an increased K + -induced contractile force. This 
abnormality may be a malfunction of the sarcoplasmic reticulum, as recently 
observed in femoral arteries of SHR [13]. 
Isoprenaline-mediated relaxation of K + -precontraction 
Cumulative addition of isoprenaline induced a partial relaxation of the 
mesenteric resistance arteries, precontracted with 40 mM K + , in both SHR and 
WKY In an earlier study, we have shown that this relaxation was not the result 
of a release of endothelium-denved relaxing factor (EDRF), and therefore is 
probably the result of a direct stimulation of ß-adrenergic receptors on vascular 
smooth muscle cells [14]. The precontraction and absolute isoprenaline-induced 
relaxation were not significantly different between SHR and WKY. However, 
when expressed as a fraction of the precontraction, the isoprenaline-induced 
relaxation was significantly lower in SHR arteries. Moreover, the pD2 for 
isoprenaline was significantly lower in SHR as compared to WKY. These results 
are similar to those observed in a number of studies with conducting arteries of 
SHR [4-10], in which the ß-adrenergic receptor-mediated relaxation was 
expressed as a fraction of the papaverme-mduced relaxation. The decreased 
pD2-value of the SHR arteries for isoprenaline indicates that the responsiveness 
of arterial ß-adrenergic receptors may be attenuated in hypertension. 
Isoprenaline-mediated relaxation of phenylephrine-induced precontraction 
In order to study the role of the precontraction on the ß-adrenergic receptor-
mediated relaxation, we used phenylephrine, an o^selective adrenergic receptor 
agonist [12], as a contracting agent. This ayselective adrenergic agonist 
induces contraction through the inositol phospholipid metabolism [15], without 
the inhibition of cAMP production, as described for o2-adrenergic receptors [16]. 
The latter would interfere with the isoprenaline-mediated stimulation of the 
cAMP production, and hamper the interpretation of the relaxation experiments. 
Phenylephrine induced oscillating contractions of the resistance arteries in 
both SHR and WKY. These oscillations were also observed in rat resistance 
arteries contracted with noradrenaline [17], in human omental small arteries [18] 
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and are probably the result of the release of eicosanoids [19] In contrast to K + -
precontraction, the precontraction with phenylephrine could almost completely 
be relaxed by isoprenaline in both SHR and WKY. Moreover, the pD2 for 
isoprenalme tended to be higher in the SHR as compared to the WKY, which is 
in marked contrast to the results obtained with K + -precontraction These results 
indicate that the ß-adrenergic receptor-mediated relaxation of resistance arteries 
and its attenuation in SHR depend on the kind of precontraction used. This is in 
agreement with the results of Abe and Karaki [20], who showed that dibutyryl 
cyclic AMP could relax rat aorta strips more effectively after σ-adrenergic 
receptor-mediated precontraction than after precontraction with K + . 
Effect of precontraction on ß-adrenergic receptor-mediated relaxation 
The difference in isoprenahne-mediated relaxation of K + - and phenylephrme-
precontracted arteries may be explained by the way in which these compounds 
induce contraction In a recent report Jensen et al [21] showed that K + 
induces contractions of mesenteric resistance arteries mainly by increasing the 
intracellular Ca2 +-concentration, whereas noradrenaline induces contraction by 
increasing the sensitivity of the contractile apparatus for Ca2_h, together with a 
relatively small increase m the intracellular Ca2 +-concentration. Moreover, the 
cAMP-induced relaxation of vascular tissue has been reported to be the result of 
both a decrease in the Ca2 +-sensitivity of the contractile apparatus and a 
decrease in the intracellular Ca2 +-concentration [22] The complex relation 
between the intracellular Ca2 +-concentration and tension, and the dual mecha-
nism by which cAMP can induce relaxation may help to explain the precontrac-
tion-dependence of the isoprenahne-mediated relaxation, observed in the present 
study Simultaneous measurements of intracellular Ca2 "-concentration and 
force will be necessary to explain the role of the precontraction on the isopre-
naline-mediated relaxation and its possible alterations in hypertension. 
Forskolin-mediated relaxation of K + -precontraction 
Besides ß-adrenergic receptor-mediated relaxations of the mesenteric resis-
tance arteries, the relaxations in response to forskolin were compared between 
SHR and WKY Forskolin could almost completely relax a precontraction with 40 
mM K+ in both SHR and WKY mesenteric arteries. Also, no difference in the 
pD2 value was observed This indicates, that the stimulation with forskolin does 
not result in a difference in adenylyl cyclase activity between SHR and WKY 
rats Therefore, it can be concluded that the possible defect in the ß-adrenergic 
receptor system in SHR, which gives rise to an attenuated relaxation upon K + -
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precontraction, is located in the (i-adrenergic receptor G-protein coupling rather 
than ¡n the second messenger synthesis. 
Conclusions 
The results of the present study suggest that the responsiveness of the ß-
adrenergic receptor system for relaxation of a K + -induced contraction is de-
creased in SHR mesenteric resistance arteries as compared to WKY. On the 
other hand, the relaxation of a phenylephrine-induced contraction is not diffe-
rent between the two groups. This suggests that an attenuation in the IÌ-
adrenergic receptor responsiveness may be present in mesenteric resistance 
arteries of SHR, but that its appearance is dependent on the way the vascular 
tissue is precontracted. These observations may be explained by the complex 
relationship between force and Ca2"^-concentration in the arterial smooth 
muscle cells. 
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ENDOTHELIUM-DEPENDENT CONTRACTION AND RELAXATION 
ABSTRACT 
The endothelium-dependent relaxation by methachohne and its inhibition by 
NG-monomethyl-L-arginine (L-NMMA) were studied in mesenteric resistance 
arteries from spontaneously hypertensive rats (SHR) and Wistar Kyoto (WKY) 
rats, mounted in a small vessel myograph. The maximal relaxation and the pD 2 
for methachohne were not significantly different between the t w o groups Only 
in SHR arteries, higher concentrations of methacholine-mduced transient 
contractions These contractions could be abolished by storage of the tissue for 
24 h at 4 °C before preparation of the arteries L-NMMA induced a decrease in 
the maximal relaxation, which was similar for SHR and WKY, and a rightward 
shift in the concentration response curve for methachohne The decrease in pD 2 
for methachohne was significantly larger in SHR during 10"4 M L-NMMA. In 
conclusion, the endothelium-dependent relaxation with methachohne is unal­
tered in mesenteric resistance arteries from SHR, but L NMMA induces a 
significantly stronger decrease in the pD 2 for methachohne in this group. 
INTRODUCTION 
The role of the endothelium in the local regulation of vascular tone has well 
been established [1,2] Since the original experiments by Furchgott and Zawad-
ski [3], in which the endothelium-dependent relaxation of vascular tissue was 
demonstrated, three endothehum-mediated mechanisms for the modulation of 
vascular tone have been described 1) The release of endothehum-denved 
relaxing factor (EDRF), identified as nitric oxide, which induces vasodilation [4]; 
2) The release of endothehum-denved contracting factor (EDCF), consisting of 
endothehn and several other factors [5], which induces vasoconstriction; 3) The 
release of endothehum-denved hyperpolanzing factor (EDHF), which is less well 
characterized but can induce vasodilation through hyperpolanzation of the 
vascular smooth muscle cells [6]. The release of endothehum-denved modula­
tors of vascular tone can be stimulated by shear stress, but compounds such as 
muscarinic and σ-adrenoceptor agonists can also induce endothelium-dependent 
modulation of vascular tone [1] 
It has recently been suggested that alterations in endothelium-dependent 
modulation of vascular tone may play a role in the increased peripheral resis­
tance which is generally observed in hypertension [1]. Either a decreased 
baseline production of EDRF or an attenuated EDRF release after stimulation by 
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e.g. shear stress may result in an increased peripheral resistance. Moreover, an 
increased release of EDCF [5] or a decreased release of EDHF [7] may also 
explain this phenomenon. In rat models of hypertension, a decreased endotheli-
um-dependent relaxation [8-10], an increased EDCF-production [5] and a 
decreased EDHF-release [7] have been reported. For these studies conducting 
arteries, like the aorta, were used. However, the main part of the peripheral 
resistance is generated in resistance arteries. Since the peripheral resistance is 
increased in hypertension [11], resistance arteries seem a more appropriate 
target for the study of alterations of endothelium-dependent modulation of 
vascular tone. 
In the present study, we compared the methacholme-induced modulation of 
vascular tone in mesenteric resistance arteries of spontaneously hypertensive 
rats (SHR) and normotensive Wistar Kyoto (WKY) rats, mounted in a wire 
myograph [12]. NG-monomethyl-L-argmine (L-NMMA) was used as a specific 
inhibitor of EDRF synthesis [4], and its effects on baseline vascular tone and 
methacholine-mduced relaxation were studied. 
MATERIALS AND METHODS 
Materials 
Methacholine was purchased from Janssen, Beerse, Belgium, and NG-mono-
methyl-L-arginine (L-NMMA) from Sigma, St Louis MO, USA. All other reagents 
were of analytical grade. 
Preparation of the mesenteric arteries 
Male SHR and WKY rats were obtained from Harlan Olac LTD., Bicester, UK. 
At the age of 12-18 weeks, the rats were killed by cervical dislocation, 
whereafter the intestine was removed and submerged under PSS-solution (120 
mM NaCI, 4.7 mM KCl, 2 5 mM CaCI2, 25 mM NaHC0 3 , 1.17 mM MgCI 2 , 1.2 
mM K H 2 P 0 4 , 2 7 μΜ EDTA and 5.5 mM glucose). Parts of the small intestine, 
7-15 cm from the stomach, were fixed on a wax plate and submerged under 
PSS. Side branches of the superior mesenteric artery were dissected and 
mounted on a small vessel myograph as described [12]. Briefly, two stainless 
steel wires (diameter 40 μηη) were inserted into the lumen of the resistance 
arterioles. The wires were mounted between an isometric force transducer 
(Kistler Morse DSC 6, Seattle WA, USA) and a displacement device (Mitatoyo, 
Tokyo, Japan) in a 10 ml organ chamber. The organ chamber was filled with 
116 
ENDOTHELIUM-DEPENDENT CONTRACTION AND RELAXATION 
PSS solution, maintained at 37 °C and continuously aerated with 9 5 % 0 2 and 
5% C 0 2 (pH 7.4). After equilibration for 1 hr at 37 °C, the arteries were set to 
a normalized internal circumference (Ц), estimated to be 0 9 times the circum­
ference they would maintain if relaxed and exposed to a transmural pressure of 
100 mm Hg ( L 1 0 0 ) , a procedure described in detail [12]. The mean internal 
diameter at 100 mm Hg was 220 ± 10 цт and 250 ± 9 //m (mean ± SE) for 
SHR and WKY, respectively, which is characteristic for resistance arteries [12]; 
the arteries mounted in the myograph were 1.8-2.0 mm long. 
Contraction and relaxation of resistance arteries 
In this study, 15 mesenteric resistance arteries from SHR and 12 from WKY 
were used. For both groups, 8 arteries were prepared immediately after removal 
of the intestine, whereas the other ones were prepared from intestines which 
were stored for 24 hrs in PSS at 4 °C. After normalization, the arteries were 
contracted for 1 mm by exchanging the PSS for K-PSS, in which all NaCI was 
replaced by KCl (total К "^-concentration 125 mM), followed by rinsing twice 
with PSS. This procedure was repeated after 15 mm 
A cumulative concentration response curve for K + was recorded by increas­
ing its concentration stepwise from 10 to 125 mM. After washing twice in 15 
mm, the arteries were contracted with a mixture of 3 0 % K-PSS and 7 0 % PSS 
(total K + -concentration 40 mM), which gave precontractions of 70-90% of the 
maximal contractions observed in the concentration response curves for K + . 
The endothelium-mediated relaxation was then studied by a stepwise increase in 
the concentration of methacholme (3.2 nM - 10 μΜ) Then the arteries were 
washed twice in 15 mm with PSS. 
Inhibition of EDRF-production by L-NMMA 
After the control concentration response curve with methacholme, the 
arteries were incubated with 10 5 M of L-NMMA for 15 mm Then the arteries 
were precontracted and a concentration response curve for methacholme was 
recorded in the presence of 10 5 M L-NMMA as described above. After wash­
ing, the arteries were incubated with 10"4 M L-NMMA, and the same procedure 
was repeated in the presence of 10"4 M L-NMMA. In pilot experiments, repeated 
recordings of methacholme concentration response curves in the absence of L-
NMMA did not affect the relaxation characteristics 
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Data analysis 
The concentration response curves were analyzed using GraphPad, a non­
linear curve fitting program (GraphPad, Institute for Scientific Information, San 
Diego, CA, USA). Sensitivities to drugs, expressed as pD 2 values, and maximal 
effects were calculated on the basis of data from individual arteries. The data 
are expressed as mean ± SE. Statistical analysis of the results was performed 
using a two-sample Wilcoxon rank sum test for comparison of the SHR and 
WKY arteries, and a paired Wilcoxon signed rank test for comparison of the L-
NMMA effects. A p-value < 0.05 (two-sided) was considered to be statistically 
significant, whereas insignificant differences are indicated by NS (not signific­
ant) in the text. 
RESULTS 
Concentration response curves for K + 
The maximal contraction of the mesenteric resistance arteries, induced by 
K + , was significantly higher in SHR than in WKY (6.7 ± 0.4, η = 15 vs. 5.5 ± 
0.4 mN, η = 12, respectively; ρ = 0.03). The pD2-value for K + was not 
significantly different between the two groups (1.49 ± 0.05 vs. 1.47 ± 0.05, 
respectively; NS). The higher maximal contraction in SHR arteries with no 
alteration in pD 2 is in agreement with own observations (Chapter 6 of this 
thesis). Storage for 24 h at 4 °C had no significant effect on the K + -induced 
contraction in both SHR and WKY. 
Endothelium-dependent relaxations and contractions 
In Fig. 1, original tracings from cumulative additions of the muscarinic 
receptor agonist methacholine to SHR and WKY mesenteric resistance arteries, 
precontracted with 40 mM K + , are shown. At low concentrations of methacho­
line, a dose-dependent relaxation was seen in both SHR and WKY arteries. 
However, higher concentrations of methacholine induced marked but transient 
contractions in the fresh SHR artery (Fig. 1 A). Storage of the intestine for 24 h 
at 4 °C resulted in an unchanged methacholine-induced relaxation but a 
completely abolished contraction of the SHR arteries at higher methacholine 
concentrations (Fig. 1 B). In WKY, the transient contractions were not observed 
in either fresh (Fig. 1 C) or stored tissue. 
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40mM K* 
FIGURE 1 : Drawings of original tracings of the relaxation of mesenteric resistance arteries from 
SHR and WKY rats induced by cumulative addition of methacholme. The arteries were precontracted 
with 40 mM K + ; methacholme concentrations (-log Ml are indicated in the tracings. In panel A, the 
response of a fresh SHR artery is shown, whereas in panel В the response of an artery from the 
same rat, after storage for 24 h at 4 °C, is depicted. In panel C, the response of a fresh WKY artery 
is shown. Note the transient methacholine-induced contractions at higher concentrations in the fresh 
SHR artery, but not in the stored one. 
The transient contractions, observed in SHR mesenteric resistance arteries, 
are further illustrated in Fig. 2, left panel. For this figure, only the data from 
fresh arteries, prepared immediately after removal of the intestine, were used 
(n = 8 for both SHR and WKY). Seven out of 8 of the SHR arteries showed a 
marked but transient contraction after the addition of methacholine concentra­
tions of 3 χ 10"7 M and higher. In contrast, only 1 of the 8 WKY arteries 
showed a slight contraction at higher methacholme concentrations (Fig. 2, right 
panel). Storage of the intestine for 24 h in PSS at 4 °C, followed by preparation 
and mounting of the mesenteric resistance arteries, could completely prevent 
the occurrence of contractions of SHR arteries at higher methacholine-concen-
trations (n = 7 for SHR). Repeated recording of a methacholine concentration 
response curve showed, that endothelium-dependent contraction occurred only 
in the first concentration response curve in most of the arteries. 
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FIGURE 2: Endothelium-dependent relaxation and contraction of fresh SHR (left panel, η = 81 
and WKY (right panel, η = 8) mesenteric resistance arteries. The continuous line represents the 
tension after 1 mm of stable response, whereas for the dashed line the peaks of the methacholine· 
nduced transient contractions were used. Note, that in WKY arteries hardly any methacholine-
nduced contraction was observed, whereas in SHR arteries these contractions, although transient, 
were quite marked. Data are presented as mean ± SE. 
Effects of L-NMMA 
L-NMMA can inhibit the production of nitric oxide (EDRF) and therefore can 
selectively block endothelium-dependent relaxation [4]. Since both baseline and 
methacholine-stimulated production of EDRF may be altered in hypertension, we 
used L-NMMA in two concentrations (10'5 and 10"4 M). In preliminary experi­
ments, 10' 3 M of L-NMMA was shown to block the methacholine-evoked 
endothelium-dependent relaxation completely (data not shown), whereas 10 
and 10 4 M of this compound induced a slight and a considerable reduction of 
endothelium-dependent relaxation, respectively. 
In Fig. 3, the concentration response curves for methacholine of SHR (n = 
15) and WKY (n = 12) arteries, and the effects of L-NMMA are shown. For 
these curves, the force after 1 min of stable response was used, so the tran­
sient contractions in the SHR arteries at higher methacholine concentrations 
were not taken into account. The maximal methacholine-mediated relaxation of 
the resistance arteries was 49 ± 5 % of precontraction in SHR (n = 15) and 
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52 ± 4 % (η = 12) in WKY, a difference which was not statistically signifi­
cant. Treatment with L-NMMA resulted in a significantly higher precontraction 
as compared to control in both SHR and WKY, but the increase in precontrac­
tion was not significantly different between the two groups (Table 1). The 
concentration response curves for methacholine were shifted to the right and 
the maximal relaxation of the resistance arteries was decreased by L-NMMA 
(Fig. 3). With ΙΟ"4 M L-NMMA, no methacholine-evoked relaxation was ob­
served in 3 arteries from SHR as well as from WKY; therefore, the data from 
these arteries could not be included in the concentration response curves for 
this L-NMMA concentration (Fig. 3) and no pD 2 could be calculated. As shown 
in Fig. 4, the decrease in pD 2 for methacholine was larger in SHR as compared 
to WKY, reaching statistical significance for 10"4 L-NMMA. 
WKY 
0 0 - 4 h 
C -8 -7 -6 -5 
log [methacholine] 
С -8 -7 -6 -5 
log [methacholine] 
FIGURE 3: Concentration response curves for the methacholine-mduced relaxation of mesenteric 
resistance arteries of SHR (left panel) and WKY (right panell, precontracted with 4 0 mM K + . 
Absolute relaxations, expressed in mN, are given. The contmous line represents the curves in the 
absence of L-NMMA (SHR. η = 15; WKY η - 12). Forces after 1 mm of stable response were 
used, so the transient contractions of the SHR arteries are not shown in the curves. In the presence 
of L-NMMA (dashed line. 10 5 M, dotted line· 10"4 M) a significant inhibition of the methacholine-
induced relaxation was observed With 10' 4 M L-NMMA, methacholine failed to induce relaxation in 
3 arteries from SHR and 3 arteries from WKY so no concentration-response curves could be 
constructed for these arteries with this L-NMMA concentration. Data are presented as mean ± SE. 
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TABLE 1: Effect of L-NMMA treatment on the precontraction wi th 4 0 rnM K + and on the pD 2 for 
methacholme 
PRECONTRACTION 
SHR 
WKY 
control 
5.15 ± 0.51 
NS 
4.06 ± 0.53 
10" 5 L-NMMA 
5.91 ± 0.59 
NS 
4.83 ± 0 . 5 7 s 
1 0 ^ L-NMMA 
7.18 ± 0 . 7 4 b 
NS 
6.24 ± 0.56 c 
p D , 
SHR 
WKY 
7.35 ± 0 12 
NS 
7 06 ± 0.10 
6.43 ± 0 . 1 3 c 
NS 
6.38 ± 0 . 1 0 c 
6.19 ± 0 . 0 8 c 
ρ = 0.02 
6.39 ± 0 . 0 9 b 
Precontractions are expressed in mN, data are presented as mean ± SE. °. ρ < 0.05: b ' ρ < 0 0 1 ; 
c : ρ < 0 005 versus control values (Wilcoxon's signed rank test for paired observations). Between 
values for SHR and WKY, significance level for the comparison is given (Wilcoxon's rank sum 
test). 
ûpD 2 
FIGURE 4 : Decrease In pD2 for me-
thacholme induced by treatment with L-
NMMA in arteries from SHR (solid bars) 
and WKY (hatched bars). The decrease 
was significantly larger in SHR arteries 
after treatment with 10"4 M of L-NMMA 
(* : ρ < 0.05I . 
ισ
5 IO4 
[L-NMMA] 
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DISCUSSION 
In the present study, a methachohne-induced relaxation was observed in 
mesenteric resistance arteries, precontracted with 40 mM K + . This relaxation 
could be inhibited by L-NMMA, a specific inhibitor of EDRF release No signifi-
cant difference in methachohne-induced relaxation was observed between SHR 
and WKY. In contrast, in SHR but not in WKY arteries a transient contraction 
could be induced by higher concentrations of methacholme 
Endothelium-dependent relaxation and contraction in hypertension 
In ring preparations of conducting arteries from SHR and WKY rats, the 
endothelium-dependent relaxation and contraction have been studied quite 
extensively In general, at low concentrations of muscarinic agonist similar 
relaxations were observed in both groups, probably by EDRF-release mediated 
by M2-muscannic receptors [13] However, at muscarinic agonist con-
centrations of 10 6 M and higher, a contraction was observed in the SHR but 
not in the WKY arteries [8-10]. This finding was confirmed for mesenteric 
resistance arteries from stroke-prone SHR, mounted in a small vessel myograph 
[14], and by the results of the present study In contrast, in the forearm 
vascular bed of primary hypertensive subjects, an attenuated EDRF-release 
without endothelium-dependent contractions has been reported [15,16]. 
The EDCF involved in the methachohne-induced contraction of conducting 
arteries from SHR could be identified as either prostaglandin F2a [8] or prosta-
glandin H2 [10] Since the observations in our study are in agreement with 
those from conducting arteries, it is likely that the contractions of the SHR 
resistance arteries are the result of an increased release of these EDCFs. 
Endothelium-dependent modulation of resistance artery tone 
Alterations in the endothelium-dependent modulation of resistance artery tone 
in hypertensive rats have mainly been investigated using perfusion techniques 
[17,18] or by measuring the vascular diameter by video analysis [19,22,23] 
The results of these studies are quite inconsistent: a decrease in muscarinic 
agonist-induced relaxation [22,23], a decreased pD2 for methacholme [17] and 
no change m acetylcholine-induced endothelium-dependent modulation of 
vascular tone [18,19] in the hypertensive rats were reported with these tech-
niques. It is interesting to note that in none of the studies with perfusion 
techniques an endothelium-dependent contraction of arteries from hypertensive 
rats was reported at higher muscarinic agonist-concentrations, as observed in 
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the present study This is in marked contrast with the results observed with 
vascular ring preparations, mounted in an organ bath or a small vessel myo-
graph This would suggest that the isometric method for registration of vascular 
tension is necessary for the observation of the endothelium dependent contrac-
tion in resistance arteries from SHR 
Transient nature of EDCF-release 
In none of the studies concerning the enhanced EDCF release in SHR the 
transient nature of the contraction of the SHR arteries was observed However, 
in the present study it was shown that methacholme induced transient contrac-
tions of SHR resistance arteries which were almost completely reversible, and 
generally restricted to the first concentration response curve for methacholme 
In most cases, a second registration in the same artery, either in the presence or 
absence of L NMMA, showed no endothelium-dependent contraction in SHR 
Moreover, storage of the intestine for 24 h at 4 °C did not affect the 
endothelium-dependent relaxation but abolished the endothelium-dependent 
contraction in SHR arteries Since the contractions are transient and dependent 
on the experimental procedure used, further study will be needed to elucidate 
the role of the enhanced EDCF release in the development and maintenance of 
hypertension in SHR 
Effects of L-NMMA 
In order to study the effect of EDRF on the precontraction and methachohne-
induced relaxation of mesenteric resistance arteries, L-NMMA was used as a 
specific inhibitor of EDRF production [4] Both in SHR and WKY arteries, a 
concentration-dependent increase in the precontraction with 40 mM K+ was 
observed However, this increase in precontraction was not significantly 
different between SHR and WKY This indicates, that the baseline release of 
EDRF plays a role in the control of vascular tone in mesenteric resistance 
arteries, but that this control mechanism is unaltered in SHR This is in agree-
ment with the results from infusion experiments with L-NMMA in SHR and WKY 
rats in vivo [20] 
As expected, L-NMMA reduced the methacholine-induced relaxation of 
mesenteric resistance arteries in a concentration-dependent way The decrease 
in maximal methacholine-induced relaxation after L-NMMA treatment was not 
significantly different between SHR and WKY, but the rightward shift in the 
concentration response curve for methacholme, reflected by a decrease in pD2 , 
was significantly higher in SHR as compared to WKY arteries From these 
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experiments, it can be concluded that the methacholine-induced production of 
EDRF in SHR is more sensitive to inhibition by L-NMMA as compared to WKY. 
Involvement of EDHF 
In aorta of renal hypertensive rats, the EDHF-release was reported to be 
decreased [7]. Because EDHF, like EDRF, induces relaxation of the vascular 
smooth muscle, endothelium-dependent relaxations may in part be explained by 
EDHF release. However, in our study the arteries were precontracted by a 
depolarization of the smooth muscle cells with K + , so no hyperpolarization by 
EDHF will occur [7] . On the other hand, in most of the other studies concerning 
endothelium-dependent relaxation, noradrenaline or σ-adrenoceptor agonists 
were used as precontracting agents. Under these conditions, EDHF release as 
well as σ-adrenoceptor-mediated EDRF release [21] can play a role the vascular 
relaxation, which may complicate the interpretation of the data from these 
studies. 
Conclusions 
In mesenteric resistance arteries from SHR, the methacholine-induced 
relaxation mediated by EDRF is not impaired, but treatment with L-NMMA 
causes a significantly stronger decrease in the pD 2 for methacholine. The 
enhanced release of EDCF, observed in SHR at high methacholine-concentrat-
ions, may lead to an increased vascular tone. However, its transient nature and 
the absence of reports of these contractions in perfusion experiments compli­
cate the interpretation of this finding. Because of the precontraction with K + , 
which induces a depolarization of the vascular smooth muscle, a contribution of 
EDHF to the endothelium-dependent relaxation, observed in the present study, 
is unlikely. 
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EFFECT OF L-NMMA ON U-ADRENOCEPTOR MEDIATED RELAXTION 
ABSTRACT 
(i-Adrenoceptors are present on vascular smooth muscle and on endothelium 
We investigated whether the endothelial l i adrenoceptors induce relaxation of 
rat mesenteric resistance arteries by stimulation of endothehum-derived relaxing 
factor (EDRF) release To this end, the relaxation was studied in the presence 
and absence of 100 μΜ NG-monomethyl-L-argmine (L-NMMA), a specific inhibi­
tor of the production of EDRF The maximal relaxation with isoprenahne, 
expressed as a percentage of the precontraction, was 44 0 ± 4 0 % (n = 12) 
in the L NMMA treated group and 58 0 ± 2 6 % (n = 13) in the untreated 
group, a statistically significant difference (P = 0 008). However, the precon 
traction with 40 mM K + tended to be higher in the presence of L-NMMA. The 
pD2-value for isoprenahne was not significantly changed by the L-NMMA 
treatment We conclude that the isoprenalme-mediated relaxation of mesenteric 
resistance arteries is inhibited by L-NMMA, but that this effect can at least in 
part be ascribed to an inhibition of baseline EDRF release 
INTRODUCTION 
Relaxation of arteries can be mediated by post-synaptic ß-adrenoceptors of 
the ß2-subtype [1] and by the release of endothelium-denved relaxing factor 
(EDRF), identified as nitric oxide [2] EDRF release can be induced by several 
compounds [3], including σ-adrenergic and muscarinic agonists Whether ß-
adrenoceptors also can mediate the release of EDRF is not well established, 
although for rat aorta a relation between endothelium and ß-adrenoceptor-
mediated relaxation has been suggested [4] However, on vascular endothelium 
ß-adrenoceptors were shown to be present using autoradiographic techniques 
[5] ß Adrenoceptors were also identified on bovine vascular endothelial cells in 
culture, and they were found to be functionally coupled to adenylyl cyclase, the 
enzyme which synthesizes the second messenger cyclic AMP [6] Therefore, it 
is of interest to investigate the possible role of EDRF in the ß-adrenoceptor-
mediated relaxation To this end, concentration response curves for isopre-
nahne, a ß-adrenoceptor agonist, were compared between two groups of 
mesenteric resistance arteries In one group 100 μΜ N G monomethyl-L-arginine 
(L-NMMA) was used as a specific inhibitor of EDRF release [7], whereas the 
other group served as a control 
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METHODS 
Mesenteric resistance arteries were isolated from 12-18 week old male Wistar 
Kyoto rats. The arteries were mounted in a small vessel myograph, filled with 
PSS-solution (120 mM NaCI, 4.7 mM KCl, 2.5 mM CaCI2, 25 mM NaHC0 3 , 
1.17 mM MgCI 2 , 1.2 mM KH 2 P0 4 , 2.7 μΜ EDTA and 5.5 mM glucose) [8]. The 
myograph was maintained at 37 °C and continuously aerated with 9 5 % 0 2 / 
5% C 0 2 . After equilibration for 1 h, the arteries were set to a normalized 
internal circumference (Ц), estimated to be 0.9 times the circumference they 
would maintain if relaxed and exposed to a transmural pressure of 100 mm Hg, 
as described by Mulvany & Halpern [8]. Then the arteries were contracted twice 
with PSS-solution in which all NaCI was replaced by KCl (K-PSS, total K + -
concentration 125 mM). The contractions were followed by washing with PSS-
solution for 15 mm. The arteries were precontracted with a mixture of PSS and 
K-PSS, with a final Κ+-concentration of 40 mM. In order to study the 
endothelial function of the arteries, the maximal relaxing effect of methacholine 
(1-10 μΜ), which induces the release of EDRF [2], was determined. After 
washing with PSS for 15 mm, the arteries were incubated for 15 mm in PSS, 
either in the presence (n = 12) or absence (n = 13) of 100 μΜ L-NMMA 
(Sigma, St Louis, MO, USA) Then the arteries were precontracted with 40 mM 
K + and the IS-adrenoceptor-mediated relaxation was studied with isoprenalme 
(Lansberg, Uden, The Netherlands) in the presence or absence of 100 μΜ L-
NMMA. The isoprenalme concentration was increased stepwise from 10 nM to 
3.2 μΜ. The concentration response curves were analyzed using the GraphPAD 
program, a nonlinear least square curve fitting program (Institute for Scientific 
Information, La Jolla, CA, USA). The effects are expressed in mN/mm vascular 
tissue. Data are presented as mean ± SE. For comparisons between the groups 
Wilcoxon's rank sum test was used; a P-value < 0.05 (two-sided) was con­
sidered to be statistically significant. 
RESULTS 
The maximal relaxation of mesenteric resistance arteries with methacholine 
was 52 + 4 % of precontraction in the group which was later treated with L-
NMMA and 48 ± 4 % in the control group, a difference which was not statisti­
cally significant. Treatment with 100 μΜ of L-NMMA resulted in a decreased 
methacholine-induced relaxation of mesenteric resistance arteries to 9.9 ± 2.6 
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% (η = 12), which is significantly different from control (P < 0.05); incubation 
with 1 mM L-NMMA completely abolished the methacholine-induced relaxation 
of the mesenteric resistance arteries (see Chapter 7 of this thesis). 
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FIGURE 1: Effect of L-NMMA on the concentration response curves for isoprenaline ol 
mesenteric resistance arteries, precontracted with 4 0 mM K + . The continuous line represents the 
response in the presence of 100 μΜ L-NMMA (n = 121, whereas the dashed line represents the 
control curve (n = 13). Data are expressed as a percentage of the precontraction, and presented as 
mean ± SE * . Ρ < 0 0 1 . 
In Fig. 1, the concentration response curves for isoprenaline are shown. In the 
L-NMMA treated group as well as in the control group, isoprenaline induced a 
concentration-dependent relaxation of the mesenteric resistance arteries, 
precontracted with 40 mM K + . The characteristics of the isoprenaline-mediated 
relaxation are listed in Table 1. The maximal relaxation, expressed as a percen­
tage of the precontraction, was significantly lower in the L-NMMA-treated group 
as compared to control. In the presence of L-NMMA, the precontraction with 40 
mM K + tended to be higher, but the difference did not reach statistical signifi­
cance. Treatment with L-NMMA had no significant effect on the pD2-value foi 
isoprenaline, and the absolute isoprenaline-induced relaxation in the L-NMMA-
treated group was not significantly different from control. 
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TABLE 1 Characteristics of the isoprenahne induced relaxation of rat mesenteric resistance 
arteries and the effect of L NMMA 
precontraction (mN/mm) 
relaxation (mN/mm) 
relaxation (%) 
pD 2 
η 
L NMMA 
1 27 ± 0 15 
0 73 ± 0 1 0 
58 0 ± 2 6 
7 28 ± 0 0 3 
13 
+ L NMMA 
1 43 ± 0 13 
0 62 ± 0 0 6 
44 0 + 4 0 
7 43 + 0 0 7 
12 
Ρ 
NS 
NS 
0 0 0 8 
NS 
DISCUSSION 
The aim of the present study was to investigate whether the ß-adrenocep-
tors, present on vascular endothelium, can induce a release of EDRF, which in 
turn would result in relaxation of mesenteric resistance arteries For rat thoracic 
aorta, an endothelium-dependence of the isoprenahne induced relaxation was 
recently suggested [4] Before incubation with L-NMMA, the relaxation with 
methacholine was determined, and found to be not significantly different 
between the two groups However, the methacholine induced relaxations were 
approximately 50 % of the precontraction, which is somewhat lower than 
values reported for rat aorta [4,9,10] In our opinion, this may be the result of 
the precontraction with 40 mM K + , which has recently been shown to give rise 
to a lower endothelium-dependent relaxation of porcine coronary arteries than 
other precontracting agents [11J On the other hand, a precontraction with the 
more commonly used noradrenaline, which results in methacholine-induced 
relaxations of more than 80 % of the precontraction [4,9,10], may lead to IÌ-
adrenoceptor stimulation [1] and the release of endothelium-denved relaxing 
factor by stimulation of the a adrenoceptors on the endothelial cells [3,12], and 
therefore seems not to be the precontracting agent of choice for this kind of 
experiments Because interactions with endothelium dependent modulators of 
vascular tone have been reported for a number of other precontracting agents 
[3], K+ was used to induce precontraction in this study We conclude, that the 
relatively low methacholine-induced relaxation is the result of the precontraction 
with K + , rather than reflecting endothelial damage of the resistance arteries 
The concentration of L-NMMA used in the present study (100 μΜ) was 
shown to inhibit the methacholine-induced relaxation of mesenteric resistance 
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arteries significantly, which is in agreement with the literature [7]. With this 
concentration of L-NMMA, the isoprenahne-mduced relaxation was significantly 
decreased. These results suggest that L-NMMA does inhibit the ß-adrenoceptor-
mediated relaxation of mesenteric resistance arteries, when expressed as a 
percentage of the precontraction. Besides the release of EDRF after stimulation, 
however, a baseline release of EDRF has been described for arterial endothelium 
[13] In the present study, treatment with L-NMMA tended to increase the 
precontraction with 40 mM K+ This was probably the result of the inhibition of 
baseline EDRF release with L-NMMA. Although the difference was not statisti-
cally significant, the somewhat higher precontraction may, at least in part, 
explain the decreased ß-adrenoceptor-mediated relaxation in the L-NMMA-
treated group, since it was expressed as a percentage of this precontraction. 
Moreover, the absolute isoprenalme-induced relaxation, expressed in mN/mm, 
was not significantly different between the two groups. Therefore, it is ques-
tionable whether the ß-adrenoceptors present on the endothelium contribute to 
the relaxing effect of isoprenalme This is in agreement with the study of Quillen 
et al [14], who observed that EDRF release in the coronary microcirculation is 
not through a ß-adrenoceptor mechanism 
Besides EDRF-release, other endothelium-derived modulators of vascular tone, 
including endothelium-derived contracting and hyperpolanzing factor (EDCF and 
EDHF) have been described [2] Because L-NMMA is an inhibitor of EDRF 
synthesis [3], an endothelium-dependence of the ß-adrenoceptor-mediated 
relaxation would be better studied by removing the endothelium. Unfortunately, 
due to the small size of the resistance arteries in this study, it seems virtually 
impossible to remove the endothelium without damaging the smooth muscle 
cells Moreover, because precontraction was induced by depolarization with K + , 
an effect of EDHF can be excluded [15], but an effect of EDCF can not be ruled 
out Therefore, we conclude that the decreased ß-adrenoceptor-mediated 
relaxation, observed in the presence of L-NMMA, can at lest in part be explained 
by a decreased baseline release of EDRF The present study does not exclude an 
interaction between ß-adrenoceptors and other endothelium-derived modulators 
of vascular tone 
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ß-Adrenoceptor-mediated relaxation of human 
small arteries isolated from omentum biopsies 
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ß-ADRENOCEPTOR-MEDIATED RELAXATION OF HUMAN SMALL ARTERIES 
INTRODUCTION 
Alterations in the ß-adrenoceptor system have been suggested to play a role 
in the development and maintenance of primary hypertension. This hypothesis 
has been tested quite extensively using the ß2-adrenoceptors, present on mono-
nuclear leucocytes (MNL), as a model system for the ß-adrenoceptors on the 
vascular wall. However, the results obtained with this model system are not 
very conclusive: both an increase and no change in the MNL ß2-adrenoceptor 
density have been reported [1]. Moreover, as for any model system it is not 
fully known whether these results can be extrapolated to the vascular wall. 
An alternative approach for the study of the ß-adrenoceptor system in primary 
hypertension would be the use of human vascular tissue. In contrast to animal 
models of hypertension, this tissue is not easily accessible for in vitro study. 
However, with the small vessel myograph technique, developed by Mulvany and 
Halpern [2], small arteries isolated from fat biopsies can be studied. These fat 
biopsies are obtained from omental fat during laparotomy [3] or from the gluteal 
region [4]. An advantage of this technique is that small arteries, which contri-
bute largely to the total peripheral resistance [5], can be examined. Because an 
increase in peripheral resistance is one of the general findings in hypertension 
[6], this tissue preparation can be an important tool in the study of defects in 
the control of vascular tone in this disorder. 
The aim of the present study was to examine the feasibility of the use of 
human small arteries for investigation of ß-adrenoceptor-mediated relaxation. 
For this preliminary study, arteries were isolated from omental biopsies which 
were obtained from subjects undergoing laparotomy for varying diseases. In 
these arteries, contractions with KCl and the a-^ -adrenoceptor agonist phenyl-
ephrine [7], and relaxations with the ß-adrenoceptor agonist isoprenaline and 
the adenylyl cyclase stimulating agent forskolm [8] were investigated. During 
the analysis of the results, differences in response were observed between 
subjects who suffered from chronic intestinal inflammation (and generally were 
treated with corticosteroids), and subjects suffering from other diseases. 
Therefore, the experimental data were compared between these two groups. 
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MATERIALS AND METHODS 
Materials 
Isoprenalme (1mg/ml) was purchased from Lansberg, Uden, Netherlands, 
forskolm from Sigma, St Louis, MO, USA and phenylephrine from Genfarm, 
Maarssen, Netherlands All other reagents were of analytical grade 
Subjects 
Twenty-two omental biopsies were obtained from subjects undergoing 
laparotomy at the Department of Surgery for varying disorders Arteries from 
subjects using β adrenoceptor medication (β blocker (n = 2), Salbutamol (n = 1)) 
and without a precise diagnosis (n = 2) were excluded from the study The 17 
remaining subjects were subdivided into 2 groups Group 1 subjects with 
chronic intestinal inflammations (Colitis Ulcerosa ( n = 4 ) , M Crohn (n = 2), 
chronic pancreatitis (n = 2), reflux esophagitis (n = 1 ), 16 arteries from 9 biopsies 
in total). Group 2 others (Adenocarcinoma (n = 6), rectopexia (n = 1), diagnostic 
laparotomy (n = 1), 16 arteries from 8 biopsies in total) In group 1, 7 subjects 
used corticosteroids chronically (prednisone η = 6, dexamethasone n = 1) In 
group 2, 5 subjects used medication (iron supplement (n = 3), oral contracep­
tives (n = 1) and digoxin (n = 1)) Clinical parameters were obtained from the 
medical files Two subjects from group 1 and two subjects from group 2 had 
diastolic blood pressures > 90 mm Hg and therefore could be labelled as 
primary hypertensive Mean arterial pressure was calculated as diastolic blood 
pressure + 1/3 χ systolic blood pressure 
Preparation of the small arteries 
Omental biopsies were transported to the laboratory m PSS-solution (120 mM 
NaCI, 4 7 mM KCl, 2 5 mM CaCI2, 25 mM NaHC03, 1 17 mM MgCI 2 , 1 2 mM 
K H 2 P 0 4 , 2 7 /УМ EDTA and 5 5 mM glucose) They were either used directly 
ore stored at 4°C overnight Storage at 4 °C did not affect any of the parame­
ters determined in this study [13] Parts of the biopsy were fixed on a wax plate 
and submerged under PSS Small arteries were dissected and mounted on a 
small vessel myograph as described before [13] Briefly, two stainless steel 
wires (diameter 40 μπη) were inserted into the lumen of the resistance arterioles. 
The wires were mounted between an isometric force transducer (Kistler Morse 
DSC 6, Seattle, WA, USA) and a displacement device (Mitatoyo, Tokyo, Japan) 
in a 10 ml organ chamber The organ chamber was filled with PSS solution, 
maintained at 37 °C and continuously aerated with 9 5 % 0 2 and 5% C 0 2 After 
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equilibration for 1 hr at 37 °C, the arteries were set to a normalized internal 
circumference (L·,), estimated to be 0 9 times the circumference they would 
maintain if relaxed and exposed to a transmural pressure of 100 mm Hg (L1 0 0), 
a procedure which was described in detail by Mulvany and Halpern [2]. Internal 
diameters of the arteries were 375 ± 49 μπ\ (group 1) and 443 ± 48 μηη 
(group 2), the difference being not statistically significant 
Contraction and relaxation of the small arteries 
After normalization, the resistance arteries were contracted for 1 mm by 
exchanging the PSS for K-PSS, in which all NaCI was replaced by KCl (total K + -
concentration 125 mM), followed by rinsing twice with PSS. This procedure 
was repeated after 15 mm 
The arteries were contracted with a mixture of 2 0 % K-PSS and 8 0 % PSS 
(total K + -concentration 25 mM), which gave precontractions of 60-80% of the 
maximal contractions observed in the concentration response curves. When a 
stable precontraction was reached, the relaxing effect of isoprenalme was 
studied by a stepwise increase in their concentration (10 nM - 3.2 μΜ). Finally, 
a single dose of forskolin (5 μΜ) was added to the organ bath 
The effect of phenylephrine precontraction on the isoprenalme relaxation was 
studied by contracting the arteries with 3-10 μΜ of phenylephrine. Because the 
phenylephrine precontraction was not stable in some of the arteries, only the 
maximal effect of isoprenalme was studied by adding a single dose of 10 μΜ to 
the organ bath, 1 mm after stable contraction was reached With this pro­
cedure, in rat mesenteric resistance arteries a similar maximal relaxation was 
observed as with a cumulative addition of isoprenalme (not shown). Therefore, 
no pD2-values could be calculated in this case. 
Data analysis 
The concentration response curves were analyzed using GraphPad, a non­
linear curve fitting program (GraphPad, Institute for Scientific Information, San 
Diego, CA, USA) Sensitivities to drugs and maximal effects were calculated on 
the basis of data from individual arteries and expressed as pD2-values when 
possible. The responses to relaxing agents were expressed as the absolute 
decrease in tension (mN/mm artery) and as a percentage of the precontraction. 
The data are expressed as mean ± SEM. 
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TABLE 1 Clinical characteristics of the individual subjects and experimental data of the individual 
arteries 
age sex 
GROUP 1 
chronic pancreatitis 
28 m 
46 m 
colitis ulcerosa 
44 m 
42 m 
33 f 
29 f 
M Crohn 
32 f 
17 f 
reflux esophagitis 
57 f 
MAP 
86 
96 
98 
107 
83 
107 
91 
120 
HR 
84 
52 
64 
108 
-
72 
. 
84 
72 
BMI 
21 7 
26 5 
24 2 
21 5 
31 6 
19 5 
1 6 0 
18 4 
-
К pre 
0 74 
0 88 
0 61 
0 46 
0 58 
0 33 
1 60 
1 30 
0 29 
1 53 
0 34 
1 76 
3 33 
0 63 
1 16 
0 35 
К rel 
0 
0 
0 
0 0 4 
0 
0 10 
0 
0 
0 
0 2 0 
0 
0 35 
0 25 
0 13 
0 27 
0 25 
Ρ pre 
0 71 
0 78 
0 
0 57 
0 17 
0 0 8 
0 
0 
0 
0 
0 42 
0 8 8 
2 9 0 
0 13 
0 57 
0 
Ρ rel 
0 39 
0 10 
-
0 53 
0 13 
0 02 
• 
-
-
0 38 
0 79 
2 0 2 
0 13 
0 57 
-
K% 
0 
0 
0 
β 
0 
31 
0 
0 
0 
13 
0 
20 
8 
2 0 
23 
71 
Ρ% 
55 
13 
-
94 
75 
25 
• 
-
-
91 
9 0 
7 0 
100 
100 
. 
GROUP 2 
colon carcinoma 
60 f 100 90 25 4 1 30 0 0 4 0 35 0 88 
67 m 103 80 26 2 0 84 0 02 О - 3 
57 f 99 68 20 8 О 53 0 23 О 05 - 43 
0 53 0 29 О 57 
49 m 132 72 25 2 4 50 0 83 0 08 - 19 
2 25 О 0 23 О 
37 m 90 92 26 2 1 72 0 0 - О 
2 54 0 43 О - 18 
60 m 105 70 22 1 4 71 0 0 34 0 16 0 46 
3 48 0 0 79 0 31 0 39 
diagnostic laparotomy 
19 f 101 82 170 2 65 О 117 0 38 О 32 
1 30 0 12 О 30 0 05 10 17 
1 44 1 25 О 60 0 17 86 28 
1 50 0 83 1 61 0 08 56 5 
rectopexia 
55 f 83 65 21 О О 67 О 10 О - 15 
0 19 0 0 - О 
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RESULTS 
Clinical and experimental parameters of the subjects 
Because of the preliminary nature of the present study, the individual clinical 
and experimental data are supplied in Table 1. In this Table, the data are 
subdivided according to the underlying pathology of the donor. From most of 
the biopsies, two arteries could be isolated and mounted in the myograph. From 
one biopsy, two arteries were isolated immediately after the operation and two 
others after storing the rest of the biopsy overnight at 4 °C; this storage 
procedure did not affect the results. 
During the analysis of the results, marked differences were observed between 
the arteries from subjects suffering from chronic intestinal inflammation and 
those suffering from other diseases. Therefore, the data from these groups 
were analyzed separately and compared. The average clinical parameters of 
these two groups are given in Table 2. The age in group 2 (malignities) was 
significantly higher than in group 1 (chronic intestinal inflammation). For the 
other clinical parameters (heart rate, MAP and body mass index) no significant 
differences were observed between the two groups. 
TABLE 2: Clinical parameters of the subjects, subdivided according to disease 
group 1 group 2 
η 9 8 
m/f 4/5 4/4 
age (yr) 35.4 ± 2.8 a 44.9 ± 4.3 
MAP (mm HgI 97.1 ± 2.7 101.6 ± 3.4 
heart rate ( m m 1 ) 76.9 ± 4.9 77.0 ± 2.4 
BMI (kg/m2) 22.8 ± 1 . 2 21.9 ± 0.9 
Group 1: chronic intestinal inflammation, Group 2: others MAP = mean arterial pressure, η = 
number of subiects, m/f = number of males/females, BMI = body mass index. a : Ρ < 0.05 
LEGEND TO TABLE 1 : MAP = mean arterial pressure (mm Hg), HR 
body mass index (kg/m 2 ), К pre = precontraction with 25 rnM KCl, К rel = absolute relaxation of a 
KCI-precontraction with isoprenahne, К % = isoprenalme-induced relaxation, expressed as a fraction 
of the precontraction, Ρ pre = precontraction with 10 μΜ phenylephrine, Ρ rel = absolute relaxation 
of a phenylephnne-precontraction with isoprenahne, Ρ % - isoprenalme-induced relaxation, 
expressed as a fraction of the precontraction. All experimental data are in mN/mm artery. The 
clinical data from the subjects were obtained from their medical files. 
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TABLE 3: Differences in isoprenaline-mduced relaxation of K + - and phenylephrine-induced 
precontraction 
K + phenylephrine 
Group 1 
precontraction (mN/mm) 0 99 + 0.20 (16) 0.60 ± 0.22 (121 
relaxation (mN/mm) 0 20 ± 0.04 (7) 0.51 ± 0.19 (10) 
relaxation (%) 24.3 ± 7.3 17) 71.3 ± 9.8 (10) b 
p D 2 7.71 ± 0.05 (6) 
Group 2 
precontraction (mN/mm) 1 88 ± 0.34 ( 1 6 Г С 0.40 i 0.13 (14) 
relaxation (mN/mm) 0 46 + 0.14 1101 0.21 ± 0 05 (71 
relaxation 1%) 33 9 ± 9 4 (10) 36.4 ± 1 0 0 (7) 
pD 2 7 82 + 0 26 161 
Group 1: subjects suffering from chronic intestinal inflammation, Group 2: others. *: Ρ < 0.05 
compared with phenylephrine precontraction (Wilcoxon's signed rank test for paired observations). 
b : Ρ < 0 05 compared with % relaxation in group 2 c : Ρ < 0 05 compared with precontraction of 
Group 1. 
Κ
 +
-precontraction and ¡soprenaline-mediated relaxation 
Incubation of the arteries with 25 mM K+ induced contractions in all arteries. 
The magnitude of these contractions was 60-80 % of the maximal contraction 
with 125 mM K + . The contractions were sufficiently stable to study the 
cumulative ¡soprenaline-mediated relaxation. The K + -mduced contraction, 
expressed in mN per mm artery, showed a large variation in both groups: values 
between 0.3 an 5 mN/mm were observed. The precontraction with K+ was 
significantly lower group 1 than in group 2 (Table 3). Isoprenaline induced 
relaxation in 7 of the 16 arteries in group 1 and in 9 of the 16 arteries in group 
2, as shown in Table 3. In only 6 of the subjects in both groups the ¡soprena-
line-mediated relaxation was sufficiently large to calculate an accurate pD2-
value for isoprenaline. As shown in Table 3, the pD2-values were not signifi-
cantly different. Forskolin, added to the organ bath after the highest concentra-
tion of isoprenaline, induced almost complete relaxations in all arteries (not 
shown). 
Phenylephrine-induced contraction and ¡soprenaline-mediated relaxation 
Phenylephrine induced contractions in 10 of the 16 arteries in both group 1 
and 2. Generally, these contractions were lower than the contractions observed 
with 25 mM K+ in both groups (Table 3) but the difference was only statistical-
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ly significant in group 2 Moreover, in 3 of the arteries of group 2 the contrac-
tions were transient and unstable, so the relaxation with isoprenalme could not 
be determined in these arteries. In order to avoid an effect of spontaneous 
relaxation in the other arteries, the isoprenalme-mediated relaxation was studied 
by addition of 10 μΜ of isoprenalme instead of recording a cumulative dose-
response curve as performed for the K + -precontraction. Therefore, no pD2-
values for isoprenalme were determined In group 1, the isoprenalme-mduced 
relaxation, expressed as a fraction of the precontraction, was significantly larger 
during phenylephrine- than during K + -precontraction; this difference was not 
statistically significant in group 2 (Table 3) 
Correlations 
One of the aims of this study was to look for relationships between blood 
pressure or other clinical parameters and the characteristics of isoprenalme-
mediated relaxation of the small arteries To this end, the characteristics of the 
arteries were averaged for each subject and correlation coefficients were 
calculated A borderline significant correlation between MAP and K + -mduced 
precontraction was observed for the subjects in group 2 (Fig. 1, r = 0 67, ρ = 
0 07, η = 8) but not for the subjects in group 1 (r = 0.02, ρ > 0.9, η = 9). 
However, it has to be noted that the number of hypertensive subjects (n = 2) 
was too small to offer a proper blood pressure range for the calculation of such 
a correlation In the arteries for which a pD 2 for isoprenalme could be calcula­
ted, a significant negative correlation between this parameter and MAP was 
observed in both groups (r = -0 65, Ρ = 0 04, π = 10 for subjects from group 
1 and 2) No significant correlations between the isoprenalme-mediated relax­
ation and any of the clinical parameters were observed 
DISCUSSION 
The aim of the present study was to develop an in vitro test system for 
isoprenalme-mediated relaxation of human small arteries, and to relate the 
characteristics of this relaxation to clinical parameters like blood pressure. To 
our knowledge, this is the first study in which the li-adrenoceptor system is 
studied in human small arteries In the present study, the subjects were subdi­
vided into 2 groups. This was done to separate the results of subjects with 
chronic intestinal inflammation, generally treated with corticosteroids (group 1) 
from the subjects with other disorders, who mostly received no chronic medica-
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tion (group 2). Subjects receiving ß-adrenoceptor active drugs and without 
known medical history were excluded from the study. 
K + -induced contraction in the different study groups 
The contraction of the small arteries with 25 mM K+ was significantly higher 
in the subjects from group 2 compared with group 1. This may probably be the 
result of the treatment with corticosteroids, which are known to have effects on 
the cardiovascular system [9] although an effect of the underlying pathology 
can not be excluded. The higher age of the subjects in group 2 is not likely to 
explain the elevated precontraction in group 2, since no correlation between age 
and precontraction was observed in the present study or reported in the 
literature. 
,. K* precontraction (mN/mm) 
J L 
75 100 125 150 
Mean Arterial Pressure (mm Hg) 
FIGURE 1 : Correlation between the precontraction, induced with 25 mM K + , and the mean 
arterial pressure. Only subjects from group 2 were used; in the subjects from group 1 no siflnificant 
correlation was observed Correlation coefficient, r - 0.67, Ρ = 0.07, η = 8. For this correlation, 
data of each subject were averaged. 
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Mean Arterial Pressure (mm Hg) 
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FIGURE 2 Correlation between the pD2 for isoprenalme and mean arterial pressure in the 
sublets from group 1 and 2 Correlation coefficient r = 0 64, Ρ = 0 04, η = 9 Data from each 
subject were averaged for this correlation, for the other arteries no pD2 for isoprenalme could be 
determined 
Isoprenaline-mediated relaxation of arteries, precontracted with K + 
Isoprenalme induced relaxation in about half of the small arteries, 
precontracted with K + It is not known which factors make an artery respond to 
isoprenalme or not Because the number of arteries that responded to isoprena­
lme was similar in both groups, it is unlikely that the pathology or treatment 
with corticosteroids determine the response No significant difference in 
isoprenaline-mediated relaxation of the Κ+-induced precontraction was found 
between the two groups However, this relaxation, either expressed as an 
absolute value or as a percentage of the precontraction, tended to be lower in 
the subjects from group 1 The slightly attenuated relaxation in group 1 is not in 
agreement with the stimulating effect of corticosteroids on ß-adrenoceptor 
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function [10]. However, the age of the subjects may be a confounding factor. 
Feldman et al. [11) have shown that the function of vascular ß-adrenoceptors 
decreases with age Since the age of the subjects in group 2 was significantly 
higher, this may partially mask the effect of corticosteroid therapy in group 1. 
In the present study, each concentration response curve for isoprenahne was 
followed by a single dose of forskolm, a stimulator of adenylyl cyclase [8]. In all 
arteries an almost complete relaxation was observed, irrespective whether the 
artery responded to isoprenahne or not. This suggests that a defect is present in 
the li-adrenoceptor complex rather than an alteration in adenylyl cyclase is 
present in the non-responding arteries. 
Effect of precontraction on isoprenaline-mediated relaxation 
The effect of precontraction on the isoprenaline-mediated relaxation was 
studied by using both K+ and the o-|-adrenoceptor agonist phenylephrine [12] 
as precontracting agents Stimulation with an 02~ a 9 o n i s t would induce an 
inhibition of adenylyl cyclase which would interfere with the stimulation of 
adenylyl cyclase with isoprenahne In an earlier study with rat mesenteric 
resistance arteries, the kind of precontraction was found to affect the isoprena-
line-mediated relaxation [13]. In the present study, phenylephrine induced a 
contraction in 10 of the 16 arteries in both groups; in the other arteries no 
contraction was found In 3 other arteries from group 2, the contraction was 
transient and unstable so no isoprenaline-mediated relaxation could be deter-
mined. A transient and oscillating response to phenylephrine was described 
before for human omental small arteries [3] and for rat mesenteric resistance 
arteries [13]. In group 1, isoprenaline induced a significantly stronger relaxation 
of the phenylephrine precontraction than of the K + -precontraction, this finding 
is in agreement with the results of rat mesenteric resistance arteries [13]. In 
contrast, in group 2 no difference in isoprenaline-mediated relaxation was 
observed between the two kinds of precontraction. The cause of the attenuated 
relaxation of a phenylephrine precontraction is unknown, but as an explanation, 
the blunted ß-adrenoceptor response due to the higher age of the subject in 
group 2, described by Feldman [11] can be considered 
Correlations 
A borderline significant correlation was observed between MAP and the 
precontraction with K+ for the subjects in group 2. This finding is in agreement 
with the observation in spontaneously hypertensive rats, that K+ can induce 
stronger contractions of femoral artery [14] and mesenteric resistance arteries 
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13]. For the subjects in group 1, this correlation was completely absent. The 
legative relationship between the pD2 for ¡soprenaline and MAP may reflect a 
decrease in li-adrenoceptor affinity, as observed for the MNL IS2"adrenoceptor 
From primary hypertensive subjects [15]. However, because of the small number 
Df subjects, with only 2 subjects being hypertensive in group 2, it is difficult to 
:onclude whether these relationships can be reproduced in larger groups. 
Therefore, these experiments should be repeated with a larger number of 
jntreated hypertensive and normotensive subjects. 
Conclusions 
In conclusion, human small arteries from omentum biopsies can be used in 
the study of the properties of the ß-adrenoceptor complex in primary hyperten-
sion. A relationship between MAP and K+-precontraction and ß-adrenoceptor 
affinity could be identified. However, m this study it was shown that the 
underlying pathology and/or treatment may affect the results. Therefore, the 
jse of omental biopsies has disadvantages over the gluteal biopsy technique. 
Although the recruitment of hypertensive and normotensive subjects may be 
difficult, this latter technique allows the use of untreated subjects and matched 
controls. Repeating the experiments described in this report with arteries 
solated from gluteal biopsies would supply more insight in the alterations in 
contraction and Гі-adrenoceptor-mediated relaxation in primary hypertension. 
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A preliminary study on the effect of contracting 
and relaxating agents on the intracellular Ca-
concentration in smooth muscle cells of rat 
mesenteric resistance arteries 
W.M. Blankesteijn, N.J.H. Raat, Th. Thien, P.H.G.M. Willems 

INTRACELLULAR CALCIUM CONCENTRATION IN SMOOTH MUSCLE CELLS 
INTRODUCTION 
The peripheral resistance of the vasculature can be regulated by a change in 
the arterial diameter, especially from resistance arteries. Activation of ß-
adrenergic receptors is one of the mechanisms that can decrease the peripheral 
resistance by increasing the arterial diameter, resulting in vasodilation [1]. Since 
an increase in peripheral resistance has been well established in primary hyper-
tension [2], it is of interest to study the regulation of arterial diameter by ß-
adrenoceptors in resistance arteries These studies have been performed using 
mesenteric resistance arteries mounted in a small vessel myograph [3,4] 
However, the experimental data obtained with this technique proved to be 
difficult to interpret because ß-adrenoceptor-mediated relaxation was unex-
pectedly found to depend on the kind of precontraction used- a larger isoprena-
line-mduced relaxation was observed after a phenylephnne-precontraction than 
after a K+-precontraction, although the force of these two precontractions was 
similar [4] 
The arterial diameter can be regulated by extracellular signals that evoke 
contraction or relaxation of the vascular smooth muscle cells, which are 
wrapped around the arterial lumen [5] Contraction of these cells is generally 
thought to be mediated by an increase in intracellular Ca2 f concentration 
([Ca2 + ],) [6] However, it has recently been proposed that contractions can also 
be the result of an increased sensitivity of the contractile apparatus for Ca2"1" 
[7] On the other hand, relaxation of arterial smooth muscle cells by cAMP-
generating systems, such as ß-adrenoceptors, is likely to be caused by a 
decrease in [Ca2 + ], and/or sensitivity of the contractile apparatus for Ca 2 + [7]. 
In this preliminary study, we tried to find an explanation for the precontraction-
dependence of the ß-adrenoceptor-mediated relaxation, as observed in the small 
vessel myograph To this end, digital imaging microscopy of Fura-2-loaded 
mesenteric resistance arteries, isolated from normotensive Wistar rats, was 
used to monitor the free [Ca2 " 1 , in the vascular smooth muscle cells [9]. 
METHODS 
Materials 
Fura-2-AM and pluronic F127 were obtained from Molecular Probes, 
Eugene, OR, USA Isoprenaline was purchased from Lansberg, Uden, Nether-
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lands; Forskolin and dibutyryl adenosine cyclic monophosphate were from 
Sigma, St Louis MO, USA. 
Preparation of the mesenteric arteries 
Male Wistar rats were obtained from the Central Animal Laboratory of the 
University of Nijmegen. At the age of 12-18 weeks, the rats were killed by 
cervical dislocation, whereafter the intestine was removed and stored in a PSS-
solution containing 120 mM NaCI, 4.7 mM KCl, 2 5 mM CaCI2, 1.17 mM 
M g S 0 4 , 25 mM NaHC0 3 , 1 2 mM KH 2 P0 4 , 2.7 μΜ EDTA and 5.5 mM glucose, 
for less than 4 h at 4°C. Parts of the small intestine, 7-15 cm from the sto­
mach, were fixed on a wax plate and submerged under PSS. Side branches of 
the superior mesenteric artery were dissected and mounted on a small vessel 
myograph as described by Mulvany et al. [3] Briefly, two stainless steel wires 
(diameter 40 μσι) were inserted into the lumen of the resistance arterioles. The 
wires were mounted between an isometric force transducer (Kistler Morse DSC 
6, Seattle, WA, USA) and a displacement device (Mitatoyo, Tokyo, Japan) in a 
10 ml organ chamber. The organ chamber was filled with PSS solution. A glass 
capillary (diameter approximately 100/ym) was gently inserted into the lumen of 
the artery in order to stretch the artery. Then the artery was removed from the 
myograph and placed in a small plastic tube containing PSS with 10 μΜ Fura-2-
AM and 1 μΜ pluronic (total volume 500 μ\) followed by incubation at room 
temperature for 2 h in the dark. Then the incubation solution was changed, 
followed by a second incubation for 2 h. 
After loading an artery twice for 2 h with Fura-2-AM, it was transferred to a 
thermostated (30°C) perfusion chamber (Leiden chamber [10]), the bottom of 
which was formed by a glass cover slip. The tissue was immobilized by means 
of the t w o stainless steel wires, which were clamped between the bottom of 
the chamber and a perspex insert routinely used to reduce the incubation 
volume of the chamber to approximately 300 μ\ The tissue was continuously 
superfused at a flow rate of 1 ml/mm with PSS, thoroughly gassed with 100% 
0 2 . The test substances were dissolved in the medium and delivered to the 
tissue by means of superfusion In order to remove non-hydrolyzed Fura-2-AM, 
the tissue was superfused with PSS for 15 mm. After this period of equi­
libration, fluorescence measurements were started. The chamber was placed on 
the stage of an inverted microscope (Nikon Diaphot). The light from a 100 W 
xenon lamp was directed through a quartz neutral density filter (Ealing Electro-
Optics, Holliston, MA, USA) with a density > 1.5 to avoid damage of the two 
excitation filters and to reduce bleaching of intracellular^ trapped fluorochrome. 
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The excitation filters, mounted in a motor-driven rotating filter wheel, were 
bandpass filters with transmission maxima at 340 and 380 nm ( ± 12 nm) 
(Ealing Electro-Optics). An epifluorescent 40x oil immersion objective was used, 
allowing monitoring of a part of the artery. Dynamic video imaging was carried 
out using the MagiCal hardware and TARDIS software provided by Joyce Loebl 
(Dukesway, Team Valley, Gateshead, Tyne & Wear, UK) as described in detail 
by Neylon et al. [9]. Frames were captured by means of an intensified charge-
coupled device (CCD) camera (Photonics Science) operating at video frame rate 
with the filter wheel in the discontinuous stepping mode. At each excitation 
wavelength, 8 video frames with frame capture dimensions of 256 χ 256 pixels 
were collected, averaged, and written into a dynamic random access memory 
with a maximal capacity of 504 averaged frames. The interframe interval was 
40 ms between each of the 8 samples for one wavelength, 500 ms between 
the last 340 nm and the first 380 nm sample and 4 s between the last 380 nm 
and the first 340 nm sample. At the end of the experiment, a region free of 
tissue was selected and one averaged background frame was collected at each 
excitation wavelength. Before ratioing of the stored frames, the averaged 340 
and 380 nm background frames were subtracted from the corresponding 
experimental frames. The interframe interval between the ratio frames was 6.4 
s with a maximal sampling time of 27 mm The fluorescence emission ratio at 
492 nm was monitored as a measure of [Ca2 + ] r after excitation at 340 and 380 
nm [11]. 
RESULTS 
Loading of rat mesenteric resistance arteries with Fura-2-AM 
Loading of the arteries with Fura-2-AM for 4 h resulted in fluorescent 
staining of the smooth muscle cells, which could be clearly identified wrapped 
around the arterial lumen. Components of the adventitia were also stained. 
However, compared to the loading of isolated cells from other tissues, the 
fluorescence was rather weak The fluorescence at both 340 and 380 nm de­
creased during the experiment, which took approximately 20 mm, but the 
fluorescence emission ratio (340/380 ratio) remained constant. 
Increases in [Ca + ], with compounds that induce contraction 
In the present study, a glass capillary was inserted into the lumen of the 
mesenteric resistance arteries. Insertion of this capillary into the lumen of the 
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artery completely prevented the occurrence of K + - or phenylephrine-evoked 
contractions during [Ca2"""^-measurements. In the absence of a glass capillary, 
no changes in 340/380 ratio were observed during stimulation with K + . In 
contrast, with a capillary inserted, superfusion with 40 mM K + induced an 
increase in fluorescence at 340 nm and a decrease in fluorescence at 380 nm, 
resulting in a rapid increase in the 340/380 ratio (Fig. 1) from 0.87 ± 0.22 to 
1.00 ± 0.24 (mean ± SD; η = 4). 
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FIGURE 1 : Original registration of the 340/380 nm fluorescence ratio of a mesenteric resistance 
artery loaded with the Ca2 +-sensitive dye Fura-2. In the left panel, the fluorescence ratio of a single 
smooth muscle cell is shown, whereas in the right panel the average fluorescence ratio from a group 
of cells is depicted Superfusion with 40 mM K + (K,) induced an increase in 340/380 ratio 
compared to the baseline level (PSS), which was rapidly reversible by superfusing with PSS-solution 
(M). A repeated increase in the ratio with K + (K,) could not be decreased with 10 μΜ isoprenaline (I) 
or 10 μΜ forskolin IF). Phenylephrine (PI induced hardly any increase in the 340/380 ratio in this 
artery In contrast, 125 mM K + |Kh) resulted in a higher increase in the ratio than 4 0 mM K + . Note 
that the changes in fluorescence ratio are quite similar in the single smooth muscle cell and the 
group of cells. 
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After having reached its peak value, the 340/380 ratio slightly decreased to 
a plateau value which was maintained during the superfusion with K + , as 
shown in Fig. 1A. This increase was observed both in individual smooth muscle 
cells (Fig. 1A) and in the total artery (Fig. IB), and was rapidly reversible by 
superfusing the preparation with PSS. Superfusion with a higher concentration 
of K + (125 mM) resulted in a higher 340/380 ratio, which suggests that the 
increase in ratio was dependent on the K + -concentration. Phenylephrine (10 
μΜ) could also induce an increase in 340/380 ratio in three out of four experi­
ments; this increase was about 35 % of the increase observed with 40 mM K + . 
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FIGURE 2: Original recording of the effect of 10 μΜ phenylephrine (PI on the 3 4 0 / 3 8 0 ratio of 
Fura-2. Note that the Y-axis scale is different from Fig. 1. In this experiment, phenylephrine induced 
a small increase m the 340/380 ratio compared to the baseline level IM), which was reversible for 
about 5 0 % with ΙΟ μΜ of isoprenalme (P + l) 
.2 + , Effects on [Ca ]¡ by isoprenalme, forskolin and dibutyryl cAMP 
In the small vessel myograph, addition of isoprenaline (10 μΜ) generally 
results in a relaxation of ± 50 % of the precontraction evoked with 40 mM K + , 
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and ± 90 % of a precontraction evoked with 1 μΜ phenylephrine [4]. Super-
fusion with 10 μΜ isoprenaline in 40 mM K + resulted m a small decrease of ± 
10 % m the 340/380 ratio in two out of three experiments, whereas forskolin 
(10 μΜ) failed to decrease the ratio during K + superfusion in two experiments 
(in Fig. 1, a representative experiment is shown). Moreover, addition of 100 μΜ 
dibutyryl cAMP to the 40 mM K + superfusate had no effect on the 340/380 
ratio in a single experiment (not shown). In contrast, isoprenaline (10 μΜ) 
induced a decrease of ± 4 5 % in the 340/380 ratio during phenylephrine (10 
μΜ) superfusion in two experiments, as shown in Fig 2 Dibutyryl cAMP did 
not affect the ratio during phenylephrine superfusion in a single experiment. 
Forskolin was not studied during phenylephrine superfusion. 
DISCUSSION 
The aim of the present study was to investigate the effects of agents, 
known to induce contraction or relaxation of rat mesenteric resistance arteries, 
on the [Ca2 + ], in vascular smooth muscle cells. To this end, the arteries were 
loaded with the Ca2 + -sensitive dye Fura-2 and monitored by means of a digital-
imaging technique. This procedure was shown before to enable the measure­
ment of changes in [Ca2 + ], in this preparation [8]. 
Loading of the arteries with Fura-2-AM for 4 h resulted in fluorescent 
staining of the vascular smooth muscle cells, which could be identified as 
spindle-shaped structures lying across the vascular lumen. This indicates that 
Fura-2-AM is able to penetrate the vascular wall The fluorescence signal did 
not increase during the preincubation m the perfusion chamber, indicating that 
the intracellular hydrolysis of Fura 2-AM into Fura-2 was complete and that all 
extracellular Fura-2-AM was washed away. In the course of the experiment ( ± 
20 mm), the fluorescence at both 340 and 380 nm decreased slowly, but the 
340/380 ratio, which is a measure of the [ C a 2 4 ] , , was not affected This 
phenomenon can be explained by leakage of Fura-2 from the cells as well as 
bleaching, although the latter can probably be ruled out because of the use of 
the neutral density filter 
The amount of fluorescence obtained from the smooth muscle cells localized 
in the small artery is rather small when compared to isolated cells. In addition, 
the loading procedure took about 4 h, which is considerably longer than that for 
isolated cells. This is probably due to the fact that the dye has to penetrate the 
arterial wall in order to reach the smooth muscle cells. 
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The presence of a glass capillary into the lumen of the artery appeared to be 
essential for the registration of an increase in the 340/380 ratio during stimula-
tion with K + . In preliminary experiments, which were performed without this 
capillary, neither a contractile nor a [Ca2 + ],-response to K + was observed. 
These observations indicate that the smooth muscle cells need some kind of 
preload to respond to stimulating agents. In the myograph, a similar preload is 
supplied by stretching the arteries mechanically to a tension equivalent to 90 
mm Hg. In the experiments, described in this study, the glass capillary seems to 
provide sufficient preload to monitor alterations in 340/380 ratio upon stimula-
tion with K + 
The increase in 340/380 ratio with K+ was found to be concentration-
dependent. An increase in this parameter has been reported to point at an 
increase in the [Ca2 + ], [9] This is in agreement with the K + -concentration 
dependence of the contraction of the arteries in the myograph, performed under 
similar conditions [4] However, no full concentration response curves were 
recorded in the present study, so it is unknown whether the increase in 
340/380 ratio is proportional to the increase in tension, observed in the 
myograph The increase in 340/380 ratio during phenylephrine superfusion was 
considerably lower than during K+ superfusion. The latter finding is not in 
agreement with the myograph studies, in which phenylephrine (10 //M) induced 
similar, if not higher contractions of the mesenteric resistance arteries when 
compared to 40 mM K+ [4) 
The discrepancy between K+ and phenylephrine regarding the relation 
between contraction force and increase in 340/380 ratio may be explained by 
differences in the mechanisms by which both compounds induce contraction of 
mesenteric resistance arteries In swine carotid artery, phenylephrine was 
shown to induce an increase in Ca2 + -sensitivity of the phosphorylation of 
myosin by myosin light chain kinase [7], which is a key step in smooth muscle 
contraction [6] On the other hand, K+ was shown to evoke a decreased Ca2 + -
sensitivity of myosin phosphorylation [7]. This suggests that the contraction 
with K+ is the result of a considerably stronger increase in [Ca24-],, whereas the 
effect of phenylephrine is mainly due to sensitization of the contractile appa-
ratus for Ca 2 + Our observations are in agreement with this idea Moreover, 
similar results have been described by Jensen et al [8] comparing K + - and 
noradrenalme-induced contractions with increases in (Ca 1, in mesenteric 
resistance arteries 
Isoprenalme was observed to induce minimal decreases ( < 10 %) in the 
elevated 340/380 ratio of the arteries during K+ superfusion. This is in marked 
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contrast to the 50 % relaxation of a K + -precontraction, observed in the small 
vessel myograph [4] In addition, forskolm and dibutyryl-cAMP did not evoke a 
:lear decrease in the K + -mduced rise in 340/380 ratio, but induced complete 
elaxation in the myograph During the phenylephrme-mduced elevation of the 
340/380 ratio, isoprenalme could decrease the 340/380 ratio considerably 
stronger (up to 40 % ) , whereas in the myograph, a relaxation of ± 90 % of the 
Drecontraction was observed under these conditions From the literature, it is 
cnown that in swine carotid artery contracted with phenylephrine small ele 
/ations in cAMP, induced by ß-adrenoceptor stimulation or with forskolm, result 
η a decrease in [Ca2 + )l [7] When precontracted with K + , considerably higher 
Joses of forskolm were needed to induce full relaxation of this preparation, 
л/hereas no decrease in [Ca2"*], could be observed [7] Under these circum 
stances, cAMP probably induces relaxation by a desensitization of the contrac-
ile apparatus for Ca2 + Our preliminary findings therefore seem to be in good 
agreement with the results described in the literature 
The results from the present study indicate that K + and phenylephrine 
nduce contraction of mesenteric resistance arteries by different mechanisms 
This may help to explain the observation from the myograph studies, that the 
soprenalme-induced relaxation of these arteries from SHR is decreased after 
<
 +
 -precontraction but not after phenylephrine precontraction It can be hypoth-
asized that a contraction resulting from an increased intracellular Ca -concen­
tration, as induced by K + , can be counteracted less effectively by isoprenalme 
η SHR On the other hand, the relaxation of a contraction which mainly results 
from a sensitization of the contractile apparatus for Ca2 + , as induced by 
Dhenylephnne, should be unaffected in SHR This hypothesis should be further 
tested by a simultaneous measurement of force and intracellular Ca 2 + -concen-
tration 
In conclusion, rat mesenteric resistance arteries can be loaded with Fura-2 
and used for measurements of the [ С а 2 Ч , The increase in 340/380 ratio, a 
measure for [Ca2 + ] | r which was observed during K+-superfusion seems in good 
agreement with the contractions observed in the myograph under similar 
:onditions The increase in 340/380 ratio with phenylephrine was considerably 
smaller compared to that with K + , but this can probably be explained by a more 
:omplex mechanism of contraction for the σ-agonist On the other hand, the 
affects of both the cAMP-generatmg substances and the 'precontracting' agents 
эп the 340/380 ratio point to a complex mechanism of relaxation by this 
second messenger The results of this preliminary study call for a simultaneous 
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registration of force and [Ca2 + ]¡ in a small vessel myograph. This experimental 
set-up will allow the study of different mechanisms of contraction and relax-
ation of smooth muscle cells in pathophysiological conditions such as hyper-
tension. 
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Alterations in sympathetic nervous system (SNS) activity have long been 
considered to contribute to the development and maintenance of primary 
hypertension. Postsynaptic ß-adrenergic receptors present on the vascular wall 
act as mediators between the SNS and the vascular smooth muscle cells: 
Stimulation of these receptors induces vasodilation A decreased function of the 
vascular ß-adrenergic receptors would help to explain the increased vascular 
peripheral resistance, generally found in hypertension. Therefore, the aim of the 
studies, described in this thesis, was to gam insight into the function and 
regulation of ß-adrenergic receptors in hypertension. Two distinct techniques 
have been applied. In part A of this thesis (Chapter 2-5), the ß2-adrenergic 
receptor complex, present on human mononuclear leucocytes (MNL), was used 
as a model system for the vascular ß2-adrenergic receptor system. In part В 
(Chapter 6-10), the vascular ß-adrenergic receptor system itself was studied in 
small arteries, obtained from rats and human omental fat biopsies, using the 
small vessel myograph technique. 
In Chapter 2 of this thesis, the density of ß2-adrenergic receptors on MNL 
and o2-adrenergic receptors on platelets was compared between relatively large 
groups of hypertensive (HT) and normotensive (NT) subjects. No significant 
differences in a2- and ß2-adrenergic receptor density were observed between 
these two groups The results were compared with the most relevant studies 
from the literature, in some of which significant increases in these parameters 
have been described. We conclude, however, that no significant alterations are 
present in blood cell adrenergic receptor characteristics in primary hypertension 
and that some of the differences, observed in the literature, may be due to small 
subject groups or methodological flaws. 
The functional characteristics of the MNL ß2-adrenergic receptor complex 
were investigated in Chapter 3 To this end, the inhibition of the radioligand 
binding by the ß-agonist isoprenaline and the production of the second messen-
ger cyclic adenosine monophosphate (cAMP) were compared using MNL 
membranes from HT and NT subjects. No difference in the fraction of high 
affinity agonist binding sites was observed between the two groups, but the 
dissociation constants for the agonist binding to the high and low affinity 
agonist binding sites were significantly higher in the HT group, pointing to a 
decreased affinity of the receptor for agonists. The cAMP production under 
baseline conditions and after stimulation with a high concentration of isoprena-
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line were similar between the two groups, but the direct stimulation of adenylyl 
cyclase with forskolm resulted in a significantly lower cAMP production in the 
HT subjects. The results suggest that no major alterations are present in the 
characteristics of the MNL ß2-adrenergic receptor complex of the HT subjects, 
but that the adenylyl cyclase activity may be decreased in this group. Moreover, 
sex-related differences were found for the adenylyl cyclase activity during 
stimulation with forskolm. 
The regulation of the density of ß2-adrenergic receptors, present on MNL, 
was studied in Chapters 4 and 5 In Chapter 4, the short-term regulation of 
MNL ß2-adrenergic receptors was studied in vitro by a 10 mm incubation of 
intact MNL with adrenaline and noradrenaline. This study was undertaken 
because in vivo studies of short term MNL ß2-adrenergic receptor regulation by 
physical exercise or agonist infusion are seriously hampered by a redistribution 
of MNL subsets In contrast to a physical exercise test, the incubation with 
catecholamines induced a concentration-dependent down-regulation of the ß2-
adrenergic receptors, although supraphysiological concentrations were needed 
to observe this effect The down-regulation was significantly higher in the HT 
females as compared to matched NT controls Moreover, a highly significant 
correlation between the decrease in ß2-adrenergic receptor density and mean 
arterial pressure was observed in all subjects (HT or NT) included in this study 
No significant alterations in the fraction of high affinity agonist binding sites or 
dissociation constants were found The results suggest that the ß2-adrenergic 
receptor complex of the HT subjects in this study is more susceptible to down-
regulation by catecholamines as compared to their NT counterparts 
In Chapter 5, the effect of a one week treatment with the ß-adrenergic 
receptor antagonists propranolol, pindolol and dilevalol and by the ß2-adrenergic 
receptor-selective agonist salbutamol have been studied in NT volunteers. The 
full antagonist propranolol did not induce a significant change in the ß2-adre-
nergic receptor density, whereas treatment with pindolol and dilevalol (antago-
nists with weak agonistic properties) caused a significant decrease. Salbutamol 
treatment also resulted in a decrease in the ß2-adrenergic receptor density, 
which was similar to the decrease resulting from pindolol and dilevalol treat-
ment. All three ß-adrenergic receptor antagonists induced an increase in the 
dissociation constant for the radioligand The latter finding may be useful in the 
elucidation of the working mechanism of ß-adrenergic receptor antagonists, 
which is still a matter of debate. 
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In part В of this thesis, studies with small arteries isolated from spontane­
ously hypertensive rats (SHR) and human omental fat biopsies are described. In 
Chapter 6, the ß-adrenergic receptor system on mesenteric resistance arteries 
from SHR and normotensive Wistar Kyoto (WKY) rats were compared. When 
precontracted with 40 mM K + , the relaxation with isoprenaline, expressed as a 
fraction of the precontraction, was decreased in SHR and the pD2 for isoprena-
line was significantly lower in this group. However, the maximal contraction 
with K+ was found to be significantly higher in the SHR. Therefore, differences 
in the K + -precontraction may help to explain the decreased ß-adrenergic 
receptor-mediated relaxation m SHR Moreover, when precontracted with the 
^-adrenergic receptor agonist phenylephrine, the maximal isoprenaline induced 
reJaxation was significantly higher than during K+ precontraction, and the 
difference between SHR and WKY in either the maximal relaxation with isopre-
naline or in its pD2 was not observed. We conclude that the ß-adrenergic 
receptor function in isolated mesenteric resistance arteries from SHR may be 
decreased, but that the kind of precontraction used plays an important role in 
the identification of this defect 
In Chapter 7, the release of endothelium derived relaxing factor (EDRF) was 
compared between mesenteric resistance arteries from SHR and WKY rats This 
was achieved by inhibiting the methacholme-induced EDRF release with NG-
monomethyl-L-argmine (L-NMMA). The methacholme-induced relaxation of a 
K + -precontraction was similar in the two groups under control conditions. L-
NMMA treatment resulted in a concentration-dependent increase in precontrac-
tion and a decrease in methacholine induced maximal relaxation and pD2 . The 
decrease in pD2 for methacholine during L-NMMA treatment was significantly 
higher in SHR as compared to WKY From these results, we conclude that under 
control conditions, the methacholme-induced relaxation is unaltered in SHR, but 
that L NMMA can induce a stronger rightward shift in the concentration 
response curve for methacholine in SHR. 
The ß-adrenergic receptor-mediated relaxation of human small arteries, 
isolated from omental fat biopsies, is described in Chapter 9. The fat biopsies 
were obtained from 22 patients undergoing laparotomy at the Department of 
Surgery In this preliminary study, 25 mM K+ induced contractions in all 
arteries However, in the group of subjects suffering from chronic intestinal 
inflammation, usually treated with corticosteroids, this contraction was signifi-
cantly lower than in the group which underwent surgery for other reasons. In 
about half of the arteries, isoprenaline induced a relaxation of the K + -precon-
traction Precontractions with phenylephrine were lower than K + -precontrac-
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tions in most of the arteries and often transient, but the isoprenalme-mediated 
relaxation during a phenylephrine precontraction was generally higher than after 
a K + -precontraction A positive correlation between the K + -mduced precontrac-
tion and mean arterial pressure was observed in subjects not suffering from 
intestinal inflammation A significant negative correlation was found between 
the pD2 for isoprenaline and mean arterial pressure in all subjects No correlation 
was found between maximal isoprenahne-mduced relaxation and blood pressure, 
which suggests that this parameter is of minor importance in the determination 
of blood pressure in the group of subjects under study. 
One of the mam outcomes of the studies with small arteries was that the 
kind of precontraction used has a major influence on the ß-adrenergic receptor 
mediated relaxation Because contractions of smooth muscle cells are thought 
to be the result of an increase in the intracellular Ca2 + , we studied the effects 
of the different contracting and relaxating agents on this parameter in smooth 
muscle cells in mesenteric resistance arteries from WKY This was achieved by 
loading the arterial smooth muscle cells with the Ca2 +-sensitive fluorescent dye 
Fura-2 In this preliminary study, 40 mM К f seemed to induce a stronger 
increase in the intracellular Ca2 ч -concentration than phenylephrine Isoprenaline 
slightly decreased the intracellular Ca 2 + -concentration, an effect which ap­
peared to be more pronounced after phenylephrine- than after К'''-precontrac­
tion On the other hand, forskolin and the cAMP analogue dibutyryl-cAMP did 
hardly decrease the intracellular Ca2 + -concentration These results suggest a 
complex relationship between force and intracellular Ca2"""-concentration, and 
therefore call for a simultaneous registration of these two parameters This 
would gain further insight in the mechanism(s) of contraction and relaxation, 
and allow the study of possible alterations therein in hypertension 
In conclusion, no major differences were observed in the baseline characte­
ristics of ß-adrenergic receptors present on MNL from primary HT subjects when 
compared to matched NT volunteers The lack of a clear relationship between 
the ß-adrenergic receptor characteristics and blood pressure under baseline 
conditions raises questions with respect to the use of this model system in 
hypertension research On the other hand, the correlation between blood 
pressure and the down-regulation of MNL ß2-adrenergic receptors by catechol-
amines needs further attention The production of the second messenger cAMP 
after stimulation with isoprenaline was unaltered in the HT subjects, but was 
lower in this group as well as in males after stimulation with forskolin. In 
mesenteric resistance arteries from SHR an attenuated ß-adrenergic receptor-
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mediated relaxation has been observed, although this was dependent on the 
kind of precontraction used. The ß-adrenergic receptors present on the en-
dothelium do not play a role in the ß-adrenergic receptor-mediated relaxation of 
these arteries. For further elucidation of the mechanism(s) of contraction and 
relaxation of mesenteric resistance arteries, the simultaneous registration of 
force and intracellular Ca2 + -concentration will be necessary. Human small 
arteries isolated from omentum biopsies were found to be a useful model to 
study the vascular ß-adrenergic receptor complex in vitro. However, a careful 
selection of the patients with respect to medication seems important. The 
relation between the affinity for isoprenaline of this receptor complex and blood 
pressure requires further attention. 
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Hoge bloeddruk, ofwel hypertensie, is een aandoening die voorkomt bij 
ongeveer 10 % van de volwassen bevolking Hoewel de aandoening op zichzelf 
vaak weinig aanleiding geeft tot klachten bestaat er wel een verhoogde kans op 
hart- en vaatziekten Slechts in ongeveer 10 % van de gevallen is een duidelijke 
lichamelijke oorzaak aan te wijzen voor de verhoogde bloeddruk Voorbeelden 
hiervan zijn een verstoorde nierfunktie of een tumor die de stress-hormonen 
adrenaline en/of noradrenaline aanmaakt, het zgn phaeochromocytoom. In de 
andere gevallen is geen onderliggende aandoening aanwijsbaar, en in die 
gevallen spreekt men van primaire of essentiële hypertensie 
In de afgelopen decennia is intensief onderzoek verricht naar de oorzaken 
van primaire hypertensie, maar tot op heden tast men nog in het duister naar de 
onderliggende afwijking(en) Eigenlijk is er maar één algemene en constante 
bevinding bij het onderzoek van personen met hoge bloeddruk, namelijk dat de 
weerstand die het bloed ondervindt in het perifere vaatbed is verhoogd Al in 
1949 is door Page de mozaiektheone gepresenteerd, die weergeeft dat diverse 
factoren aanleiding kunnen geven tot het optreden van primaire hypertensie. In 
deze mozaïek neemt het sympatisch zenuwstelsel een belangrijke plaats in 
Daarnaast is inmiddels duidelijk geworden dat er een verband kan bestaan 
tussen primaire hypertensie en het optreden van suikerziekte (met name type II 
diabetes) en stoornissen in het lipiden-metabolisme 
Het sympatisch zenuwstelsel, dat deel uitmaakt van het onwillekeurige 
(autonome) zenuwstelsel, is een van de regelsystemen die de diameter van 
bloedvaten kunnen besturen De uiteinden van deze zenuwen staan in contact 
met de bloedvatwand Voor de overdracht van signalen wordt gebruik gemaaki 
van overdrachts-stoffen die ook wel neurotransmitters worden genoemd. Deze 
neurotransmitters worden bij stimulatie van de zenuw door de zenuwuiteinder 
afgescheiden, en vervolgens gedetecteerd door receptoren Dit zijn eiwitstructu 
ren op de gladde spiercellen m de vaatwand die zich het best laten vergelijker 
met een soort antennes Wanneer die antennes een neurotransmitter-molecuu 
binden stimuleren ze een reeks van biochemische reacties in deze spiercellen, 
die uiteindelijk tot een verandering van de diameter van de vaatwand aanleiding 
geven 
Hoewel er in het lichaam tientallen verschillende receptorsystemen bestaan, 
wordt eén type receptoren in het bijzonder van belang geacht voor de werking 
van het sympatisch zenuwstelsel Dit zijn de zogenaamde adrenerge receptoren 
Deze adrenerge receptoren kunnen worden opgedeeld in twee hoofdgroepen, te 
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weten de a- en ß-adrenerge receptoren, die elk weer diverse subtypen kennen. 
In dit proefschrift is met name aandacht besteed aan de werking van de ß-
adrenerge receptoren. Als deze receptoren in een bloedvat worden gestimuleerd, 
treedt een verwijding van dat bloedvat op. Dit fenomeen wordt ook wel vasodi-
latatie genoemd Hiermee wordt ook inzichtelijk wat het verband tussen hyper-
tensie en ß-adrenerge receptoren zou kunnen zijn: Als deze receptoren niet goed 
zouden functioneren bij mensen met hoge bloeddruk is één van de vaatverwij-
dende mechanismen gestoord. Het netto resultaat hiervan is dat de bloedvaten 
vernauwd zijn, wat kan resulteren in de verhoogde weerstand die het bloed in 
het lichaam van hypertensieve personen ondervindt 
Een van de belemmeringen bij het onderzoek naar de functie van ß-adrenerge 
receptoren is dat om voor de hand liggende redenen niet zonder meer gebruik 
kan worden gemaakt van bloedvaten van proefpersonen. Daarom zijn de ß-
adrenerge receptoren die voorkomen op witte bloedcellen gebruikt als een 
modelsysteem. Door Brodde en medewerkers is beschreven dat de eigenschap-
pen van de receptoren op witte bloedcellen vergelijkbaar zijn met die in de 
vaatwand. Hierover gaat deel A van dit proefschrift (hoofdstuk 2-5). In hoofd-
stuk 2 zijn daarnaast ook nog de σ-adrenerge receptoren die voorkomen op 
bloedplaatjes bestudeerd 
Een alternatief voor de in deel A onderzochte bloedcellen is het gebruik van 
kleine bloedvaatjes, de zogenaamde weerstands-artenolen. In deel В van dit 
proefschrift (hoofdstuk 6-10) zijn de studies met deze weerstands-artenolen 
beschreven. Dergelijke artenolen kunnen worden geprepareerd uit vetweefsel-
biopten van mensen die een operatie moeten ondergaan. Ook kan gebruik 
worden gemaakt van artenolen uit een ratte-model voor hypertensie, de spon­
taan hypertensieve rat (SHR). In een speciaal hiervoor ontworpen orgaanbad 
kunnen de eigenschappen van deze weerstands-artenolen vervolgens worden 
onderzocht. Een bijkomend voordeel van deze techniek is dat gebruik wordt 
gemaakt van bloedvaatjes die een grote bijdrage aan de totale weerstand van 
het bloed leveren, uit hun naam wordt dit al duidelijk. Het is aannemelijk dat 
eventuele afwijkingen bij hypertensie zich juist in die bloedvaatjes manifesteren, 
en zo de totale weerstand die het bloed in het lichaam ondervindt verhogen. 
De karakteristieken van o2-adrenerge receptoren op bloedplaatjes en ß2-
adrenerge receptoren op witte bloedcellen zijn bestudeerd in hoofdstuk 2. Er 
werden geen significante verschillen gevonden in de a2- en ß2-adrenerge 
receptordichtheden bij 80 primair hypertensieve proefpersonen, vergeleken met 
67 normotensieve controle-personen. Tevens werd gezocht naar een verband 
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tussen klinische parameters, zoals bloeddruk, ï\la + -uitscheiding in de urine en 
lichaamsmassa. De a2- en ß2-adrenerge receptordichtheid bleek echter slechts 
voor een zeer gering deel te verklaren te zijn uit deze klinische parameters. Dit 
suggereert dat er geen duidelijk verband bestaat tussen de bloeddruk en deze 
receptor-dichtheden Daarom hebben we de functionaliteit van de ß2-adrenerge 
receptoren onderzocht in 20 primair hypertensieve en 20 normotensieve 
proefpersonen; de resultaten hiervan staan beschreven in hoofdstuk 3. Uit dit 
onderzoek bleek dat het bindingsgedrag van de ß-adrenerge agonist isoprenaline 
(een stof die ß-adrenerge receptoren kan activeren) aan ß2-adrenerge receptoren 
op witte bloedcellen niet was veranderd in de hypertensieve proefpersonen. Ook 
de stimulatie van de synthese van de second messenger cyclisch AMP door 
isoprenaline, in de bloedvaten een schakel tussen de ß2 adrenerge receptoren en 
de relaxatie van de gladde spiercellen, verschilde niet tussen de twee groepen. 
Wel werd een significante verlaging van de cyclisch AMP produktie gemeten als 
het adenylyl cyclase, het enzym dat de second messenger synthetiseert, werd 
gestimuleerd met forskoline. Bovendien bleek deze stof bij vrouwelijke proefper-
sonen de cyclisch AMP produktie sterker te stimuleren dan bij mannen. Uit deze 
twee onderzoeken kan worden geconcludeerd dat de karakteristieken van de ß2-
adrenerge receptoren op witte bloedcellen onder basale omstandigheden niet 
nadrukkelijk verschillend zijn tussen primair hypertensieve en normotensieve 
proefpersonen De verlaagde cyclisch AMP produktie tijdens forskolme-stimula-
tie zou een aanwijzing kunnen zijn voor een verlaagde vasodilatatie via dit 
systeem bij hypertensieven en bij mannen. 
De dichtheid van ß2-adrenerge receptoren op witte bloedcellen is niet 
statisch maar kan worden veranderd door ß-adrenerge agonisten en antagonis-
ten. In hoofdstuk 4 en 5 is deze regulatie bestudeerd. In hoofdstuk 4 is de korte 
termijn-regulatie onder invloed van adrenaline en noradrenaline vergeleken bij 
primair hypertensieve en normotensieve vrouwen. Het bleek dat tijdens een 10 
minuten durende incubatie met deze stoffen de ß2-adrenerge receptordichteid in 
witte bloedcellen van de hypertensieven sterker afnam in vergelijking met de 
normotensieven. Dit suggereert dat de ß2-adrenerge receptoren in het lichaam 
van hypertensieve personen sneller een down-regulatie ondergaan dan in dat 
van normotensieven, waardoor de vaatverwijding via dit systeem kan worden 
belemmerd. In hoofdstuk 5 is een studie beschreven waarin normotensieve 
proefpersonen gedurende een week dubbelblind zijn behandeld met de ß-
adrenerge antagonisten propranolol, pindolol en dilevalol en de agonist salbuta-
mol Het effect van deze behandelingen op de receptordichtheid kwam overeen 
met de literatuur, maar daarnaast werd tijdens de behandeling met de antagonis-
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ten een verlaging van de affiniteit van de ß2-adrenerge receptoren voor het 
gebruikte radioligand (een radioactief gelabelde ß-antagonist) waargenomen. 
Deze bevinding kan worden gebruikt om het farmacologische werkingsmecha-
nisme van ß-adrenerge antagonisten, dat nog steeds niet geheel is opgehelderd, 
beter te begrijpen 
In deel В van dit proefschrift zijn de studies met weerstands-artenolen 
opgenomen Hierbij werd gebruik gemaakt de 'small vessel myograph' techniek 
Dit is een orgaanbad dat speciaal is ontworpen voor het onderzoeken van 
artenen met een interne diameter van ± 1 0 0 tot ± 300 μπ\ In hoofdstuk 6 zijn 
de ß-adrenerge receptor-gemedieerde relaxaties van mesenteriale weerstands-
artenolen uit spontaan hypertensieve (SHR) en Wistar Kyoto (WKY) ratten 
vergeleken Deze relaxatie bleek verminderd in de artenolen van SHR wanneer 
de artenolen waren geprecontraheerd met kaliumchloride Tijdens precontractie 
met de a^-adrenerge agonist phenylephrine bleek de ß-adrenerge receptor-
gemedieerde relaxatie aanzienlijk groter in beide groepen, en was bovendien de 
verlaagde relaxatie in de artenolen van SHR niet meer aantoonbaar. Omdat 
kaliumchloride en phenylephrine via verschillende mechanismen een contractie 
induceren kan worden geconcludeerd dat de verminderde β adrenerge receptor-
gemedieerde relaxatie iets te maken kan hebben met een veranderde intracellu­
laire Ca2 + -huishouding in de SHR 
In de small vessel myograph kan ook de rol van het endotheel bij de regulatie 
van de vaattonus worden bestudeerd (hoofdstuk 7) Het endotheel kan namelijk 
relaxerende (EDRF, naast stikstofoxide mogelijk nog andere stoffen) en contra-
herende (EDCF) verbindingen afscheiden, een proces dat met o a. muscanne-
receptor-agonisten zoals methachohne kan worden gestimuleerd. De afgifte van 
EDRF bleek onveranderd te zijn in de SHR, en ook het remmende effect van N G -
monomethyl-L arginine, een specifieke remmer van de EDRF produktie, was niet 
verschillend bij de twee ratte-stammen Bij hogere methacholine-concentraties 
trad in SHR een transiente contractie op, die vermoedelijk door EDCF werd 
veroorzaakt Deze contracties waren volledig afwezig in WKY. Verschillen in 
endotheelfunctie tussen SHR en WKY lijken dus meer te maken te hebben met 
een verhoogde EDCF-afgifte dan met een verminderde EDRF-produktie. Omdat 
er ook ß-adrenerge receptoren kunnen worden aangetoond op het endotheel 
waren we benieuwd of er een verband zou bestaan tussen de ß-adrenerge 
receptor-gemedieerde relaxatie van weerstands-artenolen en EDRF-produktie De 
resultaten zijn beschreven in hoofdstuk 8 De EDRF-produktie werd geremd met 
NG-monomethyl-L-arginine waarna de isoprenaline-geinduceerde relaxatie werd 
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bestudeerd. Hoewel er een vermindering van de isoprenaline-gemduceerde 
relaxatie leek op te treden ti|dens remming van de EDRF-produktie bleek dit 
meer toe te schrijven aan een verhoogde precontractie dan aan een remming 
van de absolute ß-adrenerge receptor-gemedieerde relaxatie. 
In hoofdstuk 9 van dit proefschrift worden de ß-adrenerge receptor-gemedi-
eerde relaxatie van humane artenolen beschreven. Deze artenolen werden 
geïsoleerd uit omentum-biopten, verkregen tijdens buikoperaties. In ongeveer de 
helft van de artenolen werd een relaxatie met isoprenalme gevonden. Wat de 
oorzaak is van het uitblijven van een relaxatie in de andere gevallen is onbekend. 
Wel werden effecten van het onderliggende ziektebeeld aangetoond: patiënten 
die werden geopereerd wegens chronische ontstekingen van de ingewanden 
vertoonden een verminderde contractie van de arteriolen met kaliumchloride. Of 
dit het gevolg is van de aandoening zelf of de behandeling hiervan met cortico-
steroiden is niet bekend. Daarnaast werd een relatie gevonden tussen de 
affiniteit voor isoprenalme en de bloeddruk in alle patiënten met voldoende 
meetgegevens De effecten van de precontractie op de ß-adrenerge relaxatie, 
zoals gevonden in ratten, kon worden bevestigd in de humane artenolen. 
In hoofdstuk 10 zijn metingen van de intracellulaire Ca2 +-concentratie in 
weerstands artenolen van de rat weergegeven. In deze preliminaire studie is 
gebruik gemaakt van de Ca2 + -gevoelige kleurstof Fura-2 en een digital imaging 
techniek. Het bleek mogelijk te zijn om een toename van de Ca2 +-concentratie 
in gladde spiercellen waar te nemen als gevolg van toevoeging van kaliumchlori-
de; met phenylephrine was deze toename kleiner. Isoprenalme gaf slechts 
geringe verminderingen van deze verhoogde Ca2 +-concentratie. De resultaten 
bevestigen de waarnemingen in de small vessel myograph, dat de effecten van 
de precontractie op de ß-adrenerge receptor-gemedieerde relaxatie waarschijnlijk 
het gevolg zijn van verschillen in de Ca2 + -huishoudmg tijdens contractie met 
kaliumchloride en phenylephrine 
Uit het onderzoek kan worden geconcludeerd dat de dichtheid en de functio-
naliteit van ß2 adrenerge receptoren op witte bloedcellen onder basale omstan-
digheden onveranderd is bij primair hypertensieve proefpersonen vergeleken met 
normotensieve controle-personen Het gebrek aan een relatie tussen de ß-
adrenerge receptor-karakteristieken en bloeddruk roept vragen op met betrekking 
tot het gebruik van dit modelsystem in hypertensie-onderzoek. Wel lijken de 
receptoren gevoeliger voor down-regulatie onder invloed van catecholamines. 
Bovendien was het adenylyl cyclase minder sterk te stimuleren met forskoline m 
hypertensieven en in mannen in het algemeen. Deze waarnemingen behoeven 
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nadere studie. In mesenteriale weerstands-arteriolen uit de spontaan hyperten-
sieve rat kon, afhankelijk van de gebruikte precontractie, wel een verminderde 
β-adrenerge receptor-gemedièerde relaxatie worden aangetoond. De resultaten 
suggereren echter dat de verandering meer in de Ca2 + -huishouding moet 
worden gezocht dan in de IS-adrenerge receptoren zelf. De ß-adrenerge recepto-
ren op het endotheel dragen niet bij aan de relaxatie van mesenteriale weer-
stands-arteriolen via het endotheel. Ook humane artenolen, geïsoleerd uit 
Dmentum-biopten, zijn bruikbaar voor de studie van het ß-adrenerge receptor-
systeem. Wel moet rekening worden gehouden met effecten van de onderlig-
gende pathologie en/of medicatie. De relatie tussen bloeddruk en affiniteit voor 
soprenaline in deze vaatjes behoeft nadere aandacht. 
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manier bijgedragen, op het gevaar af mensen te vergeten wil ik er een aantal 
speciaal bedanken 
Als eerste wil ik mijn promotoren en co-promotoren bedanken voor hun 
bijdragen aan dit proefschrift De leden van de 'circulatie-groep' wil ik bedanken 
voor de collegiale sfeer, voor bloedprikken of -geven heb ik nooit tevergeefs een 
beroep op jullie gedaan De assistentie van Eugenie Olde Riekerink en Joeke 
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De schrijver van dit proefschrift werd op 27 mei 1963 geboren te Nijmegen. 
Na het behalen van het diploma Atheneum В aan de Nijmeegse Scholengemeen­
schap werd in 1981 begonnen met de studie Biologie aan de Katholieke Univer­
siteit Nijmegen. In september 1985 werd daar het kandidaatsexamen Biochemie 
(B4) behaald. De doctoraalexamens Biologie en Scheikunde (hoofdvakken 
Biochemie en Farmacochemie, bijvak Chemische Cytologie) werden respec­
tievelijk in juni en oktober 1988 afgelegd. 
Van 1 november 1988 tot 1 november 1992 was hij als Assistent in Oplei­
ding verbonden aan de afdeling Algemeen Interne Geneeskunde van de Kliniek 
voor Inwendige Ziekten van het St. Radboudziekenhuis te Nijmegen, waar onder 
begeleiding van Prof. Dr. Th. Thien het in dit proefschrift beschreven onderzoek 
werd uitgevoerd. Sinds 1 januari 1993 is hij als post-doctoraal medewerker 
verbonden aan de afdeling Farmacologie van de Rijksuniversiteit Limburg te 
Maastricht. 
183 

BIBLIOGRAPHY 

BIBLIOGRAPHY 
LIST OF PUBLICATIONS 
Theuvenet APR, Kessels BGF, Blankesteijn WM, Borst Pauwels GWFH: A 
comparative study on K + -loss from a Cadmium-sensitive and a Cadmium-
resistant strain of Saccaromices cerevisiae. FEMS Lett 1987, 43:147-153. 
Van Koppen CJ, Blankesteijn WM, Klaassen ABM, Rodrigues de Miranda JF, 
Beld AJ, van Ginneken CAM: Autoradiographic visualisation of muscarinic 
receptors in pulmonary nerves and ganglia. Neurosci Lett 1988, 83:237-240. 
Van Koppen CJ, Blankesteijn WM, Klaasen ABM, Rodrigues de Miranda JF, Beid 
AJ, van Ginneken CAM: Autoradiographic visualisation of muscarinic receptors 
in human bronchi. J Pharm Exp Ther 1988, 244:760-764 
Mulders JWM, Hendriks W, Blankesteijn WM, Bloemendal H, de Jong WW: 
Lambda crystallin, a major rabbit lens protein, is related to hydroxy-CoA-
hydrogenase. J Biol Chem 1988, 263:15462-15466. 
Blankesteijn WM, Graafsma SJ, Hectors MPC, Olde Riekerink EAM, Rodrigues 
de Miranda JF, Thien Th: Does treatment with beta-adrenergic blocking agents 
cause a decrease in beta2-adrenoceptor affinity7 Eur J Clin Pharmacol 1992, 
42:613-618. 
Blankesteijn WM, Siero HLM, Rodrigues de Miranda JF, van Megen YBM, Rüssel 
FGM: Characterization of muscarinic receptors in rat kidney. Eur J Pharmacol 
1993, 244:21-27. 
Blankesteijn WM, Thien Th: Effect of NG-monomethyl-L-arginine on the ß-
adrenoceptor-mediated relaxation of rat mesenteric resistance arteries. Life Sci 
1993, 52:PL135-PL139. 
Blankesteijn WM, Graafsma SJ, Van Tits LJH, Hectors MPC, Thien Th: 
Adrenoceptors on blood cells in patients with primary hypertension: Correlations 
with blood pressure and some related variables. J Hypertens, in press. 
Blankesteijn WM, Willems PHGM, Graafsma SJ, de Pont JJHHM, Thien Th: 
Forskolin stimulated adenylyl cyclase activity is decreased but ß 2 " a d r e n o c e P t ° r 
characteristics are unchanged in primary hypertension. J Cardiovasc Pharmacol, 
in press. 
187 
Blankesteijn WM, Thien Th: Beta-adrenergic receptor mediated relaxation of 
mesenteric resistance arteries of spontaneously hypertensive and Wistar-Kyoto 
rats: the role of precontraction. Submitted for publication. 
Blankesteijn WM, Thien Th: Endothelium-dependent relaxation and contraction 
of mesenteric resistance arteries from spontaneously hypertensive and Wistar-
Kyoto rats: effects of NG-monomethyl-L-arginine. Submitted for publication. 
ABSTRACTS 
Blankesteijn WM, Graafsma SJ, Hectors MPC, Olde Riekerink, Thien Th: 
Treatment with beta-blocking agents causes decrease in beta-adrenoceptor 
affinity. Pharm Weekbl (Sci Ed) 1ЭЭ0, 1 2 J 4 . 
Blankesteijn WM, Graafsma SJ, Willems PHGM, de Pont JJHHM, Rodrigues de 
Miranda JF, Thien Th: l i 2 "
a c
'
r e n o c e p t o r characteristics in essential hypertension. 
Pharm Weekbl (Sci Ed) 1991, 13:E4. 
Blankesteijn WM, Graafsma SJ, Willems PHGM, Rodrigues de Miranda JF, de 
Pont JJHHM, Thien Th: Beta2adrenoceptor function in essential hypertension. 
Acta Clin Belg 1991, 46:262. 
Blankesteijn WM, Graafsma SJ, Willems PHGM, Thien Th: Decreased forskolin 
mediated stimulation of adenylyl cyclase in primary hypertension. Circulation 
1 9 9 1 , 84(suppl ll):ll-480. 
Blankesteijn WM, Thien Th: Contraction and relaxation of mesenteric resistance 
arteries from SHR and WKY rats. J Vase Res 1992, 29:86. 
Blankesteijn WM, Thien Th: Contraction and relaxation of mesenteric resistance 
arteries from SHR and WKY rats. J Hypertens 1992, 10(suppl 4):S92. 
Blankesteijn WM, Thien Th: Effect of precontraction on isoprenaline-mediated 
relaxation of mesenteric resistance arteries from SHR and WKY rats. Pharmacol 
Toxicol 1993, 72(suppl ll):14. 
188 




STELLINGEN 
behorende bij het proefschrift: 
ß-adrenergic receptor function and regulation 
in hypertension 
Matthijs Blankesteijn 
Nijmegen, 21 september 1993 
1. De dichtheid van adrenerge receptoren op bloedcellen vertoont een 
marginale correlatie met de bloeddruk, en is daarom geen bruikbaar 
instrument binnen het hoge-bloeddrukonderzoek (dit proefschrift, hoofd-
stuk 2) 
2. De koppeling tussen ß2-adrenerge receptoren en Gs-eiwitten vertoont 
geen duidelijke afwijkingen in circulerende mononucléaire leucocyten van 
personen met primaire hypertensie (dit proefschrift, hoofdstuk 3) 
3. Behandeling met ß adrenerge antagonisten (de zgn β blokkers) induceert 
een verlaging van de affiniteit van ß2-adrenerge receptoren op mononu-
cléaire cellen voor dit type verbindingen, hetgeen mogelijk een deel van 
hun werkingsmechanisme kan verklaren (dit proefschrift, hoofdstuk 51 
4 Het optreden van een verminderde ß adrenerge receptor-gemedieerde 
relaxatie in mesenteriale weerstandsarteriolen van spontaan hypertensieve 
ratten is afhankelijk van het type precontractie waaraan deze vaatjes 
worden onderworpen (dit proefschrift, hoofdstuk 6) 
5 Hoewel ß-adrenerge receptoren zijn aangetoond in het endotheel van 
artenen, is de ß-adrenerge receptor-gemedieerde relaxatie van mesen-
teriale weerstandsarteriolen van de rat niet afhankelijk van de produktie 
van endothelium-derived relaxing factor (EDRF) (Gray DW, Marshall I: Br 
J Pharmacol 1991, 102 (suppl)125P; dit proefschrift, hoofdstuk 8) 
6 Voor het onderzoek naar de veranderingen in het ß-adrenerge receptor-
systeem op weerstands artenolen is een gelijktijdige registratie van de 
spanning in het vaatje en de intracellulaire calcium-concentratie in de 
gladde spiercellen van de vaatwand aan te bevelen (dit proefschrift, 
hoofdstuk 101 
7 Om verzekerd te zijn van voldoende toestroom van humaan onderzoeks-
materiaal is de kliniek de meest aangewezen werkplek voor diegene die 
onderzoek wil doen naar veranderingen in receptor karakteristieken bij 
primaire hypertensie Nauwe samenwerking met fundamentele weten-
schappers is echter onontbeerlijk voor het welslagen van een dergelijk 
onderzoek 
De stroom van nieuwe receptor-subtypen die de laatste jaren met recom-
binant-DNA technieken kon worden aangetoond, biedt nieuwe mogelijk-
heden aan de farmacologie voor het ontwikkelen van geneesmiddelen op 
maat met minder bijwerkingen. 
De sterke groei van het aantal Assistenten in Opleiding, zonder dat aan 
hen perspectief op een verdere wetenschappelijke carrière kan worden 
geboden, getuigt van weinig prospectief beleid. 
De waarneming van statistisch significante verschillen tussen relatief 
kleine onderzoekspopulaties geeft regelmatig aanleiding tot discrepanties 
in de literatuur. Dit -vaak retrospectieve- oneigenlijk gebruik van de 
statistiek is daarom verantwoordelijk voor een niet onaanzienlijk deel van 
de wetenschappelijke publikaties. 
De door diverse gezondheidscampagnes gepropageerde 'gezonde' levens-
wijze zal een toename van de gemiddelde levensverwachting tot gevolg 
hebben De hieraan verbonden (psycho)geriatnsche problematiek maakt 
het twijfelachtig of hier op de lange termijn van winst gesproken zal 
kunnen worden. 
Op de Nederlandse auto(snel)wegen zou het bestuurders van voertuigen 
met een toegestane maximumsnelheid van 80 km/h verboden moeten 
worden om gebruik te maken van de meest linkse rijstrook De hierdoor 
bewerkstelligde afname van het aantal obstructies zou de circulatie van 
het verkeer in dit land weer wat aezonder kunnen maken 



